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In this study, a broad spectrum fungicide (Dimethyl 4,4'-(o-phenylene)bis(3-thioalIophanate) 
commonly known as methyl thiophanate (MT) and an organophosphorus (OP) insecticide (0,0 
diethyl S-ethylthiomethyl phosphorodithioate) also known as phorate have been chosen to 
investigate their interactions, nature, extent and mechanism of damage to biological 
macromolecules. 
Methyl thiophanate (MT)-DNA interaction and induced genotoxicity 
• Interaction of MT with calf thymus DNA was studied by monitoring the changes in the intrinsic 
fluorescence of MT at varying molar ratios of MT-DNA. Addition of DNA in increasing 
concentrations to the fixed amount of MT progressively quenches its intrinsic fluorescence. At 
the highest MT-DNA molar ratio of 1:2 around 61% fluorescence quenching was observed. The 
binding affinity (Ka) and capacity («) of DNA for MT were determined to be 0.5 x 10^  Imol"' 
and 1.6, respectively. The intrinsic fluorescence of MT in combination with DNA alone and 
MT-DNA-Cu (II) decreased to the extent of 35.53 % and 40.61 %, respectively, suggesting the 
significant DNA-Cu (II) mediated MT fluorescence quenching as compared to DNA or Cu (II) 
alone. 
• The preferential binding of MT to DNA minor groove has been assessed by Distamycine A 
(DistaA), which selectively binds to the minor groove of DNA. A gradual decline in the 
fluorescence emission spectra of DNA-DistaA complex with increasing concentrations of MT 
clearly exhibited the replacement of MT with Dista A bound to minor groove of DNA. 
• The cyclic voltammogram of MT, as a ligand, exhibited a quasi-reversible redox peak with AEp 
value of 293 mV. Addition of DNA and DNA + Cu (II) to MT in solution changes the AEp 
values to 243 and 224 mV, respectively. The electrochemical data thus corroborate the strong 
binding of MT with DNA and the formation of a new complex in presence of transition metal 
ion. 
• MT-DNA binding was also studied by CD spectroscopy. MT was found to be optically active 
for CD and exhibited characteristic positive bands at 205, 207, 210, 211, 214 and 216, 
respectively. The equimolar addition of ct-DNA to MT has resulted in the disappearance of MT 
peaks at 214 and 216. The parental peaks of MT at 205, 207, 210 and 211 have red shifted by 
1.0, 6.0, 8.0 and 9.0 nm with broadening in all peaks. MT in presence and absence of DNA and 
Cu (II) exhibits prominent reduction in ellipticity. 
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• The complexation of MT with Cu (II) has been substantiated with stoichiometric data. The Jobs 
plot suggested the binding of 7 equivalents of Cu (II) to 1 equivalent of MT and reduction of Cu 
(II) to Cu (I). 
• The genotoxicity of MT has been assessed by DNA repair deficient E. coli K-12 strains. 
Exposure of bacterial strains with the increasing concentrations of MT resulted in dose 
dependent reduction in the colony forming ability of the DNA repair defective mutants vis-a-vis 
wild-type AB1157 cells. The decrease in percent survival of MT treated bacteria was 
determined to be in the order aspolPC > lexA~ > recA > uvrA mutants. The mutant {polA ) 
defective in polymerase I enzyme showed 82 % reduction in the survival at the highest dose of 
600 nM MT. 
• MT-induced mutagenesis has been studied employing alpha complementation lacZ 
mutagenicity assay. The data revealed significant mutagenicity of MT in concentration range of 
250-1000 \xM as evident from the reduction in the number of transformed blue colonies with 
concomitant increase in number of mutant white colonies on X-Gal and IPTG LB agar plates. 
• The quantitative assessment of DNA strand breaks has been ascertained with alkaline 
unwinding assay. Treatment of calf-thymus DNA with MT resulted in concentration dependent 
decrease in the fraction of duplex DNA. At the highest DNA nucleotide/MT molar ratio of 1:10 
in absence and presence of Cu (II), approximately 4.4 and 8.9 strand breaks per unit of DNA 
were produced. 
• The alkaline hydrolysis of MT-treated DNA exhibited progressive increase in the amount of 
acid-soluble nucleotides released upon exposure to 0.1 and 0.5 M NaOH. At the highest, DNA 
nucleotide/MT molar ratio of 1:10, the percent hydrolysis were estimated to be 45.6 % and 64.4 
% with 0.1 and 0.5 M NaOH, respectively. The transition metal ion Cu (II) in presence of MT 
resulted in significantly higher DNA hydrolysis. 
• MT-induced single strand breaks in human lymphocytes have been demonstrated using single 
cell gel electrophoresis (SCGE or comet assay) under alkaline conditions. The comet data 
revealed significant difference (p < 0.001) in the Olive tail moment (40.28 AU), tail DNA 
(44.39 %) and tail length (201.22 ^m) at 1000 ^M MT treatment vis-a-vis the values of Olive 
tail moment (3.29 AU), Tail DNA (8.52 %) and Tail length (45.23 )jm) in untreated control. 
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• Exposure of human lymphocytes to MT resulted in micronuclei (MN) formation as monitored 
by cytokinesis-blocked micronucleus (CBMN) assay. At treatment of cells with 50, 100 and 
200 i^ M MT, the mean binucleated micronucleated (BNMN) cells were determined to be 13.5, 
21, and 45, respectively. 
• The flow cytometric data analysis revealed adverse effect of MT on mitochondrial membrane 
potential (AWm). The reduction in A'Fm to the extent of 19.51% and 55% have been noticed 
with 50 and 100 |aM MT, respectively. 
• The fluorescence studies employing 2',7'-dichlorofluorescin diacetate (DCFH-DA), as 
fluorescence probe for detection of reactive oxygen species (ROS) demonstrated the MT-
induced intracellular generation of ROS. MT treated cells in concentration range of 100-500 i^ M 
exhibited 20.5 % to 33.4 % higher fluorescence intensity of DCF, respectively. 
• The MT-induced oxidative damage was assessed by measuring the level of 8-oxodG as a 
promutagenic oxidative lesion in DNA. P-postlabeling data revealed significantly higher 
levels of 5.29 ± 1.1 and 6.20 ± 0.01 8-oxodG adduct/10^ nucleotides (p<0.05) with MT 50 and 
o 
150 nM, respectively vis-a-vis 3.67 ± 0.9 adducts/10 nucleotides in untreated ct-DNA. 
• Based on the structure-activity relationship of MT-DNA in the absence and presence of Cu (II) 
ions, a theoretical model indicating possible interactions has been suggested. The proposed 
model suggests that the interaction can facilitates the release of methyl cations from MT. The 
methyl moieties could be preferentially trapped at the nucleophilic centers 0-6 and N-3 
positions of guanine, N-6 and N-3 of adenine and 0-2 of thiamine. The addition of methyl 
group to the nitrogenous base perturbs their aromatic character, causing hydrogen bond 
breakage and consequent GC to AT mispairing. Although, the MT-induced DNA methylation 
has not been experimentally proved in this study, but based on the earlier reports on DNA 
alkylation it is likely that the suggested alkylation at 0-6, N-3 positions of guanine and N-6 and 
N-3 of adenine and 0-2 of thiamine could be an additional factor promoting MT genotoxicity. 
MT-Human Serum Albumin interaction and induced protein damage 
• MT-HSA interaction was studied using a sensitive spectrofluorometeric technique. The 
fluorescence emission spectra of HSA alone and in presence of varying molar ratios (30:1) of 
MT-HSA was recorded in the in the range of 290-380 nm. The total percent quench determined 
with different molar ratios (2-30) of MT were 9.73%, 14.32%, 19.40%, 24.56%, 30.38%, 
XI 
34.95%, 39.12%, 44.3%, 47.34%, 50.39%, 54.75%, 56.36%, 58.79%, 61.49% and 64.42%, 
respectively. From the slope and intercept of the straight line obtained on the plot Q/[B] x 10' 
vs Q the binding constant {Ka) and binding capacity {n) of HSA towards MT were determined 
to be 4.5 X 10^ Imole"' and 26, respectively. 
• The electrochemical analysis of MT-HSA at equimolar concentration shows the decline in the 
cathodic peak current {ipc) of MT. This suggests the formation of non-electrochemical complex, 
which blocks the electron transfer between the quasi reversible peaks of MT and electrode and 
thus validated the MT-HSA interaction. 
• The site specificity of MT on HSA molecules was studied using bilirubin and diazepam as site I 
and site II markers, respectively. A maximum decrease in the fluorescence intensity of about 
83.09 % of HSA-MT complex upon addition of bilirubin confirmed the MT preferred binding 
site in the hydrophobic pockets at or near the site I within sub domain IIA of albumin molecule. 
• Effect of MT on the conformation of native structure of HSA has also been noticed by the 
synchronous fluorescence spectroscopy. The moderate red shift of emission maxima at A?i was 
60 nm further suggests that MT binds to the hydrophobic cavity of HSA and induces 
conformational change in HSA, as a consequence of increased polarity around the tryptophan. 
• The effect of MT at lower molar ratios (1:0.02 and 1:0.04) on the secondary structure of HSA 
has been ascertained with circular dichroism (CD) analysis. Interaction between MT and HSA 
distinctly reduces the band intensity at 209 and 222 nm in the far-UV region without any 
significant shift of the peaks. At 0.2 \xM. of MT the loss in protein helicity was determined to be 
8 % vis-a-vis 54.81 % a-helical content in native untreated HSA. This clearly indicates 
considerable changes in the protein secondary structure, in terms of reduction in the a-helical 
content of protein. 
• Treatment of HSA with higher doses of MT resulted in protein degradation. The SDS PAGE 
results clearly showed significant reduction in the intensity of HSA band due to fragmentation 
of HSA at higher MT concentrations. 
• The quantitative spectrophotometric assays demonstrated significant release of carbonyl and 
acid soluble amino groups from the MT treated HSA. The 2 h MT treatment to HSA at the 
varying concentrations of 200, 400, 600, 800 and 1000 i^M resulted in the release of 72.2, 
129.4, 222.4, 271.8 and 332.1 \xM of carbonyl groups. The absolute amount of acid soluble 
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amino groups released from MT (200-1000 \iM) treated HSA were determined to be 1.1, 3.0, 
4.1, 5.9 and 7.1 \iM. The data explicitly suggested substantial MT-induced structural alteration 
at lower dose and gross conformational change followed by significant degradation of proteinat 
higher MT concentrations. 
Phorate-DNA interaction and induced genotoxicity 
• Interaction of phorate with calf thymus DNA was studied by monitoring the changes in the 
intrinsic fluorescence of phorate at varying (0.05-1.0) DNA-phorate molar ratios. A progressive 
quenching in the intrinsic fluorescence of phorate has been recorded with the addition of DNA 
in increasing concentrations. At the highest DNA/phorate molar ratio, the percent quench of 
phorate fluorescence was determined to be 65 %. 
• The Scatchard data revealed the binding affinity {Ka) and the binding capacity {n) values of 
DNA for phorate as 0.48 x 10^  Imole"' and 0.9, respectively. The intrinsic fluorescence of 
phorate in combination with DNA alone and phorate-DNA-Cu (II) decreased to the extent of 
53.48 % and 57.52 %, respectively. 
• The electrochemical data showed a change in the AEp value to 327 mV. However, no change in 
the AEp was observed with the addition of equimolar concentration of Cu (II). The cathodic 
{ipc) and anodic {ipa) peak currents alone as well as their ratio (ipa/ipc) undergo a decrease 
upon electrostatic binding of phorate with DNA. 
• Based on CD analysis, phorate was found to be optically active, and exhibited characteristic 
positive bands at 201, 207, 210, 213 and 215 nm, respectively. At the highest phorate-DNA 
molar ratio of 1:5 the characteristic peaks of phorate at 201, 210 and 213 nm have almost 
disappeared with the addition of ct-DNA. At the same molar ratio, the parental peak of phorate 
at 215 rmi has blue shifted by 7 nm with the appearance of a peak at 214 nm suggesting a 
prominent reduction in the phorate ellipticity, due to structural alterations in phorate and 
formation of phorate-DNA binary complex. 
• The stoichiometric data obtained from the Job plot with bathocuproine, a Cu (I) specific 
chelating agent, suggested the binding of 5 equivalents of Cu (II) to 1 equivalent of phorate and 
its subsequent reduction to Cu (I). 
• Genotoxicity assessment of phorate with E. coli K-12 bacterial strains exhibited a concentration 
dependent decline in the percent survival of mutant strains. At the highest dose of 400 JJM 
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phorate the polymerase I deficient strain pol A" was found to be the most sensitive and showed 
88 % reduction in survival followed by 66 %, 54 % and 36 % survival oilex A", rec A" and uvr 
A" mutants, respectively. 
• Phorate- induced dose dependent mutagenesis has been demonstrated with the increase in the 
mutated white colonies of E. coli DH5a and simultaneous decrease in the blue colonies. 
Treatment of plasmid pUC19 DNA with varying concentrations of phorate (250, 500 and 1000 
I^ M) resulted in the loss of percent transformation efficiency of the plasmid in E. coli DH5a 
cells. 
• Phorate-induced strand breaks in the DNA were quantitated by alkaline unwinding assay using 
hydroxyapatite batch procedure. The total number of strand breaks (n) determined for phorate 
and phorate-Cu (II) complex were; 0.91, 1.5, 2.2, 2.8, 4.0 and 1.6, 2.8, 3.7, 4.6, 6.5, 
respectively. 
• The alkaline hydrolysis of phorate-treated DNA exhibited progressive increase in the amount of 
acid-soluble nucleotides. At the highest, DNA nucleotide/phorate molar ratio of 1:10, the 
percent hydrolysis were estimated to be 38.0 % and 47.8 % with 0.1 and 0.5 M NaOH, 
respectively. Higher DNA hydrolysis was observed with phorate treatment in presence of 
transition metal ion Cu (II). 
• The potential of phorate to induce DNA strand breaks in human lymphocytes has been 
examined by comet assay. Exposure of human lymphocytes with increasing concentrations of 
phorate (10-1000 |JM) for 3 h at 37 V has resulted in a dose dependent increase in the comet 
tail formation. At 1000 jiM phorate, DNA migration with an OTM value of 26.12 ± 1.97 was 
noticed as compared to the OTM of 3.25 ± 0.08 and 3.72 ± 0.09 with untreated and DMSO 
controls, respectively. 
• Phorate-induced chromosomal breaks in human lymphocytes have been examined by CBMN 
assay. The mean BNMN with 50, 100, and 200 |aM of phorate were determined to be 11, 16.5 
and 26.5, respectively. 
• Effect of phorate on mitochondrial membrane potential {A 'Fm ) has been investigated by flow 
cytometric analysis with mitochondrial specific dye Rhl23. The extent of reduction in A *Fm was 
measured as 71.18 %, 75.65 % and 81.77 % with 50, 100 and 200 i^M phorate, respectively. 
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• The fluorescence studies employing 2',7'-dichlorofluorescin diacetate (DCFH-DA), as 
fluorescence probe for detection of reactive oxygen species (ROS), demonstrated the phorate-
induced intracellular generation of ROS. Phorate treated cells in concentration range of 50-500 
|iM exhibited 17 % to 60.43 % higher fluorescence intensity of DCF. 
• Phorate-induced generation of oxidative DNA lesions (8-oxodG) has been confirmed by 
immunoassay using lesion specific antisera. The data revealed 2.3-fold higher 8-oxodG DNA 
adduct formation in the ct-DNA, upon phorate treatment. 
• The plausible mechanism of phorate-DNA interaction and consequent DNA damage has been 
elucidated. The proposed schemes explicitly suggested the possibility of ethyl group (^ CH2CH3) 
transfer to DNA nucleotides with the development of transient activated groups during the 
formation of stable phorate-Cu (11) complex. Most likely, at neutral pH, the ethyl cations as 
(electrophiles) attack on the most preferred nucleophiles N-3 and N-1 of guanine, N-4 and 0-2 
of cytosine, N-3 and N-6 of adenine and 0-2 of thiamine, respectively. The ethyl group transfer 
from phorate may perturbs the aromatic character of G and C resulting in loss of interaction and 
consequent GC—»AT, transition and may results in depurination. 
Phorate-Human Serum Albumin interaction and induced protein damage 
• Phorate interaction with human serum albumin (HSA) has been investigated by 
spectrofluorometeric technique. The fluorescence emission spectra of HSA alone and in 
presence of varying molar ratios (1:17) of HSA-phorate were recorded in the range of 290-380 
nm. Fluorescence intensities of protein decreased with increasing concentrations of phorate. 
• The binding isotherms exhibited a concentration dependent quenching of intrinsic fluorescence 
of protein. The total percent quench determined with different molar ratios (1-17) of phorate 
were 6.82 %, 12.0 %, 15.01 %, 20.53 %, 25.0 %, 28.37 %, 32.70 %, 36.97 %, 39.51 %, 42.07 
%, 44.71 %, 45.53 %, 47.05 % and 47.34 %, respectively. From the slope and intercept of the 
straight line obtained on the plot Q/fBJxlO'^ vs Q, the binding constant (Ka) and binding 
capacity (n) of HSA for phorate were determined to be 0.10 x 10^ Imole"' and 10, respectively. 
• The site specific binding of phorate on HSA molecule has been analyzed employing the site-I 
and 11 markers. With the addition of increasing concentration of site-1 marker, a gradual decline 
in the phorate-HSA fluorescence confirmed the binding of phorate to the hydrophobic pockets 
at or near the site I within sub domain IIA of HSA molecule. Furthermore, phorate-induced 
XV 
changes in the native conformation of HSA have been revealed by the synchronous fluorescence 
spectroscopy. The moderate red shift at AX, 60 nm suggested phorate binding to hydrophobic 
cavity of HSA. 
• Significant reductions in the MRE values of CD measurements corroborated alterations in 
protein conformation. At 0.2 [iM, the loss in protein helicity was determined to be 6.5 % with 
51.2 % a-helical content in treated protein vis-a-vis 54.81% a-helical content in native untreated 
HSA. 
• The SDS-polyacrylamide gel electrophoresis data clearly exhibited phorate-induced HSA 
fragmentation in the concentration range of 1-5 mM. No degradation has been noticed at 
concentration lower than 1 mM. Compared to the untreated HSA, a discernible reduction in the 
intensity of bands in lanes 5 to 7 were seen. The densitometric analysis revealed a significant 
loss in protein to the extent of 84.5 % at the highest concentration of 5 mM phorate. 
• The quantitative spectrophotometric assays demonstrated significant release of carbonyl and 
acid soluble amino groups from the phorate treated protein at low concentrations. At the highest 
concentration of 1000 |iM the absolute amount of carbonyl and acid soluble amino groups 
determined were 215 and 3.6 \xM. Most likely, protein fragmentation may occurred to the 
availability of free lone pair of electrons on the tryptophan and tyrosine residues, which may 
acts as a nucleophile to attack phorate, thus facilitating the releasing the methyl cation 
(*CH2CH3). The methyl cation then alkylates the aromatic residues, which results in the release 
of amino acids from the HSA. 
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The term pesticide refers to a group of natural and synthetic substances, which owing to 
special reactivity are particularly suited to protecting plants from harmful organisms. Most of the 
pesticides exert harmful effects on life beyond a threshold concentration of tolerance. An 
estimated 600 active pesticide ingredients are marketed in some 45,000 to 50,000 formulations, 
amounting to worldwide sales of over $ 20 billions. In spite of severe environmental pressures, 
the world market for pesticides has grown phenomenally. There is a boom in the global pesticide 
market and new insecticides, herbicides and fungicides and their formulations are being 
introduced with greater level of activity. Interestingly, in agricultural system, the quantity of 
herbicides used is much greater than that of insecticides and fungicides. Of the total 
agrochemicals in use, roughly 69 % are herbicides, 19 % insecticides and 12 % are fungicides. 
The use of pesticides resulted in increased availability, improved quality, and lower prices of 
large number of agricultural products. However the benefits of pesticides must be considered in 
the light of increasing concerns regarding environmental degradation, workers safety, and public 
health. 
In recent years, there has been increasing concern regarding the release of pesticides in the 
envirormient posing serious health risk to the exposed human population, particularly the 
agricultural workers. During pesticide applications, most exposure is via dermal absorption. 
Human adipose tissue and other non-target organisms have been found to be increasingly loaded 
with residues of pesticides and their related toxic metabolites. These residues are of concern, 
particularly when they are persistent and are able to bioaccumulate across the food chain and 
may cause pesticide poisoning. Exposure to peticides may exert both acute and chronic effects 
including acute and chronic neurotoxicity, lung damage, chemical bums and infant 
methamoglobinemia. Certain pesticides also cause damage to the hereditary material. Pesticide-
induced genetic damage has been reported to be significantly higher in exposed workers than in 
unexposed population. Studies have also shown that pesticides exhibit a high incidence of 
genotoxic insult manifested as chromosomal aberrations, sister chromatid exchanges, 
micronuclei formation, cell death and cell cycle delay. A variety of cancers have also been linked 
to the exposure to various pesticides, particularly hematopoietic cancers, non-Hodgkin's 
lymphoma, leukemia and multiple myeloma, soft tissue sarcoma. This study is based on the 
premise that binding of pesticides to biological macromolecules helps in its transport to the target 
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tissues and the pesticide-DNA and/or protein adduct formation could be an initiating event in the 
process of carcinogenesis. 
In this study, a fungicide methyl thiophanate (MT) and an insecticide phorate has been 
chosen for assessment of their genotoxic potential. So far, no concerted attempt has been made to 
understand the critical issues, such as - What is the nature and extent of interactions of 
electrophilic pesticides (MT and phorate) with DMA and protein molecules?. What type of 
structural alterations and oxidative lesions do the MT and phorate induces in these 
macromolecules ?. What is the mechanism of MT and phorate interactions with biological 
macromolecules?. In order to address these queries, this study was initiated with the aim to 
investigate the (i) binding affinity and capacity of DNA and human serum albumin (HSA) for 
MT and phorate, (ii) conformational alterations in macromolecules, (iii) extent of DNA damage, 
and (iv) role of oxygen free radicals in MT and phorate-induced DNA strand breaks. 
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In this study, a broad spectrum fungicide (Dimethyl 4,4'-(o-phenylene)bis(3-thioallophanate) 
commonly known as methyl thiophanate (MT) and an organophosphorus (OP) insecticide (0 ,0 
diethyl S-ethylthiomethyl phosphorodithioate) also known as phorate have been chosen to 
investigate their interactions, nature, extent and mechanism of damage to biological 
macromolecules. 
Methyl thiophanate (MT)-DNA interaction and induced genotoxicity 
• Interaction of MT with calf thymus DNA was studied by monitoring the changes in the intrinsic 
fluorescence of MT at varying molar ratios of MT-DNA. Addition of DNA in increasing 
concentrations to the fixed amount of MT progressively quenches its intrinsic fluorescence. At 
the highest MT-DNA molar ratio of 1:2 around 61% fluorescence quenching was observed. The 
binding affinity (Ka) and capacity («) of DNA for MT were determined to be 0.5 x 10 Imol' 
and 1.6, respectively. The intrinsic fluorescence of MT in combination with DNA alone and 
MT-DNA-Cu (II) decreased to the extent of 35.53 % and 40.61 %, respectively, suggesting the 
significant DNA-Cu (II) mediated MT fluorescence quenching as compared to DNA or Cu (II) 
alone. 
• The preferential binding of MT to DNA minor groove has been assessed by Distamycine A 
(DistaA), which selectively binds to the minor groove of DNA. A gradual decline in the 
fluorescence emission spectra of DNA-DistaA complex with increasing concentrations of MT 
clearly exhibited the replacement of MT with Dista A bound to minor groove of DNA. 
• The cyclic voltammogram of MT, as a ligand, exhibited a quasi-reversible redox peak with A£p 
value of 293 mV. Addition of DNA and DNA + Cu (II) to MT in solution changes the A£p 
values to 243 and 224 mV, respectively. The electrochemical data thus corroborate the strong 
binding of MT with DNA and the formation of a new complex in presence of transition metal 
ion. 
• MT-DNA binding was also studied by CD spectroscopy. MT was found to be optically active 
for CD and exhibited characteristic positive bands at 205, 207, 210, 211, 214 and 216, 
respectively. The equimolar addition of ct-DNA to MT has resulted in the disappearance of MT 
peaks at 214 and 216. The parental peaks of MT at 205, 207, 210 and 211 have red shifted by 
1.0, 6.0, 8.0 and 9.0 nm with broadening in all peaks. MT in presence and absence of DNA and 
Cu (II) exhibits prominent reduction in ellipticity. 
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The complexation of MT with Cu (II) has been substantiated with stoichiometric data. The Jobs 
plot suggested the binding of 7 equivalents of Cu (II) to 1 equivalent of MT and reduction of Cu 
(II) to Cu (I). 
The genotoxicity of MT has been assessed by DNA repair deficient E. coli K-12 strains. 
Exposure of bacterial strains with the increasing concentrations of MT resulted in dose 
dependent reduction in the colony forming ability of the DNA repair defective mutants vis-a-vis 
wild-type AB1157 cells. The decrease in percent survival of MT treated bacteria was 
determined to be in the order aspolA~ > lexA~ > recA~ > uvrA~ mutants. The mutant (polA~) 
defective in polymerase I enzyme showed 82 % reduction in the survival at the highest dose of 
600 i^M MT. 
MT-induced mutagenesis has been studied employing alpha complementation lacZ 
mutagenicity assay. The data revealed significant mutagenicity of MT in concentration range of 
250-1000 [iM as evident from the reduction in the number of transformed blue colonies with 
concomitant increase in number of mutant white colonies on X-Gal and IPTG LB agar plates. 
The quantitative assessment of DNA strand breaks has been ascertained with alkaline 
unwinding assay. Treatment of calf-thymus DNA with MT resulted in concentration dependent 
decrease in the fraction of duplex DNA. At the highest DNA nucleotide/MT molar ratio of 1:10 
in absence and presence of Cu (II), approximately 4.4 and 8.9 strand breaks per unit of DNA 
were produced. 
The alkaline hydrolysis of MT-treated DNA exhibited progressive increase in the amount of 
acid-soluble nucleotides released upon exposure to 0.1 and 0.5 M NaOH. At the highest, DNA 
nucleotide/MT molar ratio of 1:10, the percent hydrolysis were estimated to be 45.6 % and 64.4 
% with 0.1 and 0.5 M NaOH, respectively. The transition metal ion Cu (II) in presence of MT 
resulted in significantly higher DNA hydrolysis. 
MT-induced single strand breaks in human lymphocytes have been demonstrated using single 
cell gel electrophoresis (SCGE or comet assay) under alkaline conditions. The comet data 
revealed significant difference (p < 0.001) in the Olive tail moment (40.28 AU), tail DNA 
(44.39 %) and tail length (201.22 ^m) at 1000 i^ M MT treatment vis-a-vis the values of Olive 
tail moment (3.29 AU), Tail DNA (8.52 %) and Tail length (45.23 ^m) in untreated control. 
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• Exposure of human lymphocytes to MT resulted in micronuclei (MN) formation as monitored 
by cytokinesis-blocked micronucleus (CBMN) assay. At treatment of cells with 50, 100 and 
200 |iM MT, the mean binucleated micronucleated (BNMN) cells were determined to be 13.5, 
21, and 45, respectively. 
• The flow cytometric data analysis revealed adverse effect of MT on mitochondrial membrane 
potential {AWm). The reduction in A^m to the extent of 19.51% and 55% have been noticed 
with 50 and 100 nM MT, respectively. 
• The fluorescence studies employing 2',7'-dichlorofluorescin diacetate (DCFH-DA), as 
fluorescence probe for detection of reactive oxygen species (ROS) demonstrated the MT-
induced intracellular generation of ROS. MT treated cells in concentration range of 100-500 |a.M 
exhibited 20.5 % to 33.4 % higher fluorescence intensity of DCF, respectively. 
• The MT-induced oxidative damage was assessed by measuring the level of 8-oxodG as a 
promutagenic oxidative lesion in DNA. P-postlabeling data revealed significantly higher 
levels of 5.29 ± 1.1 and 6.20 ± 0.01 8-oxodG adduct/10^ nucleotides (p<0.05) with MT 50 and 
o 
150 |LIM, respectively vis-a-vis 3.67 ± 0.9 adducts/10 nucleotides in untreated ct-DNA. 
• Based on the structure-activity relationship of MT-DNA in the absence and presence of Cu (II) 
ions, a theoretical model indicating possible interactions has been suggested. The proposed 
model suggests that the interaction can facilitates the release of methyl cations from MT. The 
methyl moieties could be preferentially trapped at the nucleophilic centers 0-6 and N-3 
positions of guanine, N-6 and N-3 of adenine and 0-2 of thiamine. The addition of methyl 
group to the nitrogenous base perturbs their aromatic character, causing hydrogen bond 
breakage and consequent GC to AT mispairing. Although, the MT-induced DNA methylation 
has not been experimentally proved in this study, but based on the earlier reports on DNA 
alkylation it is likely that the suggested alkylation at 0-6, N-3 positions of guanine and N-6 and 
N-3 of adenine and 0-2 of thiamine could be an additional factor promoting MT genotoxicity. 
MT-Human Serum Albumin interaction and induced protein damage 
• MT-HSA interaction was studied using a sensitive spectrofluorometeric technique. The 
fluorescence emission spectra of HSA alone and in presence of varying molar ratios (30:1) of 
MT-HSA was recorded in the in the range of 290-380 nm. The total percent quench determined 
with different molar ratios (2-30) of MT were 9.73%, 14.32%, 19.40%, 24.56%, 30.38%, 
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34.95%, 39.12%, 44.3%, 47.34%, 50.39%, 54.75%, 56.36%, 58.79%, 61.49% and 64.42%, 
respectively. From the slope and intercept of the straight line obtained on the plot Q/[B] x 10'^ 
vs Q the binding constant {Ka) and binding capacity (ri) of HSA towards MT were determined 
to be 4.5 X 10^ Imole"' and 26, respectively. 
• The electrochemical analysis of MT-HSA at equimolar concentration shows the decline in the 
cathodic peak current {ipc) of MT. This suggests the formation of non-electrochemical complex, 
which blocks the electron transfer between the quasi reversible peaks of MT and electrode and 
thus validated the MT-HSA interaction. 
• The site specificity of MT on HSA molecules was studied using bilirubin and diazepam as site 1 
and site II markers, respectively. A maximum decrease in the fluorescence intensity of about 
83.09 % of HSA-MT complex upon addition of bilirubin confirmed the MT preferred binding 
site in the hydrophobic pockets at or near the site I within sub domain IIA of albumin molecule. 
• Effect of MT on the conformation of native structure of HSA has also been noticed by the 
synchronous fluorescence spectroscopy. The moderate red shift of emission maxima at AA, was 
60 nm further suggests that MT binds to the hydrophobic cavity of HSA and induces 
conformational change in HSA, as a consequence of increased polarity around the tryptophan. 
• The effect of MT at lower molar ratios (1:0.02 and 1:0.04) on the secondary structure of HSA 
has been ascertained with circular dichroism (CD) analysis. Interaction between MT and HSA 
distinctly reduces the band intensity at 209 and 222 nm in the far-UV region without any 
significant shift of the peaks. At 0.2 nM of MT the loss in protein helicity was determined to be 
8 % vis-a-vis 54.81 % a-helical content in native untreated HSA. This clearly indicates 
considerable changes in the protein secondary structure, in terms of reduction in the a-helical 
content of protein. 
• Treatment of HSA with higher doses of MT resulted in protein degradation. The SDS PAGE 
results clearly showed significant reduction in the intensity of HSA band due to fragmentation 
of HSA at higher MT concentrations. 
• The quantitative spectrophotometric assays demonstrated significant release of carbonyl and 
acid soluble amino groups from the MT treated HSA. The 2 h MT treatment to HSA at the 
varying concentrations of 200, 400, 600, 800 and 1000 \xM resulted in the release of 72.2, 
129.4, 222.4, 271.8 and 332.1 ^M of carbonyl groups. The absolute amount of acid soluble 
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amino groups released from MT (200-1000 |iM) treated HSA were determined to be 1.1, 3.0, 
4.1, 5.9 and 7.1 fiM. The data explicitly suggested substantial MT-induced structural alteration 
at lower dose and gross conformational change followed by significant degradation of proteinat 
higher MT concentrations. 
Phorate-DNA interaction and induced genotoxicity 
• Interaction of phorate with calf thymus DNA was studied by monitoring the changes in the 
intrinsic fluorescence of phorate at varying (0.05-1.0) DNA-phorate molar ratios. A progressive 
quenching in the intrinsic fluorescence of phorate has been recorded with the addition of DNA 
in increasing concentrations. At the highest DNA/phorate molar ratio, the percent quench of 
phorate fluorescence was determined to be 65 %. 
• The Scatchard data revealed the binding affinity {Ka) and the binding capacity («) values of 
DNA for phorate as 0.48 x 10^  Imole"' and 0.9, respectively. The intrinsic fluorescence of 
phorate in combination with DNA alone and phorate-DNA-Cu (II) decreased to the extent of 
53.48 % and 57.52 %, respectively. 
• The electrochemical data showed a change in the AEp value to 327 mV. However, no change in 
the AEp was observed with the addition of equimolar concentration of Cu (II). The cathodic 
{ipc) and anodic {ipa) peak currents alone as well as their ratio (ipa/ipc) undergo a decrease 
upon electrostatic binding of phorate with DNA. 
• Based on CD analysis, phorate was found to be optically active, and exhibited characteristic 
positive bands at 201, 207, 210, 213 and 215 nm, respecfively. At the highest phorate-DNA 
molar ratio of 1:5 the characteristic peaks of phorate at 201, 210 and 213 nm have almost 
disappeared with the addition of ct-DNA. At the same molar ratio, the parental peak of phorate 
at 215 nm has blue shifted by 7 nm with the appearance of a peak at 214 nm suggesting a 
prominent reduction in the phorate ellipticity, due to structural alterations in phorate and 
formation of phorate-DNA binary complex. 
• The stoichiometric data obtained from the Job plot with bathocuproine, a Cu (I) specific 
chelating agent, suggested the binding of 5 equivalents of Cu (II) to 1 equivalent of phorate and 
its subsequent reduction to Cu (I). 
• Genotoxicity assessment of phorate with E. coli K-12 bacterial strains exhibited a concentration 
dependent decline in the percent survival of mutant strains. At the highest dose of 400 ^M 
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phorate the polymerase I deficient strain pol A' was found to be the most sensitive and showed 
88 % reduction in survival followed by 66 %, 54 % and 36 % survival oilex A", rec A" and uvr 
A" mutants, respectively. 
• Phorate- induced dose dependent mutagenesis has been demonstrated with the increase in the 
mutated white colonies of E. coli DH5a and simultaneous decrease in the blue colonies. 
Treatment of plasmid pUC19 DNA with varying concentrations of phorate (250, 500 and 1000 
I^ M) resulted in the loss of percent transformation efficiency of the plasmid in E. coli DH5a 
cells. 
• Phorate-induced strand breaks in the DNA were quantitated by alkaline unwinding assay using 
hydroxyapatite batch procedure. The total number of strand breaks (n) determined for phorate 
and phorate-Cu (II) complex were; 0.91, 1.5, 2.2, 2.8, 4.0 and 1.6, 2.8, 3.7, 4.6, 6.5, 
respectively. 
• The alkaline hydrolysis of phorate-treated DNA exhibited progressive increase in the amount of 
acid-soluble nucleotides. At the highest, DNA nucleotide/phorate molar ratio of 1:10, the 
percent hydrolysis were estimated to be 38.0 % and 47.8 % with 0.1 and 0.5 M NaOH, 
respectively. Higher DNA hydrolysis was observed with phorate treatment in presence of 
transition metal ion Cu (II). 
• The potential of phorate to induce DNA strand breaks in human lymphocytes has been 
examined by comet assay. Exposure of human lymphocytes with increasing concentrations of 
phorate (10-1000 i^ M) for 3 h at 37 °C has resulted in a dose dependent increase in the comet 
tail formation. At 1000 ^M phorate, DNA migration with an OTM value of 26.12 ± 1.97 was 
noticed as compared to the OTM of 3.25 ± 0.08 and 3.72 ± 0.09 with untreated and DMSO 
controls, respectively. 
• Phorate-induced chromosomal breaks in human lymphocytes have been examined by CBMN 
assay. The mean BNMN with 50, 100, and 200 |aM of phorate were determined to be 11, 16.5 
and 26.5, respectively. 
• Effect of phorate on mitochondrial membrane potential {A ¥m ) has been investigated by flow 
cytometric analysis with mitochondrial specific dye Rhl23. The extent of reduction in A Wm was 
measured as 71.18 %, 75.65 % and 81.77 % with 50, 100 and 200 ^M phorate, respectively. 
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• The fluorescence studies employing 2',7'-dichlorofluorescin diacetate (DCFH-DA), as 
fluorescence probe for detection of reactive oxygen species (ROS), demonstrated the phorate-
induced intracellular generation of ROS. Phorate treated cells in concentration range of 50-500 
^M exhibited 17 % to 60.43 % higher fluorescence intensity of DCF. 
• Phorate-induced generation of oxidative DNA lesions (8-oxodG) has been confirmed by 
immunoassay using lesion specific antisera. The data revealed 2.3-fold higher 8-oxodG DNA 
adduct formation in the ct-DNA, upon phorate treatment. 
• The plausible mechanism of phorate-DNA interaction and consequent DNA damage has been 
elucidated. The proposed schemes explicitly suggested the possibility of ethyl group (^ CH2CH3) 
transfer to DNA nucleotides with the development of transient activated groups during the 
formation of stable phorate-Cu (II) complex. Most likely, at neutral pH, the ethyl cations as 
(electrophiles) attack on the most preferred nucleophiles N-3 and N-1 of guanine, N-4 and 0-2 
of cytosine, N-3 and N-6 of adenine and 0-2 of thiamine, respectively. The ethyl group transfer 
fi'om phorate may perturbs the aromatic character of G and C resulting in loss of interaction and 
consequent GC—>^ AT, transition and may results in depurination. 
Phorate-Human Serum Albumin interaction and induced protein damage 
• Phorate interaction with human serum albumin (HSA) has been investigated by 
spectrofluorometeric technique. The fluorescence emission spectra of HSA alone and in 
presence of varying molar ratios (1:17) of HSA-phorate were recorded in the range of 290-380 
nm. Fluorescence intensities of protein decreased with increasing concentrations of phorate. 
• The binding isotherms exhibited a concentration dependent quenching of intrinsic fluorescence 
of protein. The total percent quench determined with different molar ratios (1-17) of phorate 
were 6.82 %, 12.0 %, 15.01 %, 20.53 %, 25.0 %, 28.37 %, 32.70 %, 36.97 %, 39.51 %, 42.07 
%, 44.71 %, 45.53 %, 47.05 % and 47.34 %, respectively. From the slope and intercept of the 
straight line obtained on the plot Q/fBJxlO'^ vs Q, the binding constant (Ka) and binding 
capacity («) of HSA for phorate were determined to be 0.10 x 10^ Imole"' and 10, respectively. 
• The site specific binding of phorate on HSA molecule has been analyzed employing the site-I 
and II markers. With the addition of increasing concentration of site-I marker, a gradual decline 
in the phorate-HSA fluorescence confirmed the binding of phorate to the hydrophobic pockets 
at or near the site I within sub domain IIA of HSA molecule. Furthermore, phorate-induced 
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changes in the native conformation of HSA have been revealed by the synchronous fluorescence 
spectroscopy. The moderate red shift at AX 60 nm suggested phorate binding to hydrophobic 
cavity of HS A. 
• Significant reductions in the MRE values of CD measurements corroborated alterations in 
protein conformation. At 0.2 [iM, the loss in protein helicity was determined to be 6.5 % with 
51.2 % a-helical content in treated protein vis-a-vis 54.81% a-helical content in native untreated 
HSA. 
• The SDS-polyacrylamide gel electrophoresis data clearly exhibited phorate-induced HSA 
fragmentation in the concentration range of 1-5 mM. No degradation has been noticed at 
concentration lower than 1 mM. Compared to the untreated HSA, a discernible reduction in the 
intensity of bands in lanes 5 to 7 were seen. The densitometric analysis revealed a significant 
loss in protein to the extent of 84.5 % at the highest concentration of 5 mM phorate. 
• The quantitative spectrophotometric assays demonstrated significant release of carbonyl and 
acid soluble amino groups from the phorate treated protein at low concentrations. At the highest 
concentration of 1000 [iM the absolute amount of carbonyl and acid soluble amino groups 
determined were 215 and 3.6 ^M. Most likely, protein fragmentation may occurred to the 
availability of free lone pair of electrons on the tryptophan and tyrosine residues, which may 
acts as a nucleophile to attack phorate, thus facilitating the releasing the methyl cation 
(^CHiCHj). The methyl cation then alkylates the aromatic residues, which results in the release 
of amino acids from the HSA. 
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What is 'Pesticide'? 
The United States Environmental Protection Agency (USEPA) defines a pesticide as 
"any substance or mixture of substances intended for preventing, destroying, repelling, or 
mitigating any pest". Pests can be insects, mice and other animals, unwanted plants 
(weeds), fungi, or microorganisms like bacteria and viruses. 'Pesticide' is commonly 
used as a synonym for insecticide, a substance that targets insect pests. However, under 
the legal definition, the following are all pesticides: fungicides to kill molds and fungi, 
herbicides to kill weeds, rhodenticides to kill rodents, and antimicrobials for killing 
bacteria and viruses (http://v\fww.epa.gov/pesticides/about/types.htm.ed). 
Historical Perspective of Pesticide Utilization 
For better food supply humans have always competed with weeds, plant diseases, 
insects and other organisms. About 10,000 insects are classified as pests that destroy 
crops, livestock and transmit diseases. At least 600 species of plants are classified as 
weeds which inhibit proper supply of nutrients and water to agriculturally important 
crops. Some 1,500 different phytopathogenic fungi cause plant diseases. Using chemicals 
to control pests is not a new idea, only the types of chemicals used today are new. The 
first recorded use of inorganic chemicals to control insect pests comes from classical 
Greece where burning of sulphur has been used as a fumigant (Smith & Secoy, 1975; 
WHO/UNEP, 1990). The Chinese in 2,000 B.C. recommended the burning of 
"brimstone" (sulfur) to control pests. Ancient Greeks recommended gall from the green 
lizard to protect apples fi"om worms and rot. Ancient Romans killed insect pests by 
burning sulfur and controlled weeds with salt. In the year 1600, ants were controlled with 
mixtures of honey and arsenic. By the late nineteenth century, U.S farmers were using 
copper acetoarsenite (Paris green), calcium arsenate, nicotine sulfate, and sulfur to 
control insect pests in field crops, but results were unsatisfactory because of the primitive 
chemistry and application methods (http://ipm.ncsu.edu/safety/factsheets/why.pdf). 
Before the development of synthetic pesticides, farmers used naturally-occurring 
substances such as arsenic and pyrethrum, derived from chrysanthemum flowers, and 
soap (lARC/WHO, 1991). During the last 100 years pest control has been revolutionized. 
An emergence in pesticide use began after World War II with the introduction of DDT, 
BHC, aldrin, dieldrin, endrin, and 2,4-D. These new chemicals were inexpensive, 
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effective, and enoraiously popular. DDT was especially favored for its broad-spectrum 
activity against insect pests of agriculture and human health. 2,4-D was an inexpensive 
and effective way to control weeds in grass crops such as com. (DDT) was first 
synthesized in 1874, however, its action as an insecticide was not discovered until 1939. 
It was used during the war for protection of military areas and personnel. The availability 
of such an effective and cheap insecticide heralded an agricultural revolution reflected in 
the phenomenal growth in pesticide production. In 1944, total world DDT production was 
limited to 4366 tormes. Alone in US, DDT production has peaked at 81,154 tonnes in 
1963 (WHO, 1979). By the late 1960's, DDT was credited with the eradication of malaria 
from the United States and Italy (Attaran & Maharaj, 2000). The history of the use of 
pesticides in India can be traced to the import of DDT for malaria control which was 
followed by the use of BHC for locust control in 1948. 
Classification of Pesticides 
Pesticides have become an integral part of modern agricultural system. Today, there 
are many categories of chemical pesticides being used worldwide, of which five principal 
classes are shown in Table 1; 
Organochlorines 
Organocholorine is a broad term used to describe a number of insecticides that are 
essentially polychlorinated hydrocarbons. Zeidler (1873) synthesized a number of 
chlorinated hydrocarbon viz. dichloro-diphenyl-trichloro ethane (DDT), p-p'-DDT, 4,4 
DDT or l,l,l-trichloro-2,2-bis(p-chlorophenyl)-2,2,2-trichloroethane. The 
organochlorine acts by interfering with the permeability of sodium and potassium ion 
channels across nerve membrane. 
Organophosphates 
The term "organophosphates" (OP) is usually used to describe the derivatives of 
phosphoric acid and similar compound OP w ere discovered at the same time when 
organochlorines were discovered, owing to the higher toxicity the OP were not 
commercialized {http://www.pesticides.gov.uk/anticholinestrase/opdefination.htm). These 
compounds are widely used as insecticides and large quantities are used to control 
Table 1. The major groups of pesticides. 
Class of Chemical 
Pesticides 
Organochlorines 
Organophosphates 
Carbamates 
Phenoxy 
Examples 
DDT 
Aldrin 
Dieldrin 
Lindane 
Chlordane 
Heptachlor 
Hexachlorobenzene 
Pentachlorophenole 
Schradan 
Parathion 
Malathion 
Carbaryl; Methomyl 
Propoxur 
Aldicarb 
2,4-D 
2,4,5-T 
Types 
Insecticide 
Acaricide 
Fungicides 
Insecticide 
Acaricide 
Fungicides 
Insecticide 
Acaricide 
Herbicide 
Effects 
Persistent, 
bioaccumulative, affect the 
ability to reproduce, 
develop, and to withstand 
environmental stress by 
depressing the nervous, 
endocrine and immune 
systems 
Non-persistent, systemic 
(cholinesterase-inhibiting), 
not very selective, toxic to 
human 
Non-persistent, 
cholinesterase-inhibiting, 
not very selective, toxic to 
birds and fish 
Selective effects on 
humans and mammals are 
not well known 
2,4-D: potential to cause 
cancer in laboratory 
animals 
Pyrethroids Fenpropanthj-in; 
Deltamethrin; 
Cypermethrin 
2,4,5-T: is the source of a 
toxic contaminant dioxin 
Insecticide Target-specific: more 
selective than the 
organophosphates or 
carbamates, generally not 
acutely toxic to birds or 
mammals but particularly 
toxic to aquatic species 
Source: htt://www.parl.gc.ca/mfoCom/36/21/ENVI/Studies/Reports/envi01/10-ch3-f.html 
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agricultural pests and disease vectors. In fact, OP compounds are one of the most 
important and widely used classes of pesticides. They are used as insecticides and, to a 
lesser extent, as herbicides (Maroni et al., 2000). 
Carbamates 
Carbamates are another important class of insecticides. Carbamates generally have 
slightly lower acute toxicity than the OP and are readily degraded in the environment. 
Carbamates were originally extracted from colabar bean, which grows in West Africa. 
Phenoxyacetic acid 
Chlorinated aromatic compounds are major group of chemicals widely used as 
herbicides, mainly responsible-for environmental pollution. They are highly toxic and 
resistant to degradation and thus tend to accumulate in the environment. 
Pyrethroids 
Pyrethroid insecticides have their origins in the naturally occurring insecticides in 
pyrethrum extracts. The name "pyrethrins" is applied to the crude mixture of naturally 
occurring pyrethroids obtained from pyrethrum extracts. Pyrethrum extracts are obtained 
from the flowers of chrysanthemum species {Chrysanthemum cinerariaefolium). 
Global Consumption of Pesticides 
The use of pesticide has resulted in increased availability, improved quality and lower 
prices of a large number of agricultural products. About 890 active ingredients are 
registered as pesticides in US and marketed in 20,700 pesticide products (USEPA, 
1996a). As per the USEPA 2000-2001 estimates report, the world pesticide consumption 
exceeded 5.0 billion pounds. Herbicides accounted for the largest portion of total use, 
followed by other pesticides viz. insecticides, fungicides and others (Figure 1). 
Consumption of Pesticides in India 
The indigenous production of pesticides in India began in 1952 with the annual 
production capacity of 5460 metric tons (MT). The bulk production of pesticides (DDT 
and BHC) has started with the establishment of manufacturing units near Calcutta in 
1958. By 1977,42 different pesticides were being manufactured in the country and the 
24 
What is 'Pesticide'? 
The United States Environmental Protection Agency (USEPA) defines a pesticide as 
"any substance or mixture of substances intended for preventing, destroying, repelling, or 
mitigating any pest". Pests can be insects, mice and other animals,! unv^anted plants 
(weeds), fungi, or microorganisms like bacteria and viruses. 'Pesticide' is commonly 
used as a synonym for insecticide, a substance that targets insect pests. However, under 
the legal definition, the following are all pesticides: fungicides to killj molds and fungi, 
herbicides to kill weeds, rhodenticides to kill rodents, and antimicrobials for killing 
bacteria and viruses (http://www.epa.gov/pesticides/about/types.htm.ed). 
i 
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Historical Perspective of Pesticide Utilization 
For better food supply humans have always competed with weeds, plant diseases, 
insects and other organisms. About 10,000 insects are classified as Ipests that destroy 
crops, livestock and transmit diseases. At least 600 species of plants are classified as 
weeds which inhibit proper supply of nutrients and water to agriculturally important 
crops. Some 1,500 different phytopathogenic fungi cause plant diseases. Using chemicals 
to control pests is not a new idea, only the types of chemicals used today are new. The 
first recorded use of inorganic chemicals to control insect pests comes from classical 
Greece where burning of sulphur has been used as a flimigant (Smith & Secoy, 1975; 
WHO/UNEP, 1990). The Chinese in 2,000 B.C. recommended the burning of 
I 
"brimstone" (sulfur) to control pests. Ancient Greeks recommended gall from the green 
lizard to protect apples from worms and rot. Ancient Romans killed insect pests by 
burning sulfiir and controlled weeds with salt. In the year 1600, ants were controlled with 
mixtures of honey and arsenic. By the late nineteenth century, U.S farmers were using 
copper acetoarsenite (Paris green), calcium arsenate, nicotine sulfate, and sulfur to 
control insect pests in field crops, but results were unsatisfactory because of the primitive 
I 
chemistry and application methods (http://ipm.ncsu.edu/safety/factsheets/why.pdf). 
Before the development of synthetic pesticides, farmers used naturally-occurring 
substances such as arsenic and pyrethrum, derived from chrysanthemum flowers, and 
soap (lARC/WHO, 1991). During the last 100 years pest control has bben revolutionized. 
An emergence in pesticide use began after World War II with the introduction of DDT, 
BHC, aldrin, dieldrin, endrin, and 2,4-D. These new chemicals ;were inexpensive. 
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effective, and enormously popular. DDT was especially favored for its broad-spectrum 
activity against insect pests of agriculture and human health. 2,4-D ^yas an inexpensive 
and effective way to control weeds in grass crops such as corn.l (DDT) was first 
synthesized in 1874, however, its action as an insecticide was not discovered until 1939. 
It was used during the war for protection of military areas and persoimel. The availability 
of such an effective and cheap insecticide heralded an agricultural revolution reflected in 
the phenomenal grovrth in pesticide production. In 1944, total world DDT production was 
limited to 4366 tonnes. Alone in US, DDT production has peaked a!t 81,154 tonnes in 
1963 (WHO, 1979). By the late 1960's, DDT was credited with the eradication of malaria 
from the United States and Italy (Attaran & Maharaj, 2000). The history of the use of 
pesticides in India can be traced to the import of DDT for malaria control which was 
followed by the use of BHC for locust control in 1948. 
Classification of Pesticides 
Pesticides have become an integral part of modern agricultural system. Today, there 
are many categories of chemical pesticides being used worldwide, of which five principal 
classes are shown in Table 1; 
Organochlorines 
Organocholorine is a broad term used to describe a number of insecticides that are 
essentially polychlorinated hydrocarbons. Zeidler (1873) synthesized a number of 
chlorinated hydrocarbon viz. dichloro-diphenyl-trichloro ethane (DDJ), p-p'-DDT, 4,4 
DDT or l,l,l-trichloro-2,2-bis(p-chlorophenyl)-2,2,2-trichloroethane. The 
organochlorine acts by interfering with the permeability of sodium and potassium ion 
channels across nerve membrane. 
Organophosphates 
The term "organophosphates" (OP) is usually used to describe the derivatives of 
phosphoric acid and similar compound OP were discovered at the same time when 
organochlorines were discovered, owing to the higher toxicity the OP were not 
I 
commercialized (http://www.pesticides.gov. uk/anticholinestrase/opdefination. htm). These 
compounds are widely used as insecticides and large quantities are used to control 
Table 1. The major groups of pesticides. 
Class of Chemical 
Pesticides Examples Types Effects 
Organochlorines 
Organophosphates 
Carbamates 
Phenoxy 
DDT 
Aldrin 
Dieldrin 
Lindane 
Chlordane 
Heptachlor 
Hexachlorobenzene 
Pentachlorophenole 
Schradan 
Parathion 
Malathion 
Carbaryi; Methomyl 
Propoxur 
Aldicarb 
2,4-D 
2,4,5-T 
Insecticide 
Acaricide 
Fungicides 
Insecticide 
Acaricide 
Fungicides 
Insecticide 
Acaricide 
Herbicide 
Persistent, 
bioaccumulative, affect the 
ability to reproduce, 
develop, and to withstand 
environmental stress by 
depressing the nervous, 
endocrine and immune 
systems 
t 
Non-persistent, systemic 
(cholinesterase-inhibiting), 
not [very selective, toxic to 
human 
I 
I 
Non-persistent, 
cholinesterase-inhibiting, 
not] very selective, toxic to 
birds and fish 
I 
Selective effects on 
hunians and mammals are 
not well known 
2,4--D: potential to cause 
cancer in laboratory 
animals 
Pyrethroids Fenpropanthrin; 
Deltamethrin; 
Cypermethrin 
2,4!,5-T: is the source of a 
toxic contaminant dioxin 
Insecticide Target-specific: more 
selective than the 
organophosphates or 
carbamates, generally not 
acutely toxic to birds or 
mammals but particularly 
toxic to aquatic species 
Source: htt://www.parl. gc. ca/infoCom/3 6/21/ENVI/Studies/Reports/enviOl/l 0-ch2-f.html 
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agricultural pests and disease vectors. In fact, OP compounds are one of the most 
important and widely used classes of pesticides. They are used as insecticides and, to a 
lesser extent, as herbicides (Maroni et al., 2000). 
Carbamates 
Carbamates are another important class of insecticides. Carbamates generally have 
slightly lower acute toxicity than the OP and are readily degraded in the environment. 
Carbamates were originally extracted from colabar bean, which grows in West Africa. 
1 
Phenoxyacetic acid 
Chlorinated aromatic compoimds are major group of chemicals widely used as 
herbicides, mainly responsible for envirormiental pollution. They are highly toxic and 
resistant to degradation and thus tend to accumulate in the envirormient. 
i 
Pyrethroids 
Pyrethroid insecticides have their origins in the naturally occurring insecticides in 
j 
pyrethrum extracts. The name "pyrethrins" is applied to the crude mixture of naturally 
occurring pyrethroids obtained from pyrethrum extracts. Pyrethrum extracts are obtained 
from the flowers of chrysanthemum species {Chrysanthemum cinerariaefolium). 
i 
Global Consumption of Pesticides j 
The use of pesticide has resulted in increased availability, improved quality and lower 
prices of a large number of agricultural products. About 890 active ingredients are 
registered as pesticides in US and marketed in 20,700 pesticide products (USEPA, 
i 
1996a). As per the USEPA 2000-2001 estimates report, the world pesticide consumption 
exceeded 5.0 billion pounds. Herbicides accounted for the largest portion of total use, 
followed by other pesticides viz. insecticides, fungicides and others (Figure 1). 
Consumption of Pesticides in India 
The indigenous production of pesticides in India began in 1952 with the annual 
production capacity of 5460 metric tons (MT). The bulk production of pesticides (DDT 
and BHC) has started with the establishment of manufacturing unit's near Calcutta in 
1958. By 1977, 42 different pesticides were being manufactured in the pountry and the 
others, 1469 
Fungicides, 475 Herbicides, 1870 
Insecticides, 1232 
Figure 1. Global utilization of pesticide active ingredients (Million lbs a.i). 
Adopted from: EPA report (http://www.epa.gov/oppbeadl/pestsales .ed) 
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annual production capacity increased to 40658 MT. The annual rate of increase in 
pesticide production between 1966 and 1977 was around 9.9 %, which was 
comparatively much higher than the average annual growth rate of agriculture or 
industries ranged between 3 to 5 %. The production of pesticides during 1978 was 44,000 
MT of which BHC and DDT alone accounted for 76.4 %. Figure 2 (A) show the year 
wise production of pesticides in India. Interestingly, India is now the largest manufacturer 
of basic pesticides among the South Asian and African countries with a total installed 
capacity of over 128,900 MT (Thirty Seventh Report of Standing Committee on 
Petroleum and Chemicals, 2002; Mathur, 1999). Since then, there has been a steady 
growth in the production of technical grade pesticides in India, ranging from 84154 in 
1997-1998 to 92352 (MT Tech. Grade) in 2000-2001. The consumption pattem of 
pesticides in India is only 0.5 kg/ha, which is comparatively much lower than countries 
like Korea and Japan where the pesticide consumption is 6.6 and 12.0 kg/ha, respectively. 
In total, 25 % of the pesticides are alone used in cultivated area. Among the frequently 
used pesticides in cultivated lands are HCH (gamma-HCH), DDT and malathion. 
Malathion alone accounts for 70 % of the total pesticides consumption. 
Small farmers selectively prefer these pesticides because they are cost effective, easily 
available, and display a wide spectrum of bioactivity. Figure 2 (B) show the overall 
consumption pattern of pesticides in India. The data indicated that, 80 % are in the form 
of insecticides, 15 % are herbicides, 1.46 % are fungicides and less than 3 % are others 
(Gupta, 2004). The Indian pesticide industry with 82000 MT of production for 2005-06 is 
ranked second in Asia (behind China) and twelfth globally. In value terms, the size of the 
Indian pesticide industry was estimated at Rs. 68 billion for 2006, including exports of 
Rs. 28 billion (www.careratings.com/current/3/2178). Currently, the consumption of 
pesticides is showing a slight declining trend, probably due to shift of farmers toward 
biopesticides, natural plant sources and other ahernative methods (Gupta, 2003). 
The benefits of pesticides in agriculture have raised its consumption, however, little 
attention is given towards the pesticide associated health hazards. In India many 
hazardous pesticides are still used frequently which are already banned in many 
developed countries. The justification from the Ministry of Agriculture, India, for the use 
of banned pesticides are; (i) non-availability of safer/cheaper substitutes, (ii) to deal with 
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specific pest and disease situation, (iii) more rapid degradation and less persistence of the 
banned pesticides in Indian environmental conditions as compared to countries in 
temperate zone, and (iv) registration of pesticides for use in safer formulations. However, 
in no way the safety should be compromised at the cost of cheaper substitutes. Therefore, 
the Thirty Seventh Report of Standing Committee on Petroleum and Chemicals (2002) 
suggested that the Indian Government should undertake a scientific study in respect of 
each pesticide which is banned or restricted in other countries and discard/ban all such 
chemicals which have deleterious effect on human health. Table 2 enlists the pesticides 
banned in India and the pesticide produced in Council for Scientific and Industrial 
Research (CSIR) laboratories as safe and cheaper alternatives. Besides, the Department 
of Biotechnology (DBT) and the Indian Council of Agricultural Research (ICAR) as well 
as a number of Agriculture Universities and Research Institutions have programs for the 
development of eco-friendly pesticides. 
Routes of Pesticide Exposure 
When mixing, loading, or applying pesticides, applicators and/or humans can be 
exposed by oral, dermal (including eyes) or respiratory routes. Oral exposure occurs 
when the mouth is open and pesticide enters the mouth and is swallowed. Spray droplets, 
mists, splashes, and ruptured hoses are examples of how this can happen. Between the 
dermal and respiratory routes of exposure, the more significant is the dermal route of 
exposure for pesticide applicators (Deer, 2003). Figure 3 shows the Indian farmers 
spraying pesticides in the agricultural fields without taking any preventive measures and 
the relative absorption of pesticide through various parts of the body after pesticide 
. exposure. 
Pesticide Poisonings in Humans 
The ability of pesticides to disperse in the enviroimient, recalcitrant nature, and 
propensity for uptake into crops and residues in livestock meat and milk, pesticides and 
their components represent a significant risk in terms of air, water, soil and food 
contamination (Torres et al, 1996; Salas et al, 2003; Pagliuca et al, 2006). Humans are 
inevitably exposed to pesticides either through environmental contamination, or 
occupational exposure during pesticide formulation, manufacture and application 
Table 2. List of pesticides which have been banned/restricted in some countries of the world 
but are still being used in India. List of pesticides manufactured by the Council of Scientific 
and Industrial Research. 
Pesticides Banned in India Pesticides Manufactured by CSIR 
Alachlor, *Alumimum Phosphide, Benomyl, 
Captan, Crbaryl, Carbofiiron, **CarbosuIfan, 
Dicofol, *DDT, Dimethoate, Diuron, 
Endosulfan, Fenarimol, **Fenpropathrin, 
* Lindane, **Linuron, Malathion, Methomyl, 
*Methoxy Ethyl Mercury Chloride, * Methyl 
Parathion, Monocrotophos, Oxyfluorfen, 
Paraquat dichloride, *Phorate, Phosphamidon, 
Pretilachlor, * Sodium Cyanide, Triazophos, 
Tridemorph, Thiomethon, *Thiram, Zinc 
Phosphide, 
Ziram 
Durofume Formulation, Minifume Tablets, 
Azadirachtin (Tech)' extraction from neem 
seed, Butachlor, Chlorpyriphos, Citicide, 
DDVP Technical & Formulation, Diazinon, 
Esfenvalerate (Chiral Pyrethroid, Diptrex, 
Glyphosate, MBC Carbendazim, 
Methoxychlor, Monocrotophos (Tech), 
Sulphur Wettable, Tetradifon, Atrazine, 
Carbonxin, Dalapon, Dimethoate, Endosulfan, 
Ethephon, Nicotine Sulphate, Nitrogen, 
Phenthoate, Quinalphos & Disulfoton, 
Simazine, Tetradifon, Methyl Thiophanate, 
Warfarin, Chlorofenvinphos, Phosphamidon, 
Pheromones for Groundnut, rice, teak and 
banana pests as part of IPM, Quinalphos 
* Pesticides reviewed and restricted for use in India, ** Pesticides not reviewed so far. 
KB. All other pesticides have been reviewed by one or other Expert Committees. 
Source: Thirty Seventh Report of Standing Committee on Petroleum and Chemicals, 2002 
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Figure 3. Indian farmers spraying pesticides in agricultural fields without any 
protective means and the relative absorption rates of different organs upon pesticide 
exposure. 
Picture Source: http://www.gov.be.ca/agf 
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processes (Hodgson et al, 1991; Bolognesi, 2003). A possibility exists that components 
with no direct pesticidal activity, in the pesticide formulation, may have a higher degree 
of toxicity than the active ingredient itself (Osano et al., 2002). Pesticide formulations are 
produced to target a specific group of pests, although absolute specificity is difficult to 
achieve and human exposure to these formulations will be likely to have toxic contra-
indications. Human intake of trace amounts of pesticide and their components is a 
growing health concern (Stewart et al., 1999). In the developing world, self-poisoning by 
pesticides is common. Each year, nearly 3 million cases of self-poisoning are reported 
worldwide, of which 2,20,000 cases are fatal (Bolognesi, 2003). In South Africa, 33 % of 
all reported self-poisoning cases are due to agrochemicals (Stewart et al., 1999). Certain 
pesticides, such as the group of OP which include methidathion and dichlorvos, are 
structurally and functionally similar to nerve agents used in biological warfare. These 
pesticides are neurotoxic even in trace amounts. In addition, many pesticides and/or their 
components are potentially carcinogenic (Campbell & Needham, 1984; Abu-Basha et al., 
1999), teratogenic (Evans & Gee, 1980), genotoxic (Hugnet et ah, 1996; Kennel et al, 
1996), hepatotoxic (Hsu 8c Kakuk, 1984; Jorens et al, 1997), neurotoxic (Ralide, 1992) 
or a combination of these (Zahm et al, 1997; Rojas et al, 2000). 
It is reported that most pesticide related deaths involve acute poisonings rather than 
chronic exposure (WHO/UNEP, 1990). Between 1991 and 1996 California EPA reported 
3,991 cases of occupational poisoning by agricultural pesticides (Reeves et al, 1999). In 
1997, 88,255 pesticide exposure emergencies were reported to the national network of 
Poison Control Centers (Litovitze^ a/., 1998). Fourteen fatalities were attributed to 
pesticide poisoning during the same period. It is widely thought that many agricultural 
poisoning cases go unreported. Many barriers to accurate reporting include lack of access 
to medical care and fear of reprisal and job loss (Reeves et al, 1999). 
Pesticide Poisonings in India 
In India, the first report of pesticide poisoning was from Kerala in 1958, where over 
100 people died after consuming wheat flour contaminated with parathion (Kamnakaran, 
1958). The poisoning has occurred by pesticide ethyl parathion commonly known as 
Folidol E 605. In the same year, careless handling and storage of wheat causes deaths of 
102 people in Kerala. Subsequently, several cases of human and animal poisonings, 
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besides deaths of birds and fishes, have been reported (Sethuraman, 1977). Malathion 
(diazole) causes 35 cases of poisoning occurred in Indore during 1967-1968 (Sethuraman, 
1977). In another report from Madhya Pradesh, 12 persons consumed wheat 
contaminated with aldrin dust and gammexane for 6-12 months and developed the 
symptoms of poisoning, which consisted of myoclonic jerks, generalized clonic 
convulsions and weakness in the extremities. In an outbreak in 1977, eight cases of grand 
mal seizers were reported from a village of Uttar Pradesh following accidental ingestion 
of HCH-contaminated wheat (Nag et al., 1977). In 1978, in Bhopal six persons died due 
to exposure to phosgene gas (Gupta, 1986). Again, in 1984, the Bhopal gas tragedy in the 
Union Carbide plant in Bhopal, Madhya Pradesh, India occurred and an estimated 8000 
or more people died (Gupta, 2004). As compared to other groups of pesticides, OP 
pesticides cause most self-poisoning deaths in southern and central India (Thomas et al., 
2000). In parts of northern India, aluminium phosphide causes most deaths (Siwach & 
Gupta 1995; Atul & Sharma 2002). Other pesticides used for self-poisoning include 
carbamates, organochlorines, and pyrethroids (Eddleston, 2000). The state of Andhra 
Pradesh and a part of southern India is an area of intensive agricultural production with 
high use of pesticide, and therefore, have the highest reported rates of pesticide poisoning 
in India (Gautami et al., 2001). 
Pesticides and Cancers 
A number of human epidemiological studies have found association between 
household or occupational pesticide exposure and childhood leukemia, brain tumors, 
Wilm's tumor, non-Hodgkin's lymphoma, sarcomas, prostate cancer, and other cancers 
(Zahm et al. 1990; Baris et al, 1998; Dich & Wiklund, 1998;). 
Cancers of Adulthood 
Hematological malignancies (Non-Hodgkins Lymphoma) 
Over the last several decades Non-Hodgkins Lymphoma (NHL) sometimes called the 
"silent epidemic incidence has been increasing by 3-4 % per year throughout the world 
(Devesa & Fears, 1992; Hartge et al, 1994). In some studies annual increases in 
incidence are as high as 4.2-8.0 % (Cartwright et al., 1999). Associations between the 
occupational exposures (in agriculture or exterminator work) and NHL has been 
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demonstrated (Fagioli et al, 1994; Zhong & Rafnsson, 1996). A large number of studies 
showed specific correlation with phenoxy herbicides such as 2,4-dichlorophenoxyacetic 
acid (2,4-D) (Zahm, 1997; Morrison et al, 1992b; Fontana et al, 1998). Although the 
phenoxy herbicides and their contaminants are the most consistently NHL-associated 
chemicals, investigators raise concern about other pesticides, including lindane (used in 
some head and body lice-treatments), organophosphate pesticides, and a variety of others, 
such as carbaryl, chlordane, dichlorodiphenyltrichlorethane (DDT), diazinon, dichlorvos, 
malathion, nicotine, and toxaphene (Zahm et al., 1993; Blair et ah, 1998). Also, some 
fungicides may also act as lymphomagens (Hardell & Eriksson, 1999). 
Multiple myeloma 
Multiple Myeloma (MM) is another hematological malignancy for which age-adjusted 
incidence seems to have increased during the last several decades. Even among 
industrialized countries: U.S. investigators found an increased incidence of 4 % per year 
from the late 1940s to the early 1980s among white men and women (Devesa et al, 
1987). Many epidemiological studies revealed an association between employment in 
farming and the chance of contracting MM, with risks as high as 5-fold (Demers et al, 
1993; Khuder & Mutgi, 1997). 
Hairy cell leukemia, myeloid leukemia and myelodysplastic syndrome 
Hairy cell leukemia (HCL) is a rare abnormality, however, reports linking it with 
pesticide exposure raised greater interest (Garry et al, 1994; Clavel et al, 1995). 
Myeloid leukemia (ML) and myelodysplastic syndrome (MDS) have been associated 
with occupational exposure to pesticides (Pasqualetti et al, 1991). A case-control study 
showed significant associations between occupational exposure to pesticides and both 
acute myeloid and lymphoid leukemia (Richardson et al, 1992). 
Soft tissue sarcomas (STS) 
Development of soft tissue sarcomas (STS) as a function of pesticide exposure is 
widely studied and frequently correlated. While some studies revealed simple association 
with gardening or farming (McDuffie, 1994), many showed more specific association 
with the phenoxy herbicides (Lynge, 1993; Kogevinas et al, 1997). Occupational 
37 
exposure to phenoxy herbicides and/or chlorophenol is repeatedly linked to STS (Saracci 
etal, 1991;Hoppine^a/., 1998). 
Carcinomas and central nervous system malignancies 
Skin cancer and cancer of the lip 
An elevated risk for skin cancer and cancer of the lip is repeatedly associated with 
farming, where ultraviolet light exposure may be a more likely causative factor than 
pesticides (Wiklund & Dich, 1995; Schreinemachers et ah, 1999). Herbicide paraquat has 
also reported to induce one specific type of skin cancer-Bo wen's disease and the 
paraquat-associated skin cancers demonstrate DNA abnormalities which differ from 
sunlight-induced skin cancers (Hsieh et al, 1994). 
Brain tumors 
The incidence of primary tumors of the Central Nervous System (CNS) particularly 
astrocytomas, including the rapidly progressive glioblastoma multiforme as well as the 
benign meningiomas appears to have increased by 50-100 % over the past several 
decades, with greatest increase among the elderly persons (Davis et al., 1996). Studies 
also show increased occurrence of high-grade neuroepithelial tumors, lymphoma, and 
other primary CNS tumors of 5-13 % per annum in the elderly peoples (Fleury et al., 
1997). Several studies of workers engaged in pesticide handling show increased risk for 
primary tumors of the brain (Khuder et ah, 1998; Figa-Talamanca et al, 1993a). 
Research analyzing risk of brain cancer among many occupational groups indicates that 
workers in occupations likely to involve pesticide exposure intensify their liability for 
brain tumors (Rodvall et al., 1996; Heineman et al., 1995). No studies have so far linked 
any specific pesticides to these observed increases. 
Respiratory tract cancer 
Modest increase in cancers of the nose and nasal cavity is reported among workers 
exposed to phenoxy herbicides and chlorophenols (Saracci et ah, 1991). A greater than 2-
fold increase in lung cancer (adjusted for smoking) has been observed among structural 
pest-control workers (Pesatori et al, 1994). Cancer of the sinonasal cavities and lungs has 
been reported in women working in agricultural settings (McDuffie, 1994). 
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Gastrointestinal cancers 
Gastric cancer has been associated with farm workers, most frequently suffering with 
colorectal cancer (Wiklund & Dich, 1995; Alavanja, et ah, 1990). A cohort study 
specifically correlated colorectal cancer with working in a herbicide alachlor 
manufacturing plant (Leet et ai, 1996). A number of studies implicate pesticides in 
pancreatic cancer (Wiklund & Dich, 1995; Kauppinen et al, 1995). Compared to the 
control group an increased mortality rate has been reported in another cohort study on 
pesticide aerial applicators as a consequence of pancreatic cancer (Cantor & Silberman, 
1999). A large prospective study of lifestyle factors and pancreatic cancer has been 
studied on 63,374 Norwegians, which confirmed the influence of smoking and also 
identified a higher risk among men occupied in farming, agriculture or forestry (Nilsen & 
Vatten 2000). Research on workers in plants that manufacture organochlorines shows a 
nearly 4-fold increased risk of gastrointestinal cancer from exposure to chlordane, 
heptachlor, endrin, aldrin, and dieldrin (Brown, 1992). 
Testicular cancer 
Studies of offspring of parents who work in agricultural activities reveal higher rates 
of testicular cancer, with occurrence manifesting in childhood as well as young adulthood 
(Kristensen et ah, 1996). Another study shows excess risk of testicular cancer among 
workers exposed to phenoxy herbicides and chlorophenols (Saracci et ah, 1991). 
Numerous studies demonstrate small but significant correlations between prostate cancer 
and occupational settings likely to lead to pesticide exposure as well as jobs involving 
direct pesticide or herbicide application (Morrison et al, 1993). 
Breast cancer 
Case studies and small analytical studies suggested an association between breast 
cancer and organochlorine pesticides, in particular DDT (Falck et al, 1992). 
Hexachlorobenzene levels have been associated with increased risk of malignancy 
(Liljegren et al, 1998). Case-control research from Colombia showed an association 
between serum dichlorodiphenyl-dichloroethane (DDE, a metabolite of DDT) levels and 
risk for breast cancer (Olaya-Contreras et al, 1998). An ecological study of breast cancer 
incidence in an agricultural district heavily contaminated with organochlorine and 
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triazine herbicides, has demonstrated statistically significant increased risk of breast 
cancer (Kettles et ah, 1997). The organochlorine pesticides have been shown to disrupt 
the estrogen activity. However, the actual effect on breast cancer risk is likely to vary 
from compound to compound and even change with different endocrine states of the host 
(Safe & Zacharewski, 1997). 
Thyroid cancer 
A cohort study of workers exposed to phenoxy herbicides and chlorophenols reveals 
increased risk of thyroid cancer among exposed populations (Saracci et al., 1991). In a 
community exposed to unusually high levels of the organochlorine hexachlorobenzene, 
high incidence of thyroid cancer has been reported (Grimalt et al., 1994). An agricultural 
region of Minnesota with heavy use of ethylene bis-dithiocarbamate fungicides such as 
maneb, mancozeb, and zineb suffered a nearly 3-fold increased risk. These fungicides are 
metabolized to ethylene thiourea, a known thyroid carcinogen in animals 
(Schreinemachers et al., 1999). 
Pesticides and Childhood Malignancies 
Some childhood tumors such as gliomas, leukemia, and Wilms' tumor are increasing 
in incidence, but the cause for most of these illnesses remains unknown (Zahm & Ward, 
1998). A review of epidemiologic studies published between 1970 and 1996 has been 
examined on the possible association between pesticides and the risk of childhood 
cancers (Daniels et al., 1997). The review found thirty-one relevant studies. In general, 
the reported relative risk estimates were modest and appeared to be stronger with 
pesticide exposure. 
Childhood leukemia and Non-Hodgkins Lymphoma (NHL) 
Parental occupational exposure to pesticides as well as home and garden pesticide 
use may increase risk of childhood leukemia. Pesticides have been linked to childhood 
NHL (Mulder et al., 1994). Children of parents engaged in agricultural work show higher 
risk of NHL (Kristensen et al, 1996). 
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Brain and nervous system tumors 
A multicenter case-control study finds that the domestic use of pesticides increases 
the risk of childhood brain cancers (Cordier et al., 1994). Other research on home 
pesticide deployment demonstrates highly significant correlation between pediatric brain 
tumors and use of sprays or foggers to dispense flea and/or tick pet-treatments (Pogoda & 
Preston-Martin, 1997). Other pesticides implicated include pest strips, termite control 
pesticides, lindane shampoo, flea collars, yard and orchard herbicides, home pesticide 
bombs, and carbaryl for outdoor use (Davis et al., 1993). Occupational pesticide use by 
parents has been associated with increased risk of childhood neuroblastoma (Kristensen 
etal, 1996). 
Sarcomas 
A study of parental occupation and childhood cancer shows a strong association 
I 
between fathers employment in agricultural work from six months prior to conception up 
to the time of diagnosis and Ewings' sarcoma in offspring (Holly ei al., 1992). Yard 
pesticide treatments have been linked to an increased rate of childhood soft-tissue 
sarcomas (Leiss & Savitz, 1995). 
Wilms' tumor 
Paternal employment in agriculture has been associated with increased risk of Wilms' 
tumor (Fear et al., 1998). Both the paternal and maternal exposures to pesticides correlate 
with increased risk of Wilms' tumor (Sharpe et al, 1995). Children with brain cancer are 
more than twice as likely to have been exposed to pesticides at home than are healthy 
children. 
Reproductive and developmental abnormalities with pesticide exposure 
Forty-three pesticides registered for use in California, including the widely-used 
fumigants methyl bromide and metam sodium, are listed by the state as known to cause 
birth defects or other reproductive harm or to impair childhood development (CEPA, 
1998). Occupational exposure to pesticides has been associated with increased risk of 
miscarriage and with a variety of birth defects, particularly of the musculoskeletal system 
(Arbuckel«& Sever 1998). 
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Pesticide and immune system abnormalities 
There are evidence that exposure to certain pesticides may compromise the immune 
system. Pesticide exposed animal studies demonstrate the immune system abnormalities, 
damage to immune organs, suppression of immune-mediating cells, and increased 
susceptibility to infectious disease (Banerjee et al., 1996). Evidence of pesticide-
associated neuropsychological defects is based primarily on studies of workers exposed 
to organophosphate or N-methyl carbamate pesticides (Keifer & Mahurin, 1997). 
Cognitive symptoms include impairment of memory and psychomotor speed, as well as 
affective symptoms such as anxiety, irritability, and depression (Jamal, 1997). 
DNA Damage 
Cellular genome is regularly exposed to wide range of external stresses and stimuli 
that can lead directly or indirectly to DNA damage. Genotoxic stresses can include 
ionizing or ultraviolet radiation, viral infections, carcinogens, synthetic chemicals, free 
radicals, and clinically administered chemotherapeutic agents (Tembe & Henderson, 
2007). In addition, the genome is also threatened from inside by the normal cellular 
metabolism by-products, such as reactive oxygen species (ROS) which includes 
superoxide anions, hydroxyl radicals, and hydrogen peroxide derived from oxidative 
respiration and products of lipid peroxidation. These ROS can induce damages and non 
repairable lesions in the DNA. A variety of lesions can occur in the DNA, including 
single- and double-strand breaks (DSBs), mismatches, and chemical adducts, therefore, 
multiple repair pathways have evolved, each directed to a specific type of lesion 
(Houtgraafe/a/., 2006). 
Figure 4 illustrates the type of DNA lesions and the repair mechanisms as a 
consequence of exogenous and endogenous damaging agents. The maintenance of 
genome integrity after DNA damage is vital for the continued proliferation and survival 
of eukaryotic cells (Gasser & Raulet, 2002). Conversely, cells with inherited defects in 
one or more DNA repair pathways are more susceptible to the harmful impact of DNA 
damage, and their ability to bypass what are known as DNA damage "check-points" 
allows these cells to accumulate a range of mutations that may lead to cell transformation 
and ultimately cancer. Normal cells have safeguards in place to control the damage 
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Figure 4. Summary of the most common types of DNA lesions that can be caused by exogenous 
or endogenous damaging agents. The assumed repair pathway that operates on the various lesions 
is also indicated. 
Source: Houtgraafet al. (2006). 
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elicited by genotoxic agents; if the damage is too severe they undergo apoptosis or 
senescence, if the damage is repairable the cell will stall in the cell cycle long enough to 
enhance fidelity of the DNA repair process (Kennedy & D'Andrea, 2006). A primary step 
in the cellular response is efficient detection of the type of DNA damage. Once the DNA 
damage or modification is registered by the cell as part of the DNA damage check-point 
(Lukas et al, 2006), a signaling cascade is triggered which slows do)vn or arrests cell-
cycle progression by inhibiting entry into S-phase and mitosis (i.e. the Gl/S or G2/M 
phase checkpoints). The overall function of these checkpoints is to recognize damaged or 
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abnormally structured DNA and to coordinate cell-cycle progression]with DNA repair. 
The check-point enable repair mechanisms to correct the genetic lesions before they are 
passed on to the next generation of daughter cells (Jeggo & Lobrich, 2006). The cells 
with modest damage may survive, whereas cells with severe damage i are more likely to 
imdergo apoptosis (Fry et al, 2005). The normal cell cycle of a cell is described in Figure 
5. 
Genotoxicity of Pesticides 
The International Agency for Cancer Research (lARC) has reviewed the potential 
carcinogenicity of a wide range of insecticides, fungicides, herbicides and other similar 
compounds. Fifty-six pesticides have been classified as carcinogenic to laboratory 
animals. Associations with cancer have been reported in human studies for chemicals 
such as phenoxy acid herbicides, 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), lindane, 
methoxychlor, toxaphene and several organophosphates (lARC, 2002). Genotoxic 
potential is a primary risk factor for long-term effects such as! carcinogenic and 
reproductive toxicology. The majority of pesticides have been tested in a wide variety of 
mutagenicity assays covering gene mutation, chromosomal alteration and DNA damage 
(Bolognesi & Merlo, 1995; lARC, 1987; Garrett et al, 1986). A review of the literature 
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dealing with genotoxicity in human groups exposed to pesticides showed a large number 
of studies employing chromosomal aberration (CA) test, sister chromatid exchange 
(SCE) analysis and micronucleus (MN) assay. Evidence of CA increases, mainly as 
structural chromosomal aberrations in occupationally exposed populations, was 
demonstrated in the vast majority of available studies. The sensitivity of SCE is lower 
M 
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Figure 5. Schematic representation of the cell cycle. DNA damage triggers 
activation of these cell cycle checkpoints, which can lead to an arrest at the 
Gl/S, intra-S, or G2/M phase (indicated in red). During cell cycle arrest, the 
DNA damage can be repaired. 
Source: Houtgraafet al, 2006. 
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than that of the CA test in detecting genotoxic effects related to pesticide exposure and 
fewer data are therefore available for MN in comparison with other cytogenetic 
endpoints. Nonetheless, the negative studies outnumber the positive ones (Joksic et al, 
1997; Bolognesi et al, 2002). 
Effect of pesticides on plant workers 
The available cytogenetic studies on pesticide plant workers yielded positive results: a 
significant difference was observed in exposed subjects with respect to controls. The 
production varies in the pesticide industry by the seasons in association with the market 
trend, characterizing on intermittent exposure of the employers. These factors could be 
responsible for the large range in cytogenetic responses observed in the studies. 
(Jablonika et al., 1989; Garaj-Vrhovac & Zeljezic, 2002). Table 3 enlists the cytogenetic 
changes in workers employed in pesticides manufacturing plants. 
Pesticide Interaction with Biological Macromolecules 
DNA-ligand interactions 
The knowledge of DNA structure and its interactions with other compounds lead to 
advances in pharmacology and diagnostic basis of many diseases (Landergren et al., 
1988; Pinar et al., 2004). Ligand interaction with DNA and can form larger complexes 
and play a major role in biological processes such as gene transcriptions or DNA 
replications. A large number of natural and synthetic ligands have been discovered, 
which bind to DNA with intercalative or nonintercalative mechanisms. Several of these 
ligands are able to recognize particular DNA sequences of near two and four base pairs, 
and some of them with cytotoxic activity are used in cancer chemotherapy (Leslie & Fox, 
2002). Many methods have been developed to explore interactions between DNA and 
ligands, such as gel footprinting, X-ray crystallography, structural modeling, NMR, 
Fourier transform infrared, circular dichroism, electric linear dichroism, viscosity and 
fluorescence spectroscopy (Pjura et al., 1987; Teng et ah, 1988; Carrondo MAAF dee? 
a/., 1989; Rohs et al., 2000; Wan et al, 2000). Small molecules or Hgands generally 
interact with DNA through three modes: electrostatic, intercalation, and groove binding 
(Wilson, 1996). 
Table 3. Cytogenetic effects in human populations exposed to pesticides-chemical plant workers. 
Study subjects 
(exposed/controls) 
Exposure Duration (years) Analysed 
biomarker^ 
Result 
44/30 
14/50, nine 
formulators, five 
packers 
19/36 
20/20 
Novozir Mn80 
(mancozeb-
contained fungicide) 
Azynphos methyl, 
dimethoate, 
malathion, methyl 
parathion, 2,4,5-T, 
2,4-D 
Pesticide mixture; 
most commonly used 
pesticides: 2,4-D, 
atrazine, alachlor, 
cyanazine, malathion 
Up to 2 
N.D. 
10-30 
4-30 (sampling 
carried out after 8 
months high 
exposure period) 
CA 
SCE 
SCE 
CA 
CA 
Pos(+1.83) 
Pos(+1.17) 
Pos(+1.21) 
MN 
20/20 SCE Pos (+2.23) 
135/111 
Organophosphates 1-24 SCE 
Pos (+1.85 
smokers) 
(+1.63 non-
smokers) 
Chromosomal aberrations, SCE and micronuclei in peripheral blood lymphocytes. 
Source: Adopted from Bolognesi, (2003). 
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Electrostatic interactions: 
Occur between the positively charged cations and negatively charged phosphate 
groups on DNA backbone, and they are weak and nonspecific. 
Intercalation: 
Intercalation involves the insertion of the planar aromatic ring system between the 
stacked base pairs of double helix DNA. The intermolecular interactions between the 
intercalator and base pairs including Van der Waals and hydrophobic interaction stabilize 
the complex. This type of binding locally elongates the DNA helix by separating the 
stacked base pairs and partially unwinds the DNA helix at the intercalation site (Gago, 
1998). Consequently, it induces the structural perturbation of the DNA duplex, which 
might prevent the replication of DNA and inhibit protein synthesis. Therefore, 
intercalators have been an important class of potential antibacterial (Wainwright, 2001) 
and antitumor agents (Denny, 2002). Most intercalators show a slight GC base pair 
preference or no base pair preference. Although, the sequence specificity of intercalators 
can be increased by adding side substituents capable of sequence recognition of major or 
minor groove, intercalators still have less sequence specificity for recognition of DNA 
sequences compared to groove binders (Wilson, 1996). 
Minor groove binding: 
Groove binding is significantly more selective than intercalation due to contact with 
more base pairs along the groove and sequence dependence of the edges of base pairs 
(Wilson, 1996). Groove binding occurs when the small molecule fits into groove and 
interacts with the base pairs on the floor of groove and the walls of the groove. Although, 
both the major and minor grooves can be targeted by ligands, small molecules generally 
bind in the DNA minor groove with more specific-recognition likely due to the tighter 
and larger contact with narrower groove, while many proteins interact with DNA in the 
wider major grooves (Jones &Palumbo, 1998). In contrast to distortion of DNA helix 
caused by intercalation, minor groove binding usually doesn't produce large structural 
perturbation of DNA helix. Also, compared with intercalating agents containing fused 
aromatic heterocyclic rings, minor groove binding agents are generally unfused aromatic 
heterocyclic cations. Most minor groove binders possess the binding preference for AT 
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sequences over GC sequences, and the preference of AT sequences mainly arises from 
following several factors (Wilson, 1996; Neidle, 2001). Firstly, structurally, the minor 
groove of AT rich sequence is narrower than GC rich sequence. It, thus, provides tighter 
contact with groove binders, causing stronger van der Waals interactions. Secondly, the 
electrostatic potentials in the AT rich regions are more negative than GC rich regions at 
the floor of the DNA minor groove (Neidle, 1997). Most minor groove binders are 
positively charged, and their cationic nature can be balanced by negatively charged AT 
base-pair floor. Thirdly, the exocyclic 2-amino group of guanine sterically blocks the 
groove binder from gaining close contact to the GC region floor and hydrogen bonding. 
Hoechst 33258, Distamycin and Netropsin are well known examples of DNA minor-
groove binding drugs (Singh et ah, 1992; Nelson et al., 2007). The structures of DNA 
bound with minor-groove binders by X-ray crystallography, NMR, spectrofluorescence 
and other biological techniques provide valuable information for better understanding of 
the sequence-dependent molecular recognition of DNA minor groove by small 
molecules. 
Oxidative damage to DNA 
Living organisms are continuously exposed to harmful agents from the environment 
and endogenous metabolic processes (Klunglanda & Bjelland, 2007). Internal sources of 
free radicals include ROS released during respiration, or by leukocytes, as part of the 
defense against foreign organisms. Tobacco smoke, ionizing radiation and intermediates 
of xenobiotic metabolism are other sources (Gedik et ah, 2002). The ROS and reactive 
nitrogen species (RNS) include hydroxyl radical ("OH), singlet oxygen ^Oi), peroxyl 
(RO2') and alkoxyl radicals (RO'), ozone (O3), nitrous acid (HNO2) and peroxynitrite 
(ONOO") and its decomposition products. The nitric oxide (NO") and its by products 
(NO'2, ONOO", N2O3, etc.) result in nitrosation and deamination of amino groups on 
DNA bases leading to point mutations (Arroyo et al, 1992; Routledge et al, 1994). 
However, the 02"" and H2O2 do not react with DNA bases at all (Lesko et al, 1980). 
Indeed, much of the toxicity of O2"" and H2O2 in vivo arises by their metal ion-dependent 
conversion into highly reactive "OH and/or other powerful oxidants (Halliwell & 
Gutteridge, 1988). Hydroxyl radical produces a large number of base and sugar-derived 
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products in DNA, as well as DNA-protein cross-links (DPCs) (Dizdaxoglu, 1986; 
Oleinick et al, 1987). ROS induce the expression of a wide variety of transcription 
factors, such as NF-K;B, API, and oncogenes, such as c-fos and c-jun. Furthermore, ROS 
also induce conformational changes in p53 protein that mimic the mutant phenotype. 
These alterations, influence cell cycle mechanisms and ultimately lead to the 
development of cancer (Yeh & Yen, 2005). 
Oxidation of DNA in human cells occurs as a consequence of attack by free radicals 
which mediated the modification of DNA bases, inducing mutation and altered gene 
function (Morimura et ah, 2004). The attack of ROS on DNA bases have been reported to 
produce five types of oxidative bases viz. 8-hydroxydeoxyguanosine (8-oxodG), thymine 
glycol, 5-hydroxymethyluracil, formylamidopyrimidine, and 8-hydroxydeoxyadenine 
(Hwang, 2004). Of the four nucleobases, guanine has the lowest oxidation potential and 
is thus generally the most easily oxidized. It is likely that the formation of 8-oxodG is 
proportional to that of other DNA modifications, regardless of organisms, type of ROS, 
I 
and conditions of exposure. Therefore, measurement of 8-OHdG should be very useful in 
estimating oxygen radical-induced damage (Kanabrocki et al, 2006). 
Chemical-Induced Lesions in DNA 
Alkylation 
Humans are exposed to alkylating compounds produced endogeriously (Taverna & 
Sedgwick, 1996) and in the environment (Hamilton et al., 2003). The endogenous 
sources give rise to some 20,000 DNA lesions per day per cell. Of these, spontaneous 
depurination, damage from ROS and deamination of bases represent the main sources 
(Lindahl, 1993), while the relative contribution of alkylation damage is not well 
established. Alkylating agents are ubiquitous and are found in the air, water and foods, 
although generally in low concentrations. Alkylating agents may form adducts at all O-
and N-atoms in nucleobases, as well as on 0-atoms in phosphodiesters. The alkylation 
pattern depends on the agent, the position in DNA/RNA, and is different in single-
stranded and double-stranded nucleic acids (Drabl0s, 2004). Figure 6 shows the various 
types of oxidative lesions in purine and pyremidine bases of DNA. The action of the 
alkylating agents on the DNA is complex. Being electrophilic in nature they react with 
nucleophilic centers, particularly at the N-7 position of guanine. Mostly the ring nitrogen 
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51 
atoms and exocyclic oxygen atoms are targets for alkylation with the position-7 of 
guanine being the most preferred site. However, the exocycHc amino groups are not 
effectively targeted by the alkylating agents. The order of reactivity of different 
nucleophilic centers is N ' ' G » N ^ A > N ^ A = N ^ G = 0 ^ G (Friedberg, 1985). Base alkylations 
are both genotoxic and cytotoxic. In general, 0-alkylations (0^-alkylG and O'^ -alkylT) 
are highly mutagenic and genotoxic, whereas N-alkylations (e.g. 3-alkylA and 1-alkylA) 
are cytotoxic, but relatively less mutagenic (Krokan et al., 1997). The potential alkylating 
sites available on nitrogenous bases of DNA are summarized in Figure 7. The mutagenic 
properties of alkylating agents have been attributed to their capacities for alkylation at the 
exocyclic oxygen of guanine residues (Loveless, 1969). Also, the alkylation at exocyclic 
oxygens of thymine residues is important in mutagenesis (Singer & Essigmaim, 1991). 
In general, it seems that alkylating agents that are not particularly ionic in nature are 
localized more in the ring nitrogen atoms, whereas those that have ionic character show 
greater preferences for reaction at the oxygen atoms in DNA (Moschel et al., 1979; 
Lawley, 1984). Besides oxygen, living cells are exposed to number of endogenous 
alkylating agents, which are small reactive molecules that might cause DNA damage. The 
most important of these is S-adenosylmethionine (SAM) (Rydberg & Lindahl, 1982). 
Other endogenous methylation agents are betaine and choline and simple alkylating 
agents. The latter may be formed endogenously from cellular precursors, but they may 
also originate from exogenous sources such as diet, tobacco smoke or environmental 
pollution. The most frequent effect of DNA methylation is the generation of 7-
methylguanine and 3- methyladenine. 7-methylguanine is relatively harmless, because 
this modification does not alter the coding specificity of the base. However, 
destabilization of the glycosyl bond due to N-7 substitution on guanine results in 
generation of mutagenic apurinic (AP) sites and imidazole ring opening of 7-
methylguanine, which results in the stoppage of DNA replication (Tudek et al, 1992). 
Compounds that transfer alkyl residues to DNA include the nitrosamines, aliphatic 
epoxides, aflatoxins, lactones, nitrosoureas, mustards, haloalkanes and alkyl triazenes. 
The atmospheric halocarbons contribute a major factor for the external alkylating agent 
of DNA as it is generated by many terrestrial environments, e.g. by plants and fungi and 
also industrially. In marine environments, bromomethane and other bromo-compounds 
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are more abundant. Such compounds alkylate DNA, hence being mutagenic and possibly 
carcinogenic (Vaughan et ah, 1993). Nonetheless, pesticides exposure and appearance of 
pesticide residues in several food commodities are the potential alkylating agents (Cui et 
al., 2006). 
Arylamination 
The most heterogeneous group of carcinogens are those which transfer an arylamine 
residue to DNA. This group includes the aromatic amines and amides, the aminoazo 
dyes, the nitroaromatics and the heterocyclic aromatic amines found in trace amounts in 
cooked fish and meats. The site of substitution on the nucleoside varies substantially and 
forms a pattern that is very different from that displayed by the alkylating agents. 
Individual arylaminating agents distribute themselves over the target sites as summarized 
in Figure 8. Clearly, the C-8 atom and the amino groups of the purine nucleosides, 
particularly of deoxyguanosine, are the major targets for the arylaminating agents. These 
sites are unaffected by alkylating agents. Earlier studies have suggested that the aromatic 
amine adducts formed at C-8 of deoxyguanosine arise fiom a 7-substituted 
deoxyguanosine precursor, indicating that a reactivity towards the 7-position of 
deoxyguanosine residues may be common to both the alkylating and arylaminating 
agents (Humphreys et al, 1992). An adduct in which the nitrogen of an aromatic amine 
bound to the N-7 position of an 8-methylguanine derivative has been characterized. 
Although, the products of arylamination of DNA are reported to be more stable than 
alkylation products, some C-8 substituted deoxyguanosine adducts undergo 8,9-purine 
ring opening more frequently (Kadlubar, 1994). 
Aralkylation 
Compounds that transfer an aralkyl group to DNA include the pyrrolizidine alkaloids, 
alkenyl benzenes, the large group of polycyclic aromatic hydrocarbons and those 
nitroaromatics that are activated through the dihydrodiol epoxide mechanism. The 
alkenyl benzenes react with DNA in a way that is not dissimilar to the reactions of the 
arylaminating agents. Thus, I'-acetoxysafiole react with DNA through the formation of 
adducts at the amino group of deoxyguanosine residues and product is also formed at the 
C-8 position. The enhanced acidic ionization of 7-alkyl deoxyguanosine at pH 7.0 
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compared with the lower extent of deoxyguanosine ionization could increase the 
probability of anomalous base pairing between alkylated guanine in DNA and thymine 
(Lawley & Brookes, 1961). 
Crystal structure of Human Serum Albumin 
HSA is a monomeric, 66400 Mr protein comprising 585 amino acids, with a total of 
17 disulphide bridges (Carter & Ho, 1994). Based on sequence analysis, HSA is believed 
to have been evolved from multiple repetition of an ancestor gene corresponding to a 
protein of approximately 190 amino acids. The primary structure shows three 
homologous domains (I, II, and III, respectively), and each of the domains is in turn 
composed of two subdomains (A and B) displaying also partial inter-subdomain 
homology (Carter & Ho, 1994). The subdomain arrangements and amino acid 
composition of HSA is shown in Figure 9. The secondary structure is mainly a-helical; 
67 % of the protein structure is organized in a-helices separated by extended and 
disordered loops. Each domain contains 10 of these a-helices (hl-hlO). The first six 
helices in each domain belong to the A subdomains, while the four others correspond to 
the B subdomain. The inter subdomain partial sequence similarity is reflected in the 
structural repetition of a motif at each subdomain of a bundle of four anti parallel helices, 
corresponding to hl-h4 helices for A subdomains, and h7-hl0 helices for B subdomains, 
respectively. The amino acid sequence of HSA have reveled the higher percentage of 
cysteine (35 %) and charged amino acids. However, the amount of tryptophan, glycine 
and methionine residues contributes low percentage (Brown & Shockley, 1982). Higher 
number of amino acid residues (Asp and Glu) as compared to basic amino acid residues 
(His, Lys, Arg) gives acidic nature to albumin. Therefore, HSA have high negative 
charge at neutral pH. It has been reported that at neutral pH the domain I, II and III of 
HSA have a net charge of -10, -8, 0 respectively (Peters, 1985). The amino acid 
composition of HSA is summarized in Table 4. Extensive biochemical studies in the 
1970s resulted in the widely accepted proposal of two main drug-binding sites in HSA 
(Sudlow et ai, 1975), denoted as Sudlow site 1 and Sudlow site 2. Sudlow site 1 (located 
in subdomain IIA) was shown to prefer large heterocyclic and negatively charged 
compounds, while Sudlow site 2 (located in subdomain IIIA) was the preferred site for 
small aromatic carboxylic acids (Sudlow et ai, 1975, 1976). Nonetheless, the crystal 
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disulphide bridges. 
Adopted from Sugio et al. (1999) and redrawn in coloured format. 
Table 4. Amino acid composition of HSA. 
Amino Acids Number of Residues 
Aspartic acid 36 
Asparagine 17 
Threonine 28 
Serine 24 
Glutamic Acid 62 
Glutamine 20 
Proline 24 
Glycine 12 
Alanine 62 
Valine 41 
i/z-Cystine 35 
Methionine 6 
Isolucine 8 
Leucine 61 
Tyrosine 18 
Phenylalanine 31 
Lysine 59 
Histidine 16 
Tryptophan 1 
Arginine 24 
Total 585 ^ 
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form of HSA was earlier reported in the 1970's (McClure & Craven, 1974; Rao et al., 
1976), but they provided no structural information due to their poor reproducibility. The 
first crystal structure of HSA at low resolution was reported by Carter and co-workers in 
1989 (Carter et al., 1989; Carter & He, 1990), and its refined structure at 2.8 A resolution 
was published by the same group (He & Carter, 1992). The research group has also 
succeeded through extensive efforts in producing half a dozen different crystal forms of 
both HSA and non-human serum albumin, improving the resolution of their crystal 
structures and enhancing the knowledge of the diverse chemistry of serum albumin (Ho 
et al., 1993; Carter & Ho, 1994). 
The crystal structure obtained from x-ray crystallography is shown in Figure 10. In all 
crystal structures, a three-lobed, heart-shaped molecule is observed, with an approximate 
size of 80x80x30 A°. Each of the lobes corresponds to one of the three homologous 
domains of the protein. The in-depth analysis of crystal structure of HSA have further 
explored the fact that it does contain a number of minor binding sites (Bhattacharya et al., 
2000a; Ghuman et al., 2005) that allow multiple drug molecules to bound simultaneously 
and lead to higher drug binding capacity of HSA. 
HSA: a receptor for exogenous and endogenous ligands 
The physiological and pharmacological properties of HSA have been extensively studied 
over several decades (Peters, 1985). The studies revealed that HSA has a high affinity to 
a very wide range of endogenous and exogenous ligands. HSA specifically binds with 
endogenous ligands including non-esterified fatty acids (Carter &Ho, 1994), hemin 
(Kragh-Hansen, 1981) and bilirubin (Tayyab et al., 2003), thyroxine (Loun & Hage, 
1995), amino acids like tryptophan (SoUene et a/., 1981). 
A variety of substances differing in structure and chemical properties are known to 
bind albumin in a reversible manner and their association constants ranges from 10 to 
10^  M"' (Peters, 1985; 1992; Kragh-Hansen, 1990). In addition to these ligands, a large 
number of drugs are also known to bind to albumin with high affinity binding sites and 
several sites of much lower affinity, after their administration into the blood stream. 
These include tetracycline (Khan et al, 1998), adriamycin (Trynda-Lemiesz & 
Kozlowski, 1996), indomethacin (Trivedi et al., 1999), ibuprofen (Fanali et al, 2007;), 
warfarin (Sudlow et al., 1975; Fanali et al., 2007) and diazepam (Muller & WoUert, 
Figure 10. Schematic drawing of the HSA molecule. Each 
subdomain is marked with a different color (yellow for subdomain 
la; green, lb; red, Ila; magenta, lib; blue. Ilia; and cyan, Illb). N- and 
C-termini are marked as N and C, respectively. Argll7, Lys351 and 
Lys475, which may be binding sites for long-chain fatty acids, are 
colored white. 
Adopted from: Sugio et al. (1999) 
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1979). In addition, few studies have been conducted on the pesticides as an exogenous 
Hgand for HSA (Jaiswal et al., 2002; Silva et ah, 2004; Zhang et al, 2007), metals (Liang 
et al, 2000), vitamins (Kamaukhova, 2007), flavonoids (Kanakis et al, 2006), alkaloids 
(Wang et al, 2006) many organic dyes and pH indicator substances also bind to HSA 
(Hu et al, 2005). 
Oxidative damage to proteins 
Oxidative damage to proteins may be of particular importance in vivo, since the loss 
of protein function may affect the activity of enzymes (Davies & Goldberg, 1987b), 
receptors, and membrane transporters, among others (Meucci et al, 1991). Moreover, 
oxidatively modified proteins may contain very reactive chemical groups that could 
contribute to secondary damage to other biomolecules (Halliwell, 1996). As a result of 
free radical exposure, many changes can occur in proteins, including amino acid 
modification, fragmentation, aggregation, changes in absorption and fluorescence spectra 
(Meucci et al, 1991), decrease or loss of biological function (Davies & Goldberg, 
1987b), or increase in proteolytic susceptibility (Dean et al, 1989). Free radicals such as 
"OH and possible alkoxy (RO*) intermediates of lipid peroxidation have also been 
reported to fi-agment and crosslink proteins (Schuessler & Schilling, 1984). In the 
absence of molecular oxygen, 'OH radicals are known to induce crosslinks in proteins, 
which are often resistant to reduction, such as dityrosine (Halliwell & Gutteridge, 1984). 
Some crosslinking may also occur in the presence of oxygen without any significant 
fragmentation. Protein fragmentation by 'OH is a selective process, which generates the 
fragments of defined length (Gutteridge & Wilkins, 1983). However, the number of 
fragments produced varies from protein to protein. Fragmentation of protein in an 
aqueous solution reportedly increases the number of soluble amino groups (Wolff & 
Dean, 1986), suggesting that cleavage involves peptide bond hydrolysis. Proteins are 
fragmented and modified by H2O2 in the presence of transition metals or suitable chelates 
(Gutteridge & Wilkin, 1983). 
Earlier studies revealed that oxidative modification of certain proteins could render 
them more susceptible to enzymatic hydrolysis by a number of proteinases (Fligiel et al, 
1984). The degradation of proteins may occur by a two-step mechanism. Firstly, the 
modified protein becomes more susceptible to proteolytic attack and secondly a protease 
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specific for the modified protein catalyses the actual proteolytic degradation (Levine et 
al, 1981). In many cases, exposure of proteins to oxygen radicals, both in vivo and in 
vitro leads to increased exposure of hydrophobic svirfaces (Wolff et ah, 1986), which 
may lead to subsequent aggregation and to increased susceptibility to proteolysis (Davies, 
1987a). Conformational changes may also be involved in this process (Amado et al, 
1984). In addition, protein adduct formation is considered to be a valuable surrogate for 
DNA adduct formation. In animal models, many chemical carcinogens bind to both DNA 
and protein in blood with similar dose-response kinetics (Wild & Pisani, 1997; Kensler et 
al., 1996). Hemoglobin and serum albumin are the proteins of choice because they are 
readily accessible, more abundant than DNA, and have known rates of turnover (Skipper 
•etal,\99A). 
Why methyl thiophanate (MT) has been chosen? 
Methyl thiophanate [dimethyl [(l,2-phenylene)bis(iminocarbonothioyl)] 
bis(carbamate)], CAS No.23564-05-8, is a benzimidazole fungicide belongs to carbamate 
group of pesticides. The chemical structure of MT is shown in Figure 11. Methyl 
thiophanate, hereafter MT, was first registered by Japan in May 1971. By 1973 it has 
obtained provisional clearance for safe use in Great Britain for a number of specified 
preharvest treatments on food crops and ornamentals and for post-harvest dipping of 
apples (www.inchem.org). Afterwards, many countries viz. France, Italy, Portugal, 
Denmark, Netherlands, Belgium, Spain and Poland has followed the registration of MT 
and contributed well for its wide application on vegetables, fruits, soybeans, nuts, wheat 
and ornamental plants in comparison with other fungicides of benzimidazole group, as 
well as due to its lower general toxicity (USEPA, 2000; Canton, 1976; Traina et al, 
1998). Like other benzimidazoles, MT selectively inhibits the spindle apparatus by 
impairing the polymerization of microtubule formation during the fiingal DNA synthesis 
(Seller, 1975). MT is manufactured under the trade name Topsin®. MT formulations 
registered for use on food/feed crops include dust (D), granular (G), wettable powder 
(WP), water-disperable granular (WDG), and flowable concentrate (FlC) formulations 
(USEPA, 2000). These formulations of MT are claimed to be effective against apple and 
pear scab, powdery mildew, different moulds, rots and blights, although ineffective 
towards some specific plant-pathogenic fungi e.g. Botrytis, Gloeosporium, Sclerotinia, 
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Figure 11. Chemical structure of methyl thiophanate (MT). 
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Cercospora, Pythium sp., Phytophora sp., Alternaria sp. and also used as paint for 
pruning cuts and as a seed treatment (Hassal, 1990; www.inchem.org). MT has also 
reported to be effective in post-harvest stem-end rot control (Ritenour et al, 2004), but 
there were no data to show whether MT was effective to control post-harvest anthracnose 
and other decays when applied on citrus trees prior to harvest. However, Smilanick et al. 
(2006) reported that MT was effective for post-harvest green mould control on Navel 
oranges by the preharvest application of this product in California. The large scale use of 
this systemic fungicide results its appearance in various food commodities viz. fruits, 
vegetables, grains and green leafy plants (USEPA, 2000) and consequently raises concern 
on MT associated health risks. MT was first evaluated for its toxicity by the Joint 
Meeting of Pesticide Residue in 1973. Based on the no effect at 2 mg/kg bw per day in 
rabbits, an acceptable daily intake (ADI) of 0-0.02 mg/kg bw, MT was allocated for 
humans. The levels of MT that cause no toxic effect in rats, mouse and dogs are 29,2 and 
9 mg/kg bw per day (Thiophanate-methyl, 1995). MT is reported to be very similar to 
the other benzimidazole fungicide benomyl (Benlate^), regarding its systemic function 
and broad spectrum (Aelbers & Pak, 1970). The similarity between MT arid benomyl is 
evident by the fact that both compounds are converted into methyl 2-
benzimidazolecarbamate (MBC), which is reported to be the principal fungitoxic 
compound to which both chemicals owe their major activity (Selling et al., 1970). MT 
both in plants and animals is reported to convert into the major metabolite MBC 
(Noguchi et ah, 1971; Fujino & Kamimura, 1973a, 1973b). However, conversion of MT 
to MBC proceeds at a slower rate than benomyl (Selling et al., 1970). Nevertheless, 
MBC unequivocally demonstrated its teratogenic, clastogenic and mutagenic activities in 
microorganisms, mammalian cells/human lymphocytes (Hashimoto et al, 1972; 
Speakman & Niremberg, 1981; Gualandi & BeUicampi, 1981; National Italian Advisory 
Committee, 1992; Styles & Gamer, 1974; Georgieva e? a/., 1990). 
MT is reported to get well absorbed by oral route and distributed throughout the 
organism (Maranghi et al., 2003). However, the few available results of MT exposure in 
animal models exhibited a relatively low toxicity of MT (Seller, 1975; Hashimoto et al, 
1972; USEPA, 1988). Negative results on the genotoxic activity of this fungicide were 
obtained in bacterial and eukaryotic cells as well as in rodents (Makita et al, 1973; 
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Morya et ah, 1983). As per EPA carcinogen risk assessment guidelines, MT is classified 
as "likely to be carcinogenic to humans" (USEPA, 1996b). Being a category-Ill acute 
inhalation toxicant, it has been reported to exhibit a dose-related increase in the incidence 
of follicular and hepatocellular adenomas. It has also been shown to cause skin papilloma 
at 75 ppm in males, pituitary adenoma at 200 ppm in males, and mammary gland 
fibroadenoma at 1200 ppm in females (HIARC, 2000). Among the available literatures 
on MT, it is hard to find report addressing the interaction mechanism of MT with 
biological macromolecules (DNA and Proteins), quantitative and quantitative analysis of 
damage to biological macromolecules with especial consideration to human cells. 
Metabolic fate of MT in animals 
Noguchi et al. (1971) have reported the conversion of MT by rat liver microsomes to 
MBC and 5-OH-MBC. However, the evidence for enzyme induction could not be 
attained with liver microsomes prepared from rats fed daily with 6QQ ppm of MT for 
three months. Although, the presence of phenylene-thiourea has been suggested but there 
is no evidence from the studies in rats, mice and dogs that this metabolite actually is 
formed Figure 12. Other studies with rats, mice and dogs using '^C- or ^^S-labelled MT 
shows the 80-100 % recovery in faeces and urine within 96 hours after administration. 
The amounts recovered in faeces of above animals were 60 %, 16-27 % and 14 %, 
respectively. While urinary excretion accounted for 30 %, 66-78 % and 74 %, 
respectively (Fujino et al, 1973c). Based on the recovery of MT metabolites Fujino et al. 
(1973c) has suggested a metabolism scheme as shown in Figure 13. The major part of 
faecal excretion was in the form of unmetabolized MT, while the minor parts consisted of 
4-hydroxy-thiophanate-methyl (4-OH-TM) and dimethyl-4.4'-0-phenylenebisallophanate 
(FH-432). Methyl 2-benzimidazol carbamate (carbendazim) and 5-hydroxy-MBC (5-OH-
MBC) were also observed during TLC identifications of metabolites of faecal extracts. It 
was, however, questioned whether these two were actual metabolites in faeces or if they 
were compounds produced during the analytical procedures from MT and 4-OH-TM, 
respectively. MT and a number of metabolites could be liberated enzymatically or by acid 
treatment from water soluble conjugates in rat urine in the same studies by Fujino et al. 
(1973c). Identified compounds were MT, 4-OH-TM, 4-OH-FH-432, FH-432, 5-OH-
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Figure 12. The potential metabolites of MT described on the basis of chemical 
reactivity. 
Adopted from: Noguchi et al. (1971) 
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Thiophanate-methyl 
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Figure 13. Metabolic fate of MT in animals. 
Adopted from: Fujino et al. (1973c). 
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MBC and MBC. As was the case in faeces, the two of these compounds, namely MBC 
and 5-OH-MBC, may possibly have been formed during the analytical procedures. 
Bioconversion of MT in plants 
Conversion of MT to MBC has been followed after uptake through the roots and after 
foliar treatment of French bean seedlings {Phaseolus vulgaris) (Noguchi et ah, 1971). 
After 21 days 34.3 % of the original amount has been converted on the leaves, while 87.5 
% was metabolized into MBC when absorbed through the roots in a water culture. The 
formation of MBC from MT has been reported to be light-catalyzed (requiring at the 
same time the presence of water) (Buchenauer et al., 1973). About 42 % transformation 
of MT residues was found in cotton leaves upon four days of sunlight exposure. On 
contrary, only about 6 % transformation has been occured when the plants were kept 
under dimlight conditions. A minor metabolite, 2-aminobenzimidazole (2-AB) has also 
formed from MBC in MT as well as benomyl treated plants (Fujino & Kamimura, 
1973a). The same authors have also reported that two oxygen-analogues (DX-105 = l-(3-
methyoxy-carbonyl-2thioureido)-2-(3-methoxycarbonylureido) benzene and FH-432 
=dimethyl-4.4-0-phenylenbis(allophanate) has been identified by a reverse 
isotopedilution method. Metabolism of MT in plants is depicted in Figure 14. 
MT induced toxicity 
Acute toxicity 
Incessant and high level exposure of MT causes poisoning in rats manifested as 
tremors, which lead to tonic or clonic convulsions, nose bleeding and lacrimation. A 
slight decrease in respiratory rate, lethargy, disappearance of tonus of abdominal muscle, 
discharge from the eye and mydriasis were observed in rabbits and dogs (Hashimoto et 
al., 1972). The acute toxicity of MT is sunmiarized in Table 5. Another study, reported 
no signs of toxicity or deaths even at a dose of 5000 mg/kg bw orally (Souma & Nishibe, 
1990a). Acute inhalation of 95.3 % pure MT at concentrations close to the LC50 (1.7-1.9 
mg/1), elicit the symptoms of toxicity, causes ataxia, decreased motor activity, tremor, 
and convulsions (Saika & Nishibe, 1987). 
Evaporation 1 
Evaporation 
NHCWHCOQCH3 
NHCWHCOOCH3 
S 
(Thiophanate Methyl) 
NHCDOCH3 
^ ^ ^ ^ ^ 
(MBC) 
very minor 
biochemical 
photochemical 
solution 
losses 
0 
NHCNHCOOCH3 
N1HCNHC00CH3 
S 
(DX-1Q5) 
0 
^y-^..^^ NHCNHCOOCH3 
(2-AB) 
NHCNHCOOCH3 
D 
(FH-432) 
Figure 14. Fate of MT residues in plants. DX-105: l-(3-methyoxy-
carbonyl-2thioureido)-2-(3-methoxycarbonylureido) benzene; 2-AB: 2-
aminobenzimidazole; FH-432: dimethyl-4.4-0-phenylenbis(allophanate). 
Adopted from: Fujino & Kamimura, (1973a). 
Table 5. Acute toxicity of methyl thioplianate (MT). 
Species 
Mouse 
Mouse 
Mouse 
Mouse 
Rat 
Rat 
Rat 
Rat 
Rat 
Rat 
Guinea-pig 
Guinea-pig 
Rabbit 
Rabbit 
Rabbit 
Sex 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Male, female 
Route 
Oraf 
Intraperitoneal 
Subcutaneous 
Dermal 
Oral 
Intraperitoneal 
Subcutaneous 
Dermal 
Inhalation 
Oral" 
Oral 
Dermal 
Oral 
Dermal 
Dermal'' 
LD 50 or LC 50 
(mg/kg bw or 
mgAitre air 
3400-3514 
792-1113 
> 10 000 
> 10 000 
6640-7500 
140-1640 
> 10 000 
> 10 000 
1.7-1.9 
>5000 
3640-6700 
> 10 000 
2270-2500 
> 10 000 
>2000 
T -
gum arable in 5% sodium chloride solution; = distilled water. 
Adopted from: http://www. inchem. org/documents/jmpr/jmpmono/v95prl 7. htm. 
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Short-term toxicity 
Short term toxicity studies on ICR mice showed treatment-related deaths in groups 
fed with MT at doses of 0, 12.8, 64, 320, 1600, or 8000 ppm for six months. However, 
the body-weight gain of animals at 8000 ppm was significantly reduced. At the same 
concentration, other noticeable effects were decrease in erythrocyte counts, haematocrit 
values, increased weight of liver and prominent histopathological changes viz. hepatic-
cell irregularity, swollen hepatic cells, oedematous or granular protoplasm, cloudy 
appearance of the liver, sporadic formation, hepatic-cell degeneration. The no observable 
adverse effect level (NOAEL) in this study was 320 ppm which was equivalent to 
approximately 48 mg/kg bw per day selected on the basis hepatotoxic and haematological 
effects at 1600 and 8000 ppm (Noguchi & Hashimoto, 1970b; Hashimoto et ah, 1973). In 
an another study, exposure of a group of 12 Sprague Dawley rats have also showed more 
or less similar toxicity pattern at the higher treatment dose of 8000 ppm for six months. 
The toxicological symptoms noticed includes decrease in body weight, reduced 
erythrocyte counts, increase in blood cholesterol level, increase in weights thyroid anti 
liver thymus, histopathological changes viz. thyroid follicles, thickened follicular 
epithelium, decreased colloidal substance. The NOAEL was 1600 ppm, equivalent to 80 
mg/kg bw per day, mainly on the basis of effects on thyroid, liver, and body weights 
(Noguchi & Hashimoto, 1970c; Hashimoto et al, 1973). 
The short term toxicity of MT has also been studied in dogs exposed to MT via oral 
administration in the form of capsules at the doses of 0, 50, 200, or 400 mg/kg bw per 
day for 13 weeks, 0, 8, 40 or 200 mg/kg bw per day for one year, or 0, 2, 10, 50, or 250 
mg/kg bw per day for two years. In all the three studies, treatment-related thyroid 
hyperplasia was seen, however, the overall NOAEL was 10 mg/kg bw per day 
(Taniguchi, 1972; Auletta, 1991,1992). 
Long-term toxicity and carcinogenicity 
A two-year carcinogenicity study performed on mice fed with the MT at dietary 
levels of 0, 10, 40, 160, or 640 ppm, have shovm no evidence of any carcinogenic 
response. Considering the reduced body-weight in this study the NOAEL was 160 ppm 
(equal to 24 mg/kg bw per day) (Kosaka, 1973). Another 18 month study with 60 male 
and 60 female CD-I mice fed with the MT dietary levels of 0, 150, 640, 3000, or 7000 
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ppm have not showed any treatment-related clinical signs. However, the NOAEL set on 
the basis of treatment-related hepatotoxicity and hepatocellular tumours was 150 ppm 
(equal to 29 mg/kg bw per day) (Tompkins, 1992). 
In a two-year study of carcinogenicity in rats fed dietary levels of 0, 10, 40,160, or 
640 ppm, effects were seen on the testes (mainly hypospermatogenesis), thyroid gland, 
and growth rate at 640 ppm. No significant treatment related effects were seen on clinical 
chemical, haematological, or urinary values. No significant adverse histopathological 
effects or changes in organ weights were seen at any dose at three or 12 months. There 
was no evidence for carcinogenicity has been reported in the above study. Based on the 
testes and thyroid gland and reduced growth at 640 ppm the NOAEL was 160 ppm 
(equivalent to 8 mg/kg bw per day) (Hashimoto, 1972). MT induced carcinogenicity has 
been further studied for two year on group of rats fed with MT dietary levels of 0, 75, 
200, 1200, or 6000 ppm. Dose related histopathological changes were found in the 
thyroid, liver, kidney, and adrenal. Thyroid follicular-cell hyperplasia and hypertrophy 
were noted in animals of each sex at 1200 and/or 6000 ppm at 12 and 24 months, and the 
incidence of focal follicular-cell hyperplasia was increased. Males at 6000 ppm also had 
a statistically significant increased incidence of thyroid follicular-cell adenomas. 
Centrilobular hepatocellular hypertrophy and lipofuscin deposition were noted in animals 
of each sex at 1200 and/or 6000 ppm at 12 and 24 months and in most males and females 
at 6000 ppm which died during the study. Most males at 6000 ppm that died or were 
killed in extremis had severe nephropathy associated with hyperplasia of the parathyroid, 
demineralization of the bone, and metastatic calcification in various organs. The NOAEL 
observed in this was 200 ppm which was equal to 9 mg/kg bw per day (Takaori, 1993). 
Reproductive and developmental toxicity 
The reproductive toxicity of MT has been studied in a three-generation study on rats 
received MT at a dietary doses of 0, 40, 160, or 640 ppm, exhibited reductions in total 
litter size, weight at birth and weaning at the highest concentration of 640 ppm. The 
NOAEL observed in this study was 160 ppm which was equivalent to 8 mg/kg bw per 
day. Furthermore, the two-generation study in which rats received MT at a dietary doses 
of 0, 200, 630 or 2000 ppm have shown no evidence of a treatment-related effect on 
reproduction. The lowest dose tested in the study was equivalent to 10 mg/kg bw per day 
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which was a minimal-effect level on the basis of hepatocyte hypertrophy, thyroid 
foUicular-cell hypertrophy, and hyperplasia at all treatment levels (Thomas, 1974; 
Thomas «fe Schein, 1974). 
The teratogenic, potential of MTwas separately investigated in mice, rats, and 
rabbits. The oral exposure of mice on days 1-15 of gestation through gavage at doses of 
0, 40, 200, 500, or 1000 mg/kg bw per day of MT exhibited no evidence of teratogenicity 
or maternal toxicity. Although embryo- and fetotoxicity were seen at this dose (Noguchi, 
1970c; Makita et ah, 1973). Also, the exposure of 25 female Sprague-Dawley rats to MT 
at the doses of 0, 100, 300, or 1000 mg/kg bw per day on days 6-19 of gestation, 
exhibited negative effects on the implantation numbers, litter sizes, fetal body weights, 
sex ratio, or numbers of immature or malformed fetuses (Rodwell et ah, 1981). 
However, the oral exposure of rabbits to MT at doses of 0, 2, 6, or 20 mg/kg bw per day 
on days 6-19 of gestation exhibited maternal toxicity (reduced growth rate) at 6 mg/kg 
bw per day and above. A dose-related trend of increased fetal skeletal abnormalities (ribs, 
vertebrae, and pelvis) has also been observed (Ross et al., 1986). 
Genotoxicity ofMT 
The genotoxicity and mutagenicity of MT has been assessed in bacterial test systems 
viz. S. typhimurium strains (TA98, TAIOO, TA1535, TA1537, TA1538 and G46), E. coli 
(WP2 her and uvrA) and B. subtills (HI7, M45) in a concentration range of 10-3000 
|ig/ml. With all the above test systems MT has been reported as non genotoxic and non 
mutagenic (Shirasu et al, 1976; Kanaguchi & Nishibe, 1990; Tippins et al, 1984). Apart 
from bacterial test systems, MT has also been reported to induce no changes in gene 
mutation, CA and unscheduled DNA synthesis in Chinese hamster ovary cells and 
primary hepatocytes (Tippins et al, 1984; Murli, 1988; Myhr, 1981). The summary of m 
vitro and in vivo studies on the MT genotoxicity is enlisted in Table 6. The in vivo 
aneugenic potential of MT has been assessed in male Swiss albino mice at the doses of 
1000 mg/kg bw, which induces the formation of large micronuclei. However, the 
response of micronuclei formation was relatively weak, which categorize MT as less 
effective than benomyl or carbendazim. The same group of mice has also exhibited 
treatment-related increase in the frequency of polyploid and hyperdiploid (Barale et al, 
1993). The molecular cytogenetic analysis frirther revealed that MT-induces delayed 
Table 6. Summary of the in vitro and in vivo genotoxicity assessment of MT. 
End-point Test system Concentration 
or dose (%) 
Purity Results 
In vitro 
Reverse 
mutation 
S. yphimurium TA98, 10, 50, 100, 500, 1000 
TAIOO, TA1535, TA1537, |^ g/plate dissolved in DMSO 
TA1538,£. co//WP2hcr 
97.3 Negative'' 
Reverse 
mutation 
S. yphimurium TA9i, 39.1,78.1,156.3,312.5,625, 96.55 
TAIOO, TA1535, TA1537, 1250, 2500, 5000 ^g/plate 
E. coli WP2 mr in DMSO 
Negative^ 
Host-mediated 
mutation 
Gene mutation 
Gene mutation 
Chromosomal 
aberration 
Unscheduled 
DNA synthesis 
In vivo 
Dominant lethal 
mutation 
Cytogenicity 
S. typhimurium G46 
B.subtillsR\l,M^5 
Chinese hamster V79 cells, 
hprt locus 
Chinese hamster ovary 
cells 
Primary hepatocytes 
ICR mice 
Wistar rat bone marrow 
and spermatocytes 
1000, 3000 mg/kg bw twice 
20,100,200,500,1000, 
2000 |ig,/disk 
6.25, 12.5,25.0,50,100 
Hg/ml in DMSO' 
100, 200, 300, 400ng/mlin 
DMSO' 
250, 500, 750, 1000 ^g/ml in 
DMSO*^  
5,10,25,50, 100,250,500, 
1000 )ig/ml 
8-500 mg/kg bw 
intraperitoneally 
62.5-1000 mg/kg bw 
intraperitoneally 
97.3 
97.3 
96.36 
95,0 
100 
94 
94 
Negative 
Negative 
Negative" 
Negative 
Negative 
Negative 
Negative 
^ = Without metabolic activation; = With metabolic activation.. 
Adopted from: http://www. inchem. org/documents/jmpr/jmpmono/v95prl 7.htm 
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cellular proliferation and increases the frequency of apoptosis (Fimognari et al., 1999), 
and induces CA in human lymphocytes treated with a concentration range of 30-300 
|ig/ml under in vitro condition (Herila et ah, 1996). Also, the experiments with BALB/c 
3T3 cells demonstrated cell-transforming activity of MT. (National Italian, Advisory 
Committee, 1992). However, the information on genotoxic and carcinogenic potential of 
MT is inadequate and inconclusive, to define the possible carcinogenic risk of MT to 
humans (USEPA, 1987; National Italian, Advisory Committee, 1992). 
It has been speculated that the risk of genotoxicity from some pesticides might be 
appreciably higher than that predicted from conventional toxicity tests (Bolognesi, 2003). 
The contradictions and variance of the toxicity reports on MT as well as the differential 
sensitivity of assays used for determining MT genotoxicity, prompted us to investigate 
the mechanism of MT-DNA interaction and its DNA damaging potential. Since there is 
no concrete attempt has been made to ascertain the MT induced DNA strand breaks, alkyl 
and 8-oxodG DNA adducts, as markers of DNA alkylation and oxidative damage, 
respectively. 
Why Phorate has been chosen? 
Phorate (0,0-diethyl s-ethylthiomethyl phosphorodithioate), CAS No. 298-02-2, is 
an organophosphorus insecticide and acaricide used to control sucking and chewing 
insects, leafhoppers, leafminers, mites, some nematodes, and rootworms in pine forests, 
field crops viz. com, cotton, coffee, some ornamental and herbaceous plants, and bulbs 
(Wagner, 1989; Gallo & Lawryk, 1991). The chemical structure of phorate is shown in 
Figure 15. 
Phorate is used since 1954, and is available in emulsifiable (EC) as well as granular 
formulations (WHO, 1988). It is marketed with several trade names like, AC 8911, 
Agrimet, Geomet, Granutox, Phorate lOG, Rampart, Terrathion, Thimenox, Thimet, 
Timet, Vegfru, and Vegfru Foratox, respectively. Phorate binds moderately well to most 
soils and is slightly soluble in water. The reported field half-life of phorate varies 
between 2 to 173 days. The representative value may be approximately 60 days 
(Wauchope et ah, 1992). Actual residence time may be influenced by soil clay and 
organic matter content, rainfall, and soil pH (U.S. PubKc Health Service, 1995). Soil 
CHs-CH^. p 
CHr^H2-(/ ^-CH2-S-CH.CH 2^n3 
Figure 15. Chemical structure of phorate showing thioether group 
attached to the central phosphorous atom. 
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treatments of phorate often leave more residues in plants than foliar treatments, because 
the compound persists in the soil and is readily taken up by plant roots (Kidd & James, 
1991). On the contrary, competitive binding data of phorate reveled that it possess 
w e^aker adsorption property to four tropical soils, which makes it less mobile in most soils 
(Chen et ah, 2004). As a result phorate mainly transported with runoff via sediment and 
water. According to the U.S. Public Health Service field studies leaching of phorate is 
very low in soils, which is high in clay and organic matter content, and lower in sandy 
soils (U.S. Public Health Service, 1995). The inadequacy of data on leaching of phorate 
from soil allows suspecting that phorate may contaminate the ground water and cause 
serious threat to water bodies, which warrant concerns for direct and/or lethal effects on 
fishes. Nonetheless, phorate has reported to inhibit the carbohydrate metabolic disorders 
in the senmi of freshwater fish Clarias batrachus (Linn.) (Jyothi & Narayan, 1999). Also, 
it induces toxic effects in Pacific salmon and steelhead fishes (Odenkirchen & Turner 
2003). 
As per the EPA market estimates this thioether containing OP insecticide is widely 
use in agriculture. During 1999 the annual consumption of active ingredients of phorate 
alone in U.S was 2-3 million pounds {http://www.usda.gov/nass/). Comparatively in 
1995-96, out of the 91,913 tones of pesticides consumption in India, phorate alone 
accounted for 3900 tones (Jyothi & Narayna, 1999). The wide application and injudicious 
use of phorate has thus led its appearance in various food commodities viz. wine, fruit 
juices and milk, which has raised phorate associated health concern globally (Zambonin 
et ah, 2004; Pagliuca et ah, 2006). 
The toxicological evaluation of phorate was first reviewed by the Joint Meeting in 
1977. Based on the available data on phorate a temporary acceptable daily intake (ADI) 
of 0-0.0005 mg/kg bw was allocated for man (Phorate, 1996). Phorate is categorized as 
Class I, extremely high-risk toxic compound by EPA and PMRA 
(http://www.extonet.orst.edu/pips; PMRA, 2003). Like other OP pesticides, phorate 
inhibit acetylcholinesterase (AchE) enzyme by the formation of an enzyme inhibitor 
complex, which attack the nervous system and cause physiological and biochemical 
disorders (Hazardous Substances Data Base, 1988; O'Brein, 1976). Human subjects 
occupationally exposed to phorate has showed the reduction in (blood, plasma and brain) 
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AchE activity along with other toxicity symptoms viz. lower blood pressure, pinpoint 
pupils, convulsions, and unconsciousness, dizziness, nausea, vomiting, cardiac 
tachycardia, excessive salivation, respiratory distress, muscle fasciculations, constricted 
pupils, gastro-intestinal effects, bradycardia and neurological effects (Headache, 
Giddiness, Fatigue), lowering of heart rate and eye irritation (Hazardous Substances Data 
Base, 1988; Kashyap et al., 1984; Gallo & Lawryk, 1991). i 
The primary route of phorate exposure is dermal and inhalation, whereas in the 
general population it is inhalation, diet and dermal (Henderson et al, 2004). Even after 
taking protective measures phorate has been reported to causes poisoning in pesticide 
formulators (Kashyap et al., 1984; Young et al., 1979). Via the oral route, the LD50 
values of phorate vary between 1.1 to 3.7 mg/kg in rats (Gallo & Lawryk, 1991; Kidd & 
James, 1991), and 2.25 to 6.59 mg/kg in mice (Gallo & Lawryk, 1991; American 
Cyanamid, 1992). Phorate is highly toxic via the dermal route with reported dermal LD50 
values of 2.5 to 6.2 mg/kg in rats (Gallo & Lawryk, 1991; Kidd & James, 1991) and 5.2 
mg/kg in rabbits (Gallo & Lawryk, 1991; American Cyanamid, 1992). The recent 
evaluation of phorate in 2003 by Pest Management Regulatory Agency (PMRA) Canada, 
has classified phorate as high to extremely high risk for mammals and fresh water 
organisms. Concerning the death reports on birds and mammals in Canada, U.S and U.K, 
PMRA has reported that one granule of phorate is sufficient to kill a small bird and 
mammal (PMRA, 2003). In view of the health hazards, most of the countries worldwide 
has banned and/or restricted the use of phorate. However, it is still being used in India 
(Thirty Seventh Report of Standing Committee on Petroleum and Chemicals, 2002). In 
fact most of the health hazard assessment of phorate is based on the toxicological reviews 
issued by the Health Effect Division of the United States EPA or FAO/WHO Joint 
Meeting on Pesticide Residues either for registration eligibility or for the 
recommendation of an ADI (dinger, 1999; FAO, 1995, 1997). The toxicity profile in 
these reviews has been obtained mainly from the unpublished reports conducted merely 
for the registration or marketing purposes by the chemical companies . It should be 
realized that some of these studies were conducted in the 1960s and 1970s and do not 
meet current requirements. Among the available literatures on phorate, it is hard to find 
report addressing the interaction mechanism of phorate with biological macromolecules 
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(DNA and Proteins), quantitative and quantitative analysis of damage to biological 
macromolecules with especial consideration to human cells. 
Absorption, Distribution and Excretion of Phorate 
Phorate has the tendency to readily absorbed from the gastrointestinal tract (The Royal 
Society of Chemistry, 1988). Rats receiving a single oral dose of 2 mg/kg of''^P-labelled 
phorate excreted 35 % of the administered radioactivity in the urine and 3.5 % in the 
faeces within 144 hours. In the another set of experiment, rats fed with, the 6 daily dietary 
doses of phorate (Img/kg) has been noticed to excrete 12 % of theitotal administered 
radioactivity in the urine and 6 % in the faeces within 7 days. The brain, liver and kidney 
tissues from the animals contained unidentified and largely unextractable residues of 
phorate (Bowman & Casida, 1958). 
Metabolic Fate of Phorate in Animals 
Rats receiving oral doses of 1 mg/kg of phorate on a daily basis exhibited the 
presence of 17 % (diethyl phosphoric acid), 80 % (0,0-diethyl phosphbrothioic acid) and 
3% (0,0-diethyl phosphorodithioic acid) in urine (Bowman & Casida, 1958). Overall, the 
bioconversion product of phorate has resulted in the formation of various metabolites viz. 
phorate sulphoxide, phorate sulphone, phoratoxon sulphoxide and phoratoxon sulphone 
(Bowman & Casida, 1958). Blinn & Boyd (1967) have also reported the bioconversion of 
phorate into phorate sulphoxide and phorate sulphone after the analysis of blood of rats 
fed with atropine alongwith 1.6, 3.2 and 5.5 times higher dose of the nominal LD50 of 
phorate (3.7 mg/kg). Phorate has also been reported to get rapidly metabolized into 
phorate sulphone and phorate sulphoxide when incubated with liver homogenates under 
in vitro condition (Rao & McKinley, 1969). The tissue specific bioconversion of phorate 
has been specially studied in cow at a single oral dose 3.04 mg/kg. The urinary, blood 
and tissue metabolites resulting from this dosing were 0,0-diethyl phosphorothioic acid, 
0,0-diethyl phosphoric acid and small amounts of 0,0-diBthyl phosphorodithioic acid 
(Bowman & Casida, 1958). 
Furthermore, the human biomonitoring studies of phorate formulators have also 
showed the presence of diethyl phosphate, diethyl phosphorothioate and diethyl 
thiophosphate in their urine samples (Brokopp et ah, 1981). Substantial studies have been 
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performed to identify the role of xenobiotic metabolizing enzymes CYP450 and FMO in 
the bioconversion of phorate. Studies revealed that CYP450 alone yields highly toxic 
metabolic product i.e. oxon. While, CYP450 in combination with FMO yields a less toxic 
metabolic product i.e. sulphoxide (Hajjar & Hodgson, 1980, 1982; Hodgson et ah, 
1998). Bioconversion of phorate into different metabolites is summarized in Figure 16. 
Metabolic Fate of Phorate in Plants 
Since 1954, studies of the metabolism of phorate in plants have been conducted by 
investigators at American Cyanamid Company and by researchers in various parts of the 
world. It has been shown that when phorate is absorbed by plants, its is initially and 
rapidly oxidized to its sulphoxide and sulphone which in turn are converted to the 
sulphoxide and sulphone of the phorate oxygen analogue (Blinn, 1964; Bowman & 
Casida, 1957, 1958; Krueger, 1975; Zakil & El-Sayed, 1968). The sequence of oxidative 
reactions in the metabolism of phorate following absorption by plants is similar to that in 
animals. 
Toxicological Studies on Phorate 
Acute toxicity 
Phorate is highly toxic via the oral route with reported oral LD50 values of 1.1 to 3.7 
mg/kg in rats and 2.25 to 6.59 mg/kg in mice. It is highly toxic via the dermal route at the 
LD50 values of 2.5 to 6.2 mg/kg in rats and 5.2 mg/kg in rabbits (Gallo & Lawryk, 1991; 
Kidd & James, 1991; American Cyanamid, 1992). Guinea pigs reportedly have a dermal 
LD50 of 20 to 30 mg/kg during 24-hour exposure (Kidd & James, 1991; American 
Cyanamid, 1992). In the acute 1-hour inhalation study the LC50 for rats is reported be 
0.06 mg/L (Kidd & James, 1991). 
U.S. Public Health Services has re-evaluated the acute toxicity data of phorate and 
categorized it as extremely toxic to rats via. oral, dermal and intravenous routes with the 
LD50 values ranging from 1.1 to 10 mg/kg bw (U.S. Public Health Services, 1995). 
Phorate was also found to be severely toxic to rabbits and mice after dermal and oral 
administration. High doses may result in unconsciousness, incontinence, and convulsions 
or fatality. Toxicity appears to vary with age, with the young being more susceptible 
(U.S. Public Health Service, 1995). Nonetheless, human poisoning cases have also been 
s 
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CL 4,259 
S 0 
(C2H50)2 -P -S -CH2-S - CH2CH3 
CL 18,177 
0 
11 
CC2H50)2- P - S - C H 2 - S - CH2CH3 
0 
CL 18,161 
0 0 
CC2H50)2-P-S- 'CH2-S- CH2CH3 
/ CL 18,162 
X O 0 
CC2H5Q)2-P-OH + H3C-S-CH2-S-CH2CH3 
CX=SorO) CL 325,959 
H3C - S - CH2 - S -CH2CH3 
b 
CL 180,298 
0 
11 
H3C-S-CH2-S-CH2CH3 
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Figure 16. The proposed metabolic pathway of phorate in rat. 
CL 35,024: Phosphorodithioic acid, 0,0-diethylS-(ethylthio)methylester 
CL 18,162: Phosphorothioic acid, 0,0-diethylS-(ethylsulfinyl)methylester 
CL 18,177: Phosphorodithioic acid, 0,0-diethyl S-(ethylsulfinyl)methylester 
CL 18,061: Phosphorothioic acid, 0,0-diethyl S-(ethylsulfonyl)methylester 
CL 4,259: Phosphorothioic acid, 0,0-diethylS-(ethylthio)methylester 
CL 18,161: Phosphorodithioic acid, 0,0-diethylS-(ethylsulfonyl)methylester 
CL 180,298: Sulfoxide, (ethylsulfonyl)methyl 
CL 180,297: Sulfoxide, ethyl(methylsulfonyl)methyl 
CL 180,296: Methane, (ethylsulfonyl)(methylsulfonyl)-
CL225,959: Methane, (ethylsulfinyl)(methylsulfinyl)-
Adoptedfrom: Miller & Wu (1990). 
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reported for the phorate manufacturing workers aged between 16 to 18 years old, having 
inadequate protection while applying phorate to crops, or working around machines to 
apply phorate (Gallo & Lawryk, 1991; U.S. Public Health Service, 1995). Studies also 
indicate that direct eye exposure may cause blurring, tearing, and ocular pain (Gallo & 
Lawryk, 1991). Studies on the acute toxicity of phorate are summarized in Table 7. 
Short-term toxicity 
Administration of phorate (92.1 %) for 13 weeks to the group of CD-I ICR BR 
outbred Swiss mice at dietary levels of 0.18, 0.55 or 1.10 mg/kg bw per day for males 
and 0.23, 0.67 or 1.38 mg/kg bw per day for females, has resulted in the increased plasma 
cholinesterase activity (Trutter, 1990). Studies with rats at the dietary doses of 0, 0.22, 
0.66, 2, 6, 12 or 18 ppm for 13 weeks have also showed significant decline in the brain 
cholinesterase activity alongwith with tremors and hyperexcitability. However, groups of 
rats received 12 and 18 ppm have resulted into death (Tusing et al., 1956a). The one-
year short term toxicity study in dogs at the dietary doses of 0, 0.005, 0.01, 0.05 or 0.25 
mg/kg bw per day has resulted into decreased body weights, significant inhibition of 
erythrocyte and brain cholinesterase activity alongwith the clinical signs of cholinergic 
toxicity (Tusing et al, 1956b; Kay & Calandra, 1961; Piccirillo et al, 1987; 
Shellenberger & Tegeris, 1987). At the recommended field dose of 6728.5 mg m'^ , 
phorate induces multiple organ toxicity in mice including hepatocellular 
necroinflammatory with mild to severe multifocal cloudy, fatty degenerations with 
necrosis, emphysema and hydropic (Morowati, 1997; 1998; 2001). Phorate has also 
blamed to actively inhibit the testosterone metabolism in human liver microsomes 
(Usmani et al, 2004). 
Long-term toxicity and carcinogenicity 
Mice and rats were treated with phorate at dietary levels of 0, 1, 3 or 6 ppm for 18 
and 24 months exhibited a decrease in body weights and showed increased incidence of 
tremors, hyperactivity and excessive salivation at the dose of 6 ppm. Cholinesterase 
activity was not measured in this study. Phorate was not carcinogenic when fed to mice 
or rats at the dietary levels of 6 ppm (Litton Bionetics, 1981a, 1981b). 
Table 7. Summary of acute toxicity studies for phorate in mammals. 
Exposure 
Route 
Inhalation^ 
Dermal 
Oral 
Intravenous 
Vehiculum 
Xylene 
Xylene 
Propylene 
glycol 
Propylene 
glycol 
Peanut oil 
Peanut oil 
Propylene 
glycol 
Propylene 
glycol 
Propylene 
glycol 
Propylene 
glycol 
Species (strain) 
Rat 
(Sprague-Dawley) 
Rat 
(Sprague-Dawley) 
Rat (Sherman) 
Rat (Sherman) 
Rat 
(Sprague-Dawley) 
Rat 
(Sprague-Dawley) 
Rat 
Rabbit 
Rabbit 
Rat (Sherman) 
Rat (Sherman) 
Rat 
Rat 
Rat 
(Sprague-Dawley) 
Rat 
(Sprague-Dawley) 
Rat 
Mouse 
Rat 
(Sprague-Dawley) 
Rat 
(Sprague-Dawley) 
Sex 
Male 
Female 
Male 
Female 
Male 
Female 
Male 
Male 
Not specified 
Male 
Female 
Male 
Female 
Male 
Female 
Not 
specified 
Male 
Male 
Female 
LC50/LD50 
(duration) 
60 mg/m' (Ih) 
l l m g W ( l h ) 
6.2 mg/kg bw 
2.5 mg/kg bw 
9.3 mg/kg bw 
3.9 mg/kg bw 
5.7 mg/kg bw 
5.2 mg/kg bw 
99 mg/kg bw 
2.3 mg/kg bw 
1.1 mg/kg bw 
2.8 mg/kg bw 
1.6 mg/kg bw 
3.7 mg/kg bw 
1.4 mg/kg bw 
1 mg/kg bw 
2.25 mg/kg bw 
2.2 mg/kg bw 
1.2 mg/kg bw 
As an aerosol generated fi-om a 1 % solution in xylene. 
Adopted from: Phorate (2003). 
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Reproductive toxicity 
In a two-generation study on the phorate induced reproductive toxicity in rats fed at 
dietary levels of 0, 1, 2, 4 or 6 ppm has showed no adverse effects on reproductive 
parameters. Also, a separate three-generation study on reproductive toxicity in mice at the 
dietary levels of 0, 0.6, 1.5 or 3 ppm phorate have failed to induce reproductive changes 
(American Cyanamid,1965; Schroeder and Daly, 1991). Furthermore, the long-term 
studies on mice fed with high doses of 98.7% pure phorate have also showed no effects 
on fertility, gestation, or viability (American Cyanamid, 1992). Although, maternal and 
embryo toxicity occurred at the dietary doses of 0.5 mg/kg/day fed to rats (USEPA, 
1985). Nonetheless, the available data suggest that phorate is unlikely to cause 
reproductive effects. 
Teratogenicity and embryotoxicity 
Two studies on the teratogenic studies of phorate has been conducted in rats at the 
doses of 0, 0.125, 0.25 or 0.5 mg/kg bw per day and 0, 0.1, 0.2, 0.3 or 0.4 mg/kg bw per 
day. There was no evidence of teratogenic potential at the dose of 0.3 mg/kg bw per day. 
At the maternally lethal dose of 0.5 mg/kg bw per day, there was an increased incidence 
of fetuses with enlarged hearts. (Lochry, 1990a; 1990b). Although, rabbits treated with 
doses of 0, 0.15, 0.5, 0.9 or 1.2 mg/kg bw per day have showed maternal mortality and 
decreased body weight at the doses of 0.5 mg/kg bw per day and above. However, 
phorate has not exhibited the toxicity to either embryo or fetuses, thus categorizing it as 
non teratogenic to rabbits (Newell & Dilley, 1978; Schroeder & Daly, 1986,1987). 
Genotoxicity of phorate 
A battery of test assays viz. gene mutation, cytogenicity and other genotoxic effects 
have earlier been performed to test the genotoxicity of phorate under in vitro and in vivo 
conditions. In majority of tests phorate has exhibited negative effect on different genetic 
end points. However, data on phorate genotoxicity is meager and inconclusive, which 
have been done merely for the registration purposes by the phorate manufacturing 
companies. The data on phorate mutagenicity and genotoxicity have revealed that phorate 
at a concentration of 1000 |xg/plate did not induce mutagenicity and genotoxicity in S. 
typhimurium and E. coli p3478 tester strains (Pandita & Khoshoo, 1984). Phorate did not 
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induce mitotic recombination in 5*. cerevisae D3 and unscheduled DNA synthesis (UDS) 
cultured human fibroblasts at the concentrations of 5 % and 1 mM, respectively (Simmon 
et ah, 1977). Furthermore, phorate also failed to induce gene mutation at hprt locus in 
cultured CHO cells and SCE in human lymphocytes and CHO cells (Wang et al., 1987). 
Treatment of Sprague Dawley rats and Swiss albino mice with varying doses of 0-2.5 
mg/kg/day and 1.5 mg/kg/bw did not show incidence of CA in bone marrow cells (Ivett 
& Myhr, 1986; Pandita, 1986). 
On the contrary, a statistically significant increase in the frequency of SCE was 
reported in cultured human lymphoid cells treated with the dose range of 2 and 20 [ig/ml 
in absence of metabolic activation (Sobti et A/., 1982). Also, the frequency of CA in 
cultured CHO cells was increased at 40 |ig/ml without S9, but no change occurred in 
presence of S9 (Lin et al., 1987). A significant increase in frequency of MN formation in 
bone marrow cells of male wistar rats has been noticed after a single intraperitonial dose 
of 0.75 mg/kg bw (Grover & Mahli, 1985). The frequency of CA in bone marrow cells of 
wistar rats have increased as a consequence of daily intraperitonial injections of 0.15 and 
0.30 mg phorite /kg bw/day for consecutive 5 days (Mahli & Grover, 1987). These 
effects were confirmed in another study with wistar rats following administration of two 
intraperitonial doses of phorate at 24 h intervals. An increased CA and MN formation 
have been observed in bone marrow cells of rat that received 0.09-0.37 and 7.5-15 mg/kg 
bw of phorate, respectively (Dhingra et al., 1990). The overall genotoxicity profile of 
phorate in in vitro and in vivo test systems is summarized in Table 8. 
Table 8. Summary of the in vitro and in vivo genotoxicity of phorate. 
End-point 
In vitro 
Reverse mutation 
Reverse mutation 
Reverse mutation 
Mitotic 
recombination 
Unscheduled DNA 
syntiiesis 
In vivo 
Chromosomal 
aberration 
Dominant lethal 
mutation 
Test system 
S. yphimurium 
TAIOO, TA1535, 
TA1537,TA1538; 
E. coll WP2 
E. CO//p3478;W3110; 
B. subtilis 
Chinese hamsterovary 
cells, hprt locus 
S. cerevisiae D3 
Human fibroblasts 
WI-38 
Male and female 
Sprague-Dawley rats, 
killed after 6, 18, 30 
h 
Male mice 
Concentration 
Of phorate 
Up to lOOOmg/plate 
1 mg (on filter disc) 
30, 40, 50, 80, 100 
nl/ml 
5, 10, 12, 14, 16, 18, 20 
nl/ml 
5% w/v for 4-h 
incubation before plating 
Up to 1x10-^ 
M: 0 (corn oil), 0.25, 
1.25, 2.5 mg/kg bw per 
day; F: 0, 0.13, 0.63, 
1.25 mg/kg bw per day 
0, 5, 10, 20 mg/kg bw 
per day in diet for 7 
weeks, weekly matings 
for 8 weeks 
Purity 
(%) 
Technical 
grade 
Technical 
grade 
92.1 
Technical 
grade 
Technical 
grade 
92.1 
Technical 
grade 
Results 
Negative^ 
Negative'' 
Negative'' 
Negative^ 
Negative^ 
Negative 
Negative 
^ In the presence and absence of metabolic activation; In the absence of metabolic activation. 
Adopted from: http://www. inchem. org/documents/jmpr/jmpmono/v94pr08. htm 
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1. MATERIALS 
1.1. DNA 
Deoxyribonucleic acid (DNA) sodium salt highly polymerized (Type I) from calf 
thymus, (average MoI.Wt. one million), was obtained from Sigma Chemical Company, 
St. Louis, MO USA. 
1.2. Protein 
Human serum albumin (HSA), Grade V, w as purchased from Sigma Chemical 
Company, (St. Louis, MO, USA). In this study, HSA (95-99% pure) was used directly 
without any further purification. The low range (6,500-66,000 Da) lyophilized protein 
marker was purchased from Sigma Chemical Company, (USA). The marker was a 
composite mixtures of aprotinin from bovine lung (6,500), a-Lactalbumin from bovine 
milk (14,200), trypsin inhibitor from soybean (20,100), trypsinogen from bovine 
pancreas (24,000), carbonic anhydrase from bovine erythrocytes (29,000), 
glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle (36,000), ovalbumin 
'from chicken egg (45,000), albumin from bovine serum (66,000). 
1.3. Pesticides/Ligands 
Methylthiophanate (dimethyl 4,4'-(o-phenylene)bis(3-thioallophanate), CAS 
No.23564-05-8; 97% pure and Phorate (0,0-diehtyl-S-[(ethylthio) methyl] 
phosphorodithioate), 94.6% pure were obtained from Agrochemical Division, Indian 
Agriculture Research Institute (lARJ, New Delhi, India). Distamycine A was purchased 
from Sigma Chemical Company, (USA). Diazepam and bilirubin were obtained from 
Sisco Research Laboratories and Ranbaxy, (India). 
1.4. Reagents Used 
(a) Reagents used in agarose gel electrophoresis 
Agarose was obtained from Sigma Chemical Company, (USA). Bromophenol blue 
was obtained from Fermentas Life Sciences, (Germany). Ethidium bromide was 
obtained from Hi-Media Pvt. Ltd, (India). Trizma base (Tris [hydroxymethyl] 
aminomethane) and sucrose were procured from Qualigens Fine Chemicals, Mumbai, 
(India). 
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(b) Reagents used in DNA damage studies 
RPMI-1640 medium and fetal bovine serum (FBS) was procured from BRL life 
Technologies Inc. (Gaithersburg, MD, USA). Propiodium iodide, histopaque 1077, 
cytochalasin B (CytoB), phytohemagglutinin-M (PHA-M), low and normal melting 
temperature agarose (LMA and NMA), methyl methane sulphonate (MMS), ethyl 
methane sulphonate (EMS), 2',7'-dichlorofluorescin diacetate (DCFH-DA), Rhodamine 
123 (Rhl23), 8-Hydroxy-2'-deoxyguanosine (8-oxodG), X-gal and IPTG were obtained 
from Sigma Chemical Company, (USA). Phosphate buffered saline (PBS, Ca^+ Mg^+ 
free), antibiotic/antimycotic solution, L-Glutamine, Heparin, Giemsa powder and trypan 
blue were purchased from Hi-Media Pvt. Ltd, (India). Polyclonal primary (Goat Anti 8-
Hydroxyguanosine) and secondary (Donkey Anti Sheep/Goat IgG:HRP) antibody 
specific for 8-Hydroxy-2'-deoxyguanosine detection in DNA were purchased from 
Serotech, (U.K). Slides for microgel electrophoresis were supplied by Blue Labels 
Scientifics Pvt. Ltd, Mumbai, (India). 
(c) Reagents used in SDS-PAGE and protein degradation studies 
Acrylamide, N, N'- methylenebisacrylamide and TEMED were purchased from 
Sigma Chemical Company, (USA). Tris-HCl, glycine, coomassie brilliant blue R-250 
and sodium dodecylsulfate (SDS), ammonium persulfate, glycerol, glacial acetic acid 
and methanol were obtained from Qualigens Fine Chemicals, Mumbai, (India). 2-
Mercaptoethanol was purchased from E. Merck, Darmstadt, (Germany). 2,4-
dinifrophenylhydrazine, acetophenone, glycine and ninhydrine were purchased from s.d. 
fine chemicals, (India). 
1.5. Other reagents 
Absolute ethanol was procured from E. Merck, Darmstadt, Germany. Dimethyl 
sulfoxide (DMSO), methanol, tri-carboxylic acid (TCA), hydroxyapatite, disodium 
hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, 
potassium dihydrogen phosphate, potassium hydroxide, potassium iodide, sodium 
chloride, formamide, sulfiiric acid, hydrochloric acid, potassium dichromate, 
diphenylamine, perchloric acid (70%), and sodium hydroxide was procured from 
Qualigens Fine Chemicals, Mumbai, India. Bathocuproine disulfonic acid, methylene 
blue, triton X-100 and ethylene diaminetetra acetic acid (EDTA), nutrient agar and 
Luria-Bertani media (Hi-veg) were procured from Hi-Media Pvt. Ltd, India. 
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1.6. Miscellaneous 
Millipore filters (pore sizes 0.22 and 0.45 i^m) were purchased from Millipore Pvt. 
Ltd., Bangalore, India. Whatman filter papers (No.l) were the product of "Whatman 
International Ltd, Maidstone, England. Parafilm 'M' was obtained from American Can 
Company, CT, USA. pH indicator papers were obtained from Qualigens Fine 
Chemicals, Mumbai, India. Aluminium foil was obtained from S.R. Foil Ltd. New 
Delhi, India. Millipore (MQ, DNAase and RNAase free) water was used throughout this 
study. 
2. METHODS 
2.1. pH measurements 
pH measurements were carried out on an Elico digital pH meter, model LI 610 
using a combined electrode (Type CL-51). The least count of the pH nieter was 0.01 pH 
unit. The pH meter was routinely calibrated at room temperature with standard buffers 
of pH 4.0, 7.0 and 9.2. 
2.2. Quantitative analysis ofDNA in solution 
Spectrophotomefric estimation of DNA was carried out according to the method of 
Schneider (1957) by using diphenylamine reagent. 
(a) Diphenylamine reagent 
1.0 g of diphenylamine was accurately weighed and dissolved in 100 ml of glacial 
acetic acid. To this 2.75 ml of concentrated sulfriric acid was added and mixed 
thoroughly. The diphenylamine reagent was prepared fresh at the time of experiment. 
(b) Assay procedure 
Varying amounts of stock DNA (600 |ag/ml) in a constant volume of 1.0 ml were 
mixed with 2.0 ml of diphenylamine reagent and heated for 20 min in a boiling water 
bath. The absorbance of the blue color developed was read at 600 nm and a calibration 
curve was plotted (Figure 17). 
2.3. Quantitative estimation of free acid-soluble amino groups 
Standard calibration curve for glycine was prepared following the modified method 
of Moore and Stein (1954). In brief, glycine (ImM) was taken in a concentration range 
of 0-10 |j,M in different tubes. To this, 0.5 ml of sodium acetate buffer (pH 5.5) and 100 
m = }.8xlff 
0 100 200 300 400 500 600 
DNA (Mg/ml) 
Figure 17. Calibration curve for the estimation of calf thymus DNA. 
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\i\ of ninhydrin (0.35 g of ninhydrin reagent in 100 ml ethanol) were added. The tubes 
were heated in boiling water bath at 100 °C for 10 minutes. After cooling, 2 ml of 50 % 
(v/v) ethanol was added. The precipitation, if any, was prevented with the addition of 
0.5 ml IN HCl. The absorbance of the solution was read at 570 nm against a reagent 
blank and plotted as a fimction of glycine concentration (Figure 18). 
2.4. Quantitative analysis of carbonyl groups in solution 
Carbonyl groups were estimated using 2,4-dinitrophenyIhydrazine agent following 
the method of Lappin and Clark (1951). Increasing concentrations of acetophenone 
stock solution (10 mM) in the range of 0-600 |iM were taken in different test tubes in a 
total volume of 2 ml. To this 1.0 ml of 2,4-dinitrophenylhydrazine reagent (a saturated 
solution prepared in carbonyl free methanol) and one drop of concentrated hydrochloric 
acid were added. The loosely stoppered tubes were heated in water bath at 100 °C for 5 
minutes. After cooling, 5 ml of the potassium hydroxide solution was added. The black 
colored solution gradually changes to characteristic wine red. A calibration curve 
(Figure 19) was plotted between the absorbance at 480 rmi and concentration of 
acetophenone (carbonyl groups). 
2.5. ELISA based8-Hydroxy-2'-deoxyguanosine (8-oxodG) quantitation 
Quantitative estimation of 8-oxodG in calf thymus DNA has been done by plotting 
the standard calibration curve of commercially available 8-oxodG. In brief, varying 
concentrations (250, 500, 1000, 1500, 2000, 2500 and 3000 ng/ml) of commercially 
available 8-oxodG were immobilized by a simple dry absorption for overnight at 40 "C. 
The blocking of the non-specific sites was performed by adding 300 |al of blocking 
solution containing 3 % BSA in PBS (Ca^ "^  & Mg^ "*" free) to each well and the plates 
were fiirther incubated at 37 °C for 3h. Subsequently, 100 |il/well of polyclonal 
antibody (Goat-anti-8-Hydroxyguanosine) against 8-Hydroxy-2'-deoxyguanosine at 
1:1,00,000 dilution in blocking solution was added at ambient temperature by 
incubation for 2 h. The plates were washed three times with PBS containing Tween 20 
(0.05 %). After washing, 100 [il/well of the secondary antibody (Donkey-anti-goat 
IgG:HRP) (1:25,000 diluted) in blocking solution added and the plates were incubated 
for 2 h at 37 °C. The plates were finally washed again three times with PBS+0.05 % 
Tween 20 and then 50 |il/well of (IX) TMB (3,3',5,5'-Tetramethylbenzidine) substrate 
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Figure 18. Calibration curve for the estimation of free amino acid (glycine). 
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Figure 19. Calibration curve for the estimation of carbonyl groups. 
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was aaded. The reaction was stopped by adding of 2M H2SO4 (50 |il/well). The optical 
density of the blue colour developed was measured with a micro well plate reader 
(Labsystems, USA) at 450 rnn and plotted as a function of 8-oxodG concentration 
(Figure 20). 
2.6. Lymphocyte isolation 
Blood was obtained from the healthy male volunteer, aged between 25-28 years, 
free from the following habits; smoking, consumption of alcohol, chewing of tobacco, 
not participating in high physical activities and were not on any type of medication 
during the period of blood sampling. In order to obtain lymphocytes, 3 ml of blood was 
drawn through venous puncture and added to chilled 3 ml of RPMI1640. It was layered 
over 2 ml of histopaque and centrifuged at 800 X g for 20 min. The visible layer of 
lymphocytes formed at the media-histopaque interface was carefully aspirated. The 
lymphocytes were rinsed with RPMI by centrifugation at 250 X g for 10 min. The 
recovered pellet was resuspended in RPMI medium, and processed quickly for the 
experiments. 
2.7. Cell culture media, buffers and solutions used in SCGE (comet) assay 
(a) RPMI 1640 media preparation 
Commercially available RPMI 1640 (with L-Glutamine and without sodium 
hydrogen carbonate) in powdered form was dissolved in 500 ml of autoclaved Milli Q 
water under aseptic conditions. To this L-glutamine (300 mg) and 2 g of sodium 
hydrogen carbonate were added and mixed properly to obtain a clear solution. 
Subsequently, the antibiotic/antimycotic solution (10 ml) was also added and the final 
volume was raised to 900 ml with autoclaved Milli Q water and stored at 4 °C. 
(b) Phosphate buffered saline (PBS, Ca^^ <fe Mg^'^free) 
Dulbecco's PBS (9.6 g) was mixed with 990 ml of Milli Q water, pH was adjusted 
to 7.4 and volume was then raised to 1000 ml. The solution was autoclaved at 121 °C 
for 20 min and stored at 4 "C. 
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Figure 20. Calibration curve for the estimation of 8-Hydroxy-2'-deoxyguanosine 
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(c) Lysing solution 
The lysing solution stock has been prepared by dissolving 2.5 M NaCl (146.1 g), 
100 mM EDTA (37.2 g) and 10 mM Tris-HCl (1.21 g) in 700 ml Milli Q water. To get 
a clear solution 8 g of NaOH was added to this mixture and the pH was adjusted to 10.0. 
Final volvime of the solution was raised to 900 ml and stored at room temperature. To 
prepare firesh lysing solution, 40 ml of the stock solution were added with 1 % (400 i^l) 
of Triton X-100 and refrigerated at 4 °C at least for 30 min prior to use. 
(d) Electrophoresis buffer 
The ION NaOH and 200 mM EDTA stock solutions were prepared separately by 
dissolving 200 g of NaOH in 500 ml and 37.22 g of EDTA in 500 ml of MiUi Q water. 
The stock solutions were stored in dark at room temperature. For every electrophoresis 
run, aliquots of 30 ml NaOH and 5 ml EDTA was dissolved in chilled Milli Q water and 
the volume was raised to 1000 ml. Prior to use the pH>13 was ensured. 
(e) Neutralizing buffer 
0.4 M Tris-HCl buffer pH 7.5 was prepared in MQ water and stored at 4 °C. 
ff) Staining solution 
Concentrated stock of (10 mg/ml) of ethidium bromide (EtBr) was prepared by 
dissolving 100 mg/ml EtBr in 10 ml of Milli Q water. The stock was kept in an amber 
bottle and stored at 4 °C. Before the experiment, 20 |^ 1 of this concentrated stock were 
aspirated and added to 9.980 ml MQ water to get a fresh diluted stock 20 |ig/ml 
concentration. 
(g) Normal melting agarose (NMA 1 %) 
Agarose (1 g) was added to 70 ml of MQ water and heated to dissolve the agarose. 
Ensuring the complete dissolution, volume was raised to 100 ml to, get a concentration 
o f l % . 
(h) Low melting point agarose (LMA 1 %) 
Low mehing agarose 1 % (LMA) was prepared in PBS and aliquoted to 5 ml 
samples into glass vials and refrigerated until needed. Agarose was melted in the 
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microwave before experiment. The vials with molten agarose were maintained at 37 C 
a dry bath. 
(i) Preparation of base slide 
End frosted conventional slides with 1.5 cm frosted ends were used for comet 
analysis. The slides were dipped in methanol and exposed to blue flame for removing 
traces of machine oil. Slides were then dipped for two-third of their length into molten 
NMA 1 % (the frosted end help prevent the gel from slipping off the slide). The slides 
were wiped on the under surface and left for overnight for complete drying to obtain a 
base layer. 
2.8. Solutions used in cytokinesis blocked micronucleus (CBMN) assay 
(a) Fixative solution 
Camoy's fixative solution of methanol and glacial acetic acid was prepared in a 
ratio of 3:1 (96 ml of HPLC grade methanol was mixed with 32 ml of glacial acetic 
acid) and kept at 4 °C. 
(b) Hypotonic solution (0.56 %) 
0.56 g of potassium chloride was dissolved in 100 ml of autoclaved MiUi Q 
water and incubated at 37 "C. Freshly prepared hypotonic solution was used in each 
experiment. 
(c) Giemsa staining solution (6 %) 
0.6 g of Giemsa powder was dispensed in 33 ml of glycerol and kept in oven at 
60 °C for overnight. To this 33 ml of methanol was added and mixed properly. The 
solution was filtered through Whatman filter papers (No.l) and stored in amber colour 
bottle at room temperature until use. The working solution of Giemsa stain was 
prepared by mixing 5 ml Giemsa stock with 95 ml of potassium dihydrogen phosphate 
(31 mM) and disodium hydrogen phosphate (23 mM) solution. 
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(d) Propiodium iodide staining solution 
10 mg of propiodium iodide was accurately weighed and dissolved in 1 ml of PBS. The 
master stock was wrapped in aluminum foil and stored in dark at 4 °C. A working stock 
of 6 [ig/ml in PBS was prepared for staining of experimental slides. 
2.9. Buffers used 
(a) Tris-EDTA buffer (10 mM) 
Tris 0.12 
EDTA 0.032 
pH 8.0 ± 0.2 
(b) Sodium acetate buffer (4M) 
gl-^  
Sodium acetate 544.3 
pH 5.5 
(c) Potassium phosphate buffer (IM) 
gl-' 
K2HPO4 174.18 
KH2PO4 136.09 
pH 7.0 ±0.2 
(d) Tris-acetate-EDTA (TAE) buffer (lOX) 
Tris 48.5 
EDTA 3.5 
Glacial acetic acid 11.2 ml 
pH 7.4 ± 0.2 
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(e) Tris-Glycine buffer (5X) 
gl-' 
Tris 15.1 
Glycine 94 
10%SDS 50 ml 
(f) Normal saline solution 
gl-^  
Sodium chloride 8.68 
pH 7.0 ± 0.2 
3.0. Buffers and solutions used in ELISA 
(a) Phosphate buffer saline 
The commercially available phosphate buffered saline (PBS, Ca^ "^  Mg^ "^  free) was used. 
(b) Blocking solution (IX) 
Blocking solution was prepared by adding 5 g bovine serum albumin (BSA) in 100 ml 
ofPBS. 
(c) Wash solution 
Washing solution was prepared using detergent Tween 20 (0.05 %) v/v in PBS. 
(d) Antibody dilution buffer 
Primary and secondary antibodies were diluted in IX blocking solution. 
4.0. Bacterial growth media 
(a) Nutrient broth and nutrient agar 
(gl'^) 
Yeast extract 1.5 
Beef extract 1.5 
Peptone 5.0 
Sodium Chloride 5.0 
100 
pH 7.00 ± 0.2 
(Nutrient agar was prepared by adding 1.5% (w/v) agar-agar to nutrient broth and 
autodavedat 121 ^Cfor 15 min.). 
(b) Luria-Bertani media (Hi- Veg) (gl"') 
Hi-Veg hydrolysate 10.00 
Yeast extract 5.00 
Sodium Chloride 10.00 
pH 7.5 ± 0.2 
(LB agar was prepared by adding 1.5% (w/v) agar-agar to nutrient broth and 
autodavedat 121 ^Cfor 15 min.). 
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MT-V^JA Interaction 
v,^*-.^ and :<v^.f 
IncCucecC T>3^JA Damage 
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1. Introduction 
DNA conformational changes upon ligand binding is considered to be an interesting 
area in chemical, biological or medicinal research (Stewart & Gray, 1992; Wang & 
Schneider, 1998). The structural changes of DNA in response to different bound ligands 
have attracted several pharmacological industries to design drugs against many diseases 
(Conner et al, 1983; Pinar et al., 2004). On the contrary interaction of DNA with certain 
environmental genotoxicants and/or alkylating agents, induces structural alterations in the 
DNA molecule, detrimental for cells (Shugart, 1995, Tembe & Henderson, 2007). 
Approximately 90 % of the chemicals which covalently hinds to the DNA bases and form 
DNA-adducts are considered to be carcinogenic in humans and experimental animals, 
(Hemminki, 1993). 
Among the environmental chemicals, certain pesticides have been categorized as 
potent genotoxicants and alkylating agent for DNA (Li et al., 1993; Laurent et al., 1996; 
Cui et al., 2006). Earlier studies have shown that some insecticides interact with DNA 
and form promutagenic DNA-adducts (Dhouib et al., 1995; Shah et al., 1997). An 
insecticide carbofuran has been reported to intercalate between the base pairs of calf 
thymus DNA and form DNA-carbofuran adducts (Zhang et al., 2005a). Recently, another 
insecticide Diazinon has also exhibited the quenching of DNA-Etbr fluorescence 
(Kashanian et al., 2008). Such pesticides which either covalent binds/or intercalates in 
DNA molecules forms DNA-adducts may lead to gene mutations and initiate 
carcinogenesis if not repaired or are mis-repaired before DNA replication (Gupta & 
Spencer-Beach, 1996). Specific DNA adducts, DNA breaks, oxidative DNA damage, 
niicronuclei formation may be indicative of an increased hazard. Infact, an increased 
DNA damage enhances the probability of mutations occurring in critical target genes and 
cells, and/or that increased DNA damage is the result of a higher load of genotoxic agents 
which will enhance the process of carcinogenesis (Eisenbrand et al., 2002). 
There are several reports which corroborates the possible link between pesticide 
induced genotoxicity and damage to biological macromolecules in human populations 
exposed to either single or mixture of pesticides (Padmavathi et al, 2000; Zeljezic & 
Garaj-Vrhovac, 2002). Pesticide production in India is a year-round activity, where 
workers login 8 h per day, 6 days per week. These workers are constantly exposed to a 
103 
variety of pesticides. Nonetheless, reports on the genetic damage in populations exposed 
to pesticides jfrom India are scanty (Rita et ah, 1987; Rupa et ah, 1988, 1991a,b; 
Padmavathi et al, 2000; Grover et al, 2003). 
Methyl thiophanate (MT) is one of the broad spectrum fungicides, widely used for 
the control of some important fungal diseases of crops (Hassall, 1990). It has exhibited 
low toxicity on animals (Seller, 1975; USEPA, 1988) and is non-genotoxic to prokaryotic 
and eukaryotic cell:& (Makita et al, 1973; Morya et al, 1983). Most of the toxicity profile 
of MT has been derived from the unpublished reports of the chemical companies 
conducted only for the registration purposes and some of the tests were conducted in 
early 70s with conventional test systems. Techniques frequently employed for analyzing 
interactions of ligand with nucleic acids are fluorescence spectroscopy (Khan & 
Musarrat, 2003; Kashanian et al., 2008), circular dichroism (Zhu et al., 2000; Khan & 
Musarrat, 2003) and cyclic voltammetry (Wang et al., 2003; Kashanian et al., 2008). 
Other useful, techniques which are used to demonstrate are comet assay (Singh et al., 
1988; Tice et al., 2000), micronucleus assay (Fenech, 2000; Bonassi et al., 2001; Dhawan 
et al., 2003), ELISA (Hirayama et al., 1996; Wu et al., 2004;) and ^^P-postlabeling assay 
(Beach & Gupta, 1992; Gupta & Arif, 2001). 
In the available literature on MT, it is hard to find a report addressing the 
interaction mechanism of MT with DNA, and the qualitative or quantitative analysis of 
DNA damage in human cells. The importance of MT toxicity data on human can be 
easily judged from the recommendation of the Pesticides Safety Directorate, U.K meeting 
recommendations (Thiophanate-methyl, 1995). To the best of our information, interaction 
of MT with DNA and consequent structural alterations has not been thoroughly and 
systematically studied. The aim of this study is to address the fundamental questions 
such as: what precisely is the binding affinity of DNA for MT?, How many molecules of 
MT specifically interacts with DNA nucleotides?. Does this interaction promotes the 
DNA damage and MT-DNA adduct formation?. To address these questions, affinity of 
MT towards DNA in the absence and presence of metal ion (Cu II) have been 
determined. Techniques such as fluorescence quenching, circular dichroism and cyclic 
voltammetry were used for determining the (i) affinity and stoichiometry of DNA-MT 
complexation, (ii) effect of Cu (II) ions on DNA-MT interaction, and (iii) induced 
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conformational changes in DNA upon MT binding. Mechanism of MT-DNA interaction 
and precise role of MT in DNA damage have been elucidated based on the data generated 
through flow cytometry, single cell gel electrophoresis (SCGE/comet), cytokinesis 
blocked micronucleus assays, P '^^ -post labeling for oxidative stress. 
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2. Materials and Methods 
2.1. MT- DNA binding analysis by fluorescence spectroscopy 
For assessment of MT-DNA binding through fluorescence studies, the spectral 
measurements were made after incubating MT-DNA solution in dark for 30 min. at 25 
°C. The spectra were recorded under sub-dued light to prevent undesired 
photodegradation. The fluorescence quenching titration of MT with increasing DNA/MT 
molar ratios were performed in a continuous manner. To a fixed concentration of MT (50 
)j.M), the increasing concentrations of DNA (5-100 i^ M) were added to obtain the 
DNA/MT molar ratios from 0.1 to 2. The final volume was adjusted to 3 ml with Tris-
HCl buffer, pH 7.6. Fluorescence measurements were carried out on a Shimadzu 
spectrofluorophotometer, model RF5301PC equipped with RF 530XPC instrument 
control software, at 25 ± 0.1 "C, using a quartz cell of 1 cm path length. The excitation 
and emission slits were set at 3 nm and 10 rma, respectively. The excitation and emission 
wavelengths at which the MT fluorescence recorded were 265 nm and 294 run, 
respectively. DNA alone does not exhibit fluorescence at this wavelength range. Binding 
of MT-DNA complex was determined following methods of Popov et al. (1972) and 
Scatchard (1949), as described by Khan and Musarrat (2003), using the following 
algorithm: ^ ^ 
nKa-KaO = {DNA] [^-QJfDnigJj 
where n is the binding capacity, Ka is the association constant, Q is the ftactional quench, 
[DNAJ is the free DNA concentration, [Drugjr is the total ftmgicide (MT) and R is the 
DNA/MT molar ratio. The value of Ka was obtained from slope of a straight line plot 
between Q/DNA versus Q. The influence of divalent metal ion Cu (II) on the binding of 
MT-DNA was also studied at the molar ratios of 1:0.2. 
2.2. Assessment of MT binding at minor groove of B-DNA by fluorescence 
spectroscopy 
Binding specificity of MT to the minor groove of B-DNA has been studied by 
fluorescence spectroscopy. Distamycine A (DistaA) was used as a fluorescence probe, 
which is capable to bind with AT-rich sequences of the minor groove of B-DNA. The 
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stock solution of DistaA was prepared in absolute ethanol. The fluorescence 
measurements were done by exciting DNA-DistaA complex in the molar ratio of 1:0.2 at 
320 nm and the emission maxima were recorded at 455 nm with excitation and emission 
slits set at 5 and 10 mm, respectively. MT in an increasing molar ratios (0.5-5) was added 
to the solution and scanned for quenching of DNA-DistaA fluorescence. 
2.3. Assessment ofMT-DNA binding with cyclic voltammetry 
The redox potentials of the MT and MT-DNA complex in the absence and presence 
of Cu (II) were determined by cyclic voltammetry in aqueous medium containing 0.4 M 
KNO3, as a supporting electrolyte, at room temperature. Cyclic voltammetric experiments 
were performed using a CH Instruments Electrochemical Analyzer (Japan). A 
conventional three electrode system was employed with a platinum microcylinder as 
working electrode, platinum wire as an auxiliary electrode and Ag/AgCI as a reference 
electrode. The formal potentials (Em) was taken as the average of the anodic (£pa) and 
cathodic (^pc) peak potentials. 
2.4. Circular dichroism (CD) measurements 
CD spectra of MT alone and in combination with calf thymus DNA at the ratio of 
1:5, and in presence of Cu (II) 100 ]xM were obtained in a 1 cm path length cell. The CD 
measurements were carried out with a Jasco spectropolarimeter, model J-815, Italy. The 
instrument was calibrated with d-10-camphorsulphonic acid. All the CD measurements 
were carried out at 25 °C with a thermostatically controlled cell, holder attached to a 
NESLAB RTE-UO circulating water bath (NESLAB Instruments, Inc. USA) with an 
accuracy of ± 0.1 °C. All the spectra were collected at a scan speed of 100 nm per minutes 
with a response time of 1 sec. Each spectrum was the average of four scans and corrected 
by subtraction of a buffered blank under identical conditions. The results were expressed 
as CD[mdeg]. 
2.5. MT-Cu (H) complexation analysis by Stoichiometric titration 
The total amoimt of Cu (I) bound to MT was determined by the titration of Cu (I) 
specific chelater bathocuproine disulfonic acid (BCS). Briefly, 10 |iM MT in 10 mM 
Tris-HCl buffer, pH 7.4 were mixed with 2.5-100 \xM of CUCI2 to get the molar ration 
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between (0.25-10) in presence of constant amount (0.3 mM) of bathocuproine in a total 
volume of 1 ml. The extent of bathocuproine-Cu (I) complex formation at increasing Cu 
(II)-MT molar ratios was determined by measuring absorbance at 480 nm. 
2.6. Bacterialgenotoxicity assay 
The wild-type AB1157 and DNA repair defective strains of E. coli K-12 viz. AB 
2463 {rec A"), AB 2494 {lex A~), AB 1886 {uvr A") and JW 164 {pol A") mutant strains 
were employed for genotoxic assessment. E. coli cells (1 x 10^ CFU/ml) were harvested 
from exponentially grown cultures, and the pellets were suspended in O.OIM Tris-Cl 
buffer, pH 7.4. The cells were treated with MT in increasing concentration range of 0-600 
|j.M and photoexposed to white light for 6 h at 30 °C. The cells were centrifuged and the 
pellets were washed and resuspended in Tris-Cl buffer. Both the treated and untreated 
cells were then serially diluted and plated on nutrient agar plates to assay the colony 
forming ability. Plates were incubated overnight at 37 °C, and the colonies were counted. 
The percent survival was determined and plotted as a function of MT concentration. 
2.7. Bacterial mutagenicity assay 
Plasmid pUC19 DNA (~ 25 ng) in Tris-HCl buffer (0.1 M, pH 7.5) was treated with 
different concentrations of MT (250-1000 [xM) in a final volume of 50 |il at 37 °C for 2 h. 
The treated plasmid DNA was incubated with 0.1 ml of competent DH5a cells at 4 °C for 
30 min followed by 2 min heat shock at 42 ^C. Nutrient broth (1.0 ml) was added and the 
cells were incubated at 37 °C for 1 h for the expression of antibiotic resistance. Cells (0.1 
ml) were then plated on LB plates containing 60 |ig/ml ampicillin, 40 i^l X-gal (dissolved 
in dimethylformamide) and 40 |il IPTG. The plates were incubated overnight at 37 °C 
followed by 4 h of incubation at 4 °C to allow the development of blue colour. Colonies 
were then counted to score the number of mutants (white) colonies versus the number of 
normal (blue) colonies. Competent cells were prepared by the calcium chloride method as 
described by Sambrook et al. (1989). 
2.8. Alkaline unwinding assay 
MT-induced strand breaks in the DNA were quantitated by alkaline unwinding assay 
using hydroxyapatite batch procedure (Kanter & Schwartz, 1979). In brief, the calf 
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thymus DNA (100 |J.g) in a volume of 0.5 ml in multiple sterile tubes were treated with 
MT in the desired DNA nucleotide/MT molar ratios. The untreated and EMS treated 
DNA in the same molar ratios were taken as negative and positive controls. The reaction 
mixtures were exposed to white light (20 J/m^) at 37 °C. The tubes were immediately 
placed on ice and subjected to alkaline unwinding by rapid addition of an equal volume 
of 0.06 N NaOH in 0.01 M Na2HP04, pH 12.5 followed by brief vortexing. Alkaline 
unwinding was allowed to complete in dark for 30 min. The pH of the reaction mixture 
was then neutralized to pH 7.0 with the addition of 0.07 N HCl. Subsequently, 20 [AM 
EDTA containing 2 % SDS was added and the resultant mixture was transferred to pre-
heated stoppered glass tubes containing 0.5 M potassium phosphate buffer, pH 7.0 and 10 
% formamide. The samples were incubated at 60 °C for 2 h with intermittent vortexing. 
The relative amount of duplex and single stranded DNA present at the end of alkaline 
unwinding was quantitated. Single stranded DNA was selectively eluted from the 
hydroxyapatite matrix with 0.125 M potassium phosphate buffer, pH 7.0 containing 20 % 
formamide. However, duplex DNA was removed with 0.5 M potassium phosphate buffer, 
pH 7.0 containing 20 % formamide. Strand breaks were estimated following the equation 
In F= - (KJMN) tfi, where F is the fraction of double stranded DNA remaining after alkali 
treatment for the time t, MN is the number-average molecular weight between two strand 
breaks and ;ff is a constant that is less than 1 (Rydberg, 1975). The number of unwinding 
points (P) per alkaline unwinding unit of DNA were calculated according to the equation, 
P = ln Fx/ln Fo (Kanter & Schwartz, 1979), where, Fx and Fo are the fraction of double 
stranded DNA remaining after alkaline denaturation of treated and untreated samples, 
respectively. The number of breaks (n) per unit DNA were then determined using the 
equations = P-1. 
2.9. Alkaline hydrolysis ofMT-treated DNA 
Calf thymus DNA (500 |ig) was treated with MT in DNA nucleotide/MT molar ratio 
range of 1:1 to 1:10. The reaction mixture was exposed to white light (20 J/m^) for 2 h in 
the presence and absence of 0.1 mM Cu (II). Parallel control without MT was incubated 
under identical conditions. The pH of the reaction mixture at the end of the incubation 
was measured and found to be unchanged. Treated DNA was separately incubated with 
0.1 and 0.5 M NaOH for 1 h to determine the alkali labile sites in DNA. The DNA was 
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then precipitated by adding 1 ml of cold 14 % perchloric acid in the presence of 0.2 ml of 
10 mg/ml bovine serum albumin at 0 °C. The precipitated DNA was centrifuged at 2500 
rpm for 30 min. The pellet was discarded and the acid-soluble nucleotides were estimated 
(Schneider, 1957). 
2.10. Alkaline single cell gel electrophoresis (comet assay) 
Comet assay was performed with human lymphocytes following methods of Singh et 
al. (1988) as modified by Bajpayee et al. (2002). Freshly isolated cells were treated with 
varying concentrations (250, 500, 750 and 1000 |aM) of MT for 3 h at 37 "C. The 
lymphocytes (~ 4x10'* cells) both untreated and treated were suspended in 100 |il of Ca'^ "^  
Mg^ "^  free PBS and mixed with 100 fil of 1 % LMA. The cell suspension (80 jil) was then 
layered on one third frosted slides, pre-coated with NMA (1 % in PBS without C^'^ and 
Mg^"^ and kept at 4 °C for 10 min. After gelling, a layer of 90 \i\ of LMA (0.5 % in PBS) 
was added. The cells were lysed in a lysing solution for overnight. After washing with 
Milli Q water, the slides were subjected to DNA denaturation in cold electrophoretic 
buffer at 4 °C for 20 min. Electrophoresis was performed at 0.7 V/cm for 30 min (300 
mA, 24 V) at 4 °C. The slides were then washed three times with neutralization buffer. 
All preparative steps were conducted in dark to prevent secondary DNA damage. The 
slides were stained with ethidium bromide for 5 min and analyzed at 40X magnification 
using fluorescence microscope (Leica, Germany) coupled with charge coupled device 
(CCD) camera. Images from 50 cells (25 from each replicate slide) were randomly 
selected and subjected to image analysis usmg software Komet 3.0 (Kinetic Imaging, 
Liverpool, UK). The data were subjected to one-way analysis of variance (ANOVA). 
Mean values of the tail length (|im), Olive tail moment (OTM) and % tail DNA (% 
TDNA) were separately analysed for statistical significance, level of statistical 
significance chosen was p < 0.05, unless otherwise stated. 
2.11. Cytokinesis blocked micronucleus (CBMN) assay 
The CBMN assay was preformed following the method of Kalantzi et al. (2004). The 
whole blood (0.5 ml) was cultured in 4.5 ml complete RPMI1640 medium supplemented 
with 20 % heat-inactivated FBS, Lglutamine (0.02 mM), sodium bicarbonate (2.0 gm/L), 
penicillin (100 U/ml), streptomycin (100 jag/ml) and 7.5 |ag/ml PHA-M. Cells were 
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exposed to MT at final concentrations of 50, 100 and 200 \iM and allowed to grow at 37 
°C in presence of 5 % CO2 in air in a humidified atmosphere chamber of CO2 incubator. 
After 24 h, cells were pelleted by spinning at 1000 rpm for 10 min, washed twice with 
RPMI 1640 and resuspended in complete medium without MT. Cytokinesis was blocked 
by adding Cyto B (6 |J.g/ml) after 44 h of incubation. The binucleated lymphocytes were 
harvested after 72 h of culture condition at 1000 rpm for 10 min. Cells were then treated 
with hypotonic solution (0.56 % KCl) for 2-3 minutes to lyse erythrocytes, fixed once 
with methanol and glacial acetic acid (3:1) for overnight at 4 °C. Finally, the cell solution 
was dropped onto cold glass slides. Staining was performed by separately immersing the 
air-dried slides in 6 % Giemsa stain and propiodium iodide (6 |ig/ml in phosphate buffer) 
solution. One thousand binucleated cells for each experimental point were counted, 
following the scoring criteria adopted by the Human Micronucleus Project (Bonassi et 
ah, 2001). The mean binucleated micronucelated lymphocytes (BNMN), were evaluated 
as the number of binucleated lymphocytes containing one or more micronuclei per 1000 
binucleated cells. Moreover, 500 binucleated cells were scored to evaluate the percentage 
of binucleated cells for expressing the toxicity and/or inhibition of cell proliferation as 
nuclear division index (NDI) calculated according to the following formula: 
NDI = (Mono + 2BN + 3Tri + 4 Tetra)/500 
Where, Mono, BN, Tri and Tetra are mononuclear, binucleated, trinucleated and 
tetranucleated lymphoc5^es, respectively. The data were analyzed by one-way ANOVA 
(Tukey test) for determining statistical significance. 
2.12. Measurement of mitochondrial membrane potential 
The mitochondrial membrane potential {AWm) was measured using Rhl23 following 
the method of Lemasters et al. (1993) as described by Wang et al. (2007a). In brief, ~ 2 x 
10^  cells of human lymphocytes were exposed to 50 and 100 \xM of MT in complete 
RPMI 1640 medium. Cells were cultured for 24 h at 37 °C in presence of 5 % CO2 in air 
in a humidified atmosphere chamber of CO2 incubator. The cells were then pelleted by 
spinning at 3000 rpm for 5 min and washed twice with cold PBS and resuspended in 500 
\i\ of PBS. Cells were fiirther incubated with Rhl23 (5 ^ig/ml) for 60 min at 37 °C in dark 
with gentle shaking. The membrane potential was measured by the mean fluorescence 
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intensity (FLl-H 530 nm) of 10,000 cells using flow cytometer (FACSCalibur, Becton 
Dickinson, USA). 
2.13. Measurement of intracellular reactive oxygen species (ROS) generation 
Intracellular ROS production was detected by using a fluorescent probe DCFH-DA, 
according to the method of Huang et al. (2008) with slight modifications. About 2x10^ 
cells of human lymphocytes were exposed to varying concentrations of MT (100-500 
|LiM) in complete RPMI 1640 medium. Cells were cultured for 24 h at 37 °C in presence 
of 5 % CO2 in air in a humidified atmosphere chamber of CO2 incubator (Sheldon 
Manufacturing Inc., USA). After 24 h, the cells were pelleted by spinning at 3000 rpm 
for 5 min and washed twice with cold PBS and resuspended in 2 ml of PBS. Cells were 
incubated with DCFH-DA (5 |j,M) for 60 min at 37 °C in dark. Cells were immediately 
washed twice with PBS and finally suspended with 3 ml PBS. Fluorescence 
measurements were carried out on a Shimadzu spectrofluorophotometer (RP5301PC 
equipped with RF 530XPC instrument control software) at 37 "C, using a quartz cell of 1 
cm path length. The fluorescence intensity was recorded at an excitation wavelength of 
485 nm and emission wavelength of 525 nm. 
2.14. Enrichment and^^P- postlabeling of calf thymus DNAfor 8-oxodG analysis 
Calf thymus DNA (1 mg/ml) was treated with 50 and 150 ]xM MT and photoexposed 
for 60 min at 37 °C. Untreated and methylene blue (50 and 100 [iM) treated DNA were 
run in parallel as negative and positive controls under identical conditions. The DNA 
samples were ethanol precipitated and processed for '^^P-postlabeling analysis of 8-oxodG 
adducts in DNA following the method of Gupta and Arif (2001). In brief, an aliquot of 
the DNA digest (10 |j,l; 5 |ig) was applied to a 10 cm x 10 cm water-washed PEI-
cellulose sheet and the chromatogram was developed with 0.2 M formic acid. The elution 
was performed with 2M TEAA buffer and finally evaporated by lyophilization. The 
lyophilized product was redissolved in 75 |al of HPLC water to get a concentration of 
(66.6 ng/ |j,l). An aliquot (15 |j.l) of the enriched adduct solution (equivalent of 1000 ng of 
enriched DNA digest containing 2 ng of spiked DNA digest) was incubated with 5 [il of 
"hot mix" containing 1 \A of kinase buffer (300 mM Tris-HCl, pH 9.5, 100 mM MgCli, 
100 mM dithitheritol, and 10 mM spermidine), 0.5 \i\ of [Y-32P] ATP (>3000Ci/nimol; 
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100 iaCi/^1; <2 ^M), 0.4 [il of T4 polynucleotide kinase (10 units/|j,I) and 3.1 \xl of water. 
After incubation at room temperature for 60 min, 15 [il of nuclease PI-buffer mix (3 fil of 
500 mM sodium acetate, pH 4.5, 2 ^1 of nuclease PI (1 [ig/\i\), 2 |il of carrier dpT or dpA 
(5 \ig/\i.l) and 8 [xl of water) was added to convert the biphosphates to respective 
monophosphates, and further incubated for 45 min. Thus, the labeled solution (25 |il) 
contained 40 ng/p.1 of 8-oxodG-enriched DNA digest and 0.08 ng/fxl of spiked DNA 
digest. A larger aliquot of the labeled solution (15 |il; -600 ng of DNA) was analyzed for 
8-oxodG by 2-directional PEI-cellulose TLC, as described previously (Devanaboyina & 
Gupta, 1996), except that the development in D2 was in 2.7 M sodium phosphate, pH 5.7, 
to top of the chromatogram (Randerath et al. 1997). To analyze normal nucleotides, a 
smaller aliquot (5 fxl) was diluted to 80 |il with water and 6 |il of the diluted solution 
(-0.3 ng of DNA) was applied on a 10 cm x 10 cm water-washed PEI-cellulose thin 
layer. The sheet was developed one-directionally in 0.5 M acetic acid to 3 cm above the 
origin; the sheet was briefly developed in water to <0.5 cm prior to development in acetic 
acid. Without intermediate drying, the sheet was further developed in 1 M formic acid till 
top of the sheet. Adduct and normal nucleotide spots were detected and quantified by 
phosphoimager. 
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3. Results 
3.1. Fluorescence quenching ofMT upon binding with DNA 
The interaction of MT with calf thymus DNA was studied by monitoring the changes 
in the intrinsic fluorescence of MT at varying molar ratio of MT-DNA. Figure 21 shows 
the fluorescence emission spectra of MT and MT-DNA complex upon excitation of MT 
at 265 nm. Addition of DNA in increasing concentrations to the fixed concentration of 
MT progressively quenches the intrinsic fluorescence of MT. The binding isotherm in 
Figure 22 indicates the relative fluorescence intensities at varying MT-DNA molar ratios 
of 0.1-2.0. The results exhibit around 61% fluorescence quenching at the highest MT-
DNA molar ratio of 1:2. The corresponding Scatchard plot of Q/fBJx 10'^ vs Q is shown 
in the inset of Figure 22. The slope and intercept of the straight line obtained on this 
curve provide the binding affinity {Ka) and capacity {ri) of DNA for MT as 0.5 x 10^ 
Imol"' and 1.6, respectively. 
Figure 23 shows the representative fluorescence emission spectra of MT in absence 
and presence of 10 jiM Cu (II) ions. Considering the fluorescence intensity value of MT 
alone as 100 %, the extent of quenching at a MT-Cu (II) molar ratio of 1:0.2 was 
determined to be 9 %. However, the intrinsic fluorescence of MT in combination with 
DNA alone and MT-DNA-Cu (II) decreased to the extent of 35.53 % and 40.61 %, 
respectively (Figure 23). The results clearly exhibit significant DNA-Cu (II) mediated 
MT fluorescence quenching as compared to DNA or Cu (II) alone. 
3.2. Competitive binding of DNA-Dist&A-MT complex for minor groove of DNA 
To understand the specificity of binding of MT on DNA molecules, competitive 
binding with DNA-DistaA complex has been studied with the rationale that fluorescence 
of a complex can be quenched with the addition of second molecule (Tabassum et al., 
2005). DistaA alone does not show fluorescence at the excitation wavelength of 320, 
however, addition of DNA remarkably enhanced the fluorescence of DistaA at the same 
excitation wavelength ( Stockert e/ al., 1990). A gradual decline in the fluorescence 
emission spectra at 455 nm of DNA-DistaA complex has been obtained with the addition 
of increasing concentration of MT (Figure 24). Considering the fluorescence intensity 
value of DNA-DistaA complex as 100 %, the extent of quenching with MT at the molar 
ratios of 0.5-5 increased fiom 2.55-17.91, respectively (Figure 25). 
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Figure 21. Fluorescence emission spectra of MT in 
absence (uppermost curve) and presence of increasing 
amounts of DNA upon excitation of MT at 265 nm. The 
molar ratios of DNA to MT ranges from 0.1-2.0 (top to 
bottom). 
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Figure 22. Binding isotherm indicating DNA-induced quenching of MT 
fluorescence at increasing molar ratios. Inset shows the Scatchard plot drawn by 
fitting the fluorescence quenching titration data for determining MT-DNA binding 
parameters. 
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Figure 23. Effect of Cu (II) on MT fluorescence. MT fluorescence 
was measured in absence and presence of 50 \iM DNA and 10 [iM 
Cu (II). (Curve 1) MT alone (50 nM), (Curve 2) MT+Cu (II), 
(Curve 3) MT+DNA, (Curve 4) MT+DNA+Cu (II). 
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Figure 24. Competitive binding of MT with the DNA in presence 
of a minor groove binder DistaA. Increasing molar ratios of MT 
induces a gradual decline in the fluorescence of DNA-DistaA 
complex. Curves from top to bottom; DNA-DistaA complex 
(1:0.2), MT-DNA-DistaA molar ratios: 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 
3.5, 4.0, 4.5 and 5.0. 
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Figure 25. Fluorescence reduction in the DNA-DistaA complex with 
increasing molar ratio of MT. 
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3.3. Voltammetric analysis ofMT-DNA binding 
Figure 26 shows the interaction of MT with DNA and transition metal ion Cu (II) in 
aqueous medium containing 0.4 M KNO3 by means of cyclic voltammetry at room 
temperature within the sweep range jfrom +0.2 V to -1.2 V. The cyclic voltammogram of 
the MT, as a ligand, exhibits a quasi-reversible redox peak with Is.Ep value of 293 mV. 
Addition of DNA and DNA + Cu (II) to MT in solution changes the A£p values to 243 
and 224 mV, respectively. The cathodic (ipc) and anodic (ipa) peak currents as well as 
the ratio of ipa/ipc decreases, and the cathodic peak potential {Epc) shifts towards less 
negative value. However, the anodic peak potential {Epa) shifts towards a more negative 
value under identical conditions at a scan rate of 0.3 Vs''. The formal potential, EO' (or 
voltammetric E1/2) taken as the average of Epc and Epa has been determined to be -0.317 
with MT alone. Addition of DNA to MT solution at 1:1 molar ratio shift the value of EO' 
towards more negative potential. 
3.4. Circular dichroism ofMT-DNA-Cu (II) complexes 
The circular dichroism spectra of MT in the absence and presence of DNA and Cu 
(II) ions are shown in Figure 27. The CD spectrum of MT shows the characteristic 
positive bands at 205, 207, 210, 211, 214 and 216 respectively. The equimolar addition of 
ct-DNA to MT has resulted in the disappearance of MT peaks at 214 and 216. Also, the 
parental peaks of MT at 205, 207, 210 and 211 have red shifted by 1, 6, 8 and 9 nm, with 
broadening in all peaks. At least three regions of the spectra were found sensitive to the 
copper ions. With the addition of Cu (II) the parental peaks of MT at 205 and 210 has red 
shifted by 2 and 8 nm. While the broaden peak of MT at 207 also exhibited red shift with 
the formation of two new peaks at 212 and 213. MT peak at 211 has disappeared with the 
addition of Cu (II). MT in presence and absence of DNA and Cu (II) exhibits prominent 
reduction in ellipticity. 
3.5. Stoichiometry ofMT-Cu(II) interactions and quantitation ofCu (I) production 
The Job plot shown in Figure 28 indicates the stoichiometry of MT-Cu (II) 
interaction. An increase in absorbance at 480 nm was noticed with increasing Cu (II)-
MT ratios. The amount of Cu (I) produced in the reaction mixture forms complex with 
bathocuproine and absorbs maximally at 480 nm. The Cu (II) or MT alone does not 
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Figure 26. Cyclic voltammograms showing typical Nemstian behavior of MT 
at a scan rate of 0.3 Vs"'. The peaks 1 to 3 represent: Curve 1: MT (ImM); 
Curve 2: MT (ImM) + DNA (ImM); Curve 3: MT+DNA+Cu (II) (ImM 
each). The curves 1 to 3 and 1' to 3' represent the oxidation and reduction 
peaks, respectively. 
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Figure 27. CD spectra of MT (20 ^M) in 10 mM in Tris-HCl buffer, pH 7.4 in 
the absence and presence of DNA 100 i^M and 100 ^M Cu (II). The characteristic 
positive bands of MT are marked by arrows. 
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Figure 28. Stoichiometry of Cu (II)-MT binding at a fixed concentration of 
MT (10) (iM. The difference in absorbance at 480 nm of the samples with 
and without Cu (II) is plotted as a function of equivalents of Cu (II) per 
molar equivalent MT. The value of the independent variable at the 
intersection of the two lines is a measure of the ratio of Cu (II) to MT. The 
plotted curve show the 7.0 equivalents Cu (II) to 1 equivalent MT. 
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interfere at this absorption maxima. A linear increase in the absorbance was observed up 
to 10:1 molar ratio of eq Cu (II)/MT and reaches to a plateau at higher Cu (II)-MT molar 
ratios. The total number of Cu (I) produced were determined to be 35.30 |iM from 100 
\xM of Cu (II) added. The varying amounts of Cu (I) produced are shovm in Table 9. 
3.6. Genotoxicity assessment ofMT using E. coli K-12 strains 
Exposure of E. coli K-12 strains with the increasing concentrations of MT resulted in 
dose dependent reduction in the colony forming ability of the DNA repair defective 
mutants vis-a-vis wild-type AB 1157 cells (Figure 29). The decrease in percent survival 
of MT treated bacteria was determined to be in the order as pol A~ > lex A > rec A > 
uvr AT mutants. The mutant (pol A~) defective in polymerase I enzyme showed 82 % 
reduction in the survival at the highest dose of 600 |iM MT followed by 69 %, 59 % and 
50.6 % decline in the survival values of lex A , rec A~ and uvr A~ mutants, respectively. 
5.7. MT-induced mutations in lacZ gene 
MT induces a dose-dependent increase in the number of mutants (white colonies) of 
E. coli DH5a with concomitant reduction in the blue colonies (Figure 30). Treatment of 
plasmid pUC19 DNA with varying concentrations of MT (250, 500 and 1000 iiM) also 
resulted in loss of transformation efficiency of the plasmid in E. coli DH5a cells. As a 
consequence of MT treatment, an increase in number of mutant colonies, lacking a-
complementation, have been observed. Decline in the transformation efficiency and fold 
increase in the mutants are shown in (Figure 31). The mutants were identified on the 
basis of color change from blue to white colonies, which they formed due to mutations in 
the non-essential lacZ gene. It is well known that vectors such as plasmid pUC19 DNA 
containing a portion of the lacZ gene provides a-complementation when plated on cells 
containing lacIqZM15 cassette on the tetracycline-resistant F' episome, which makes 
possible for blue:white screening on plates supplemented with X-gal and IPTG. DMSO 
(1 %) set as a solvent control does not shovv any loss of transformation efficiency and the 
numbers of non-mutated colonies were almost similar to the untreated control plates. 
Table 9. Production of Cu (I) upon MT-Cu (II) interaction. 
Cu(II)/MT molar ratio 
MT alone (10 nM) 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
.1 
1 
0.25 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0. 
8.5 
9.0 
9.5 
10.0 
Cu (II) added 
I^ M 
0 
2.5 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
35.0 
40.0 
45.0 
50.0 
55.0 
60.0 
65.0 
70.0 
75.0 
80.0 
85.0 
90.0 
95.0 
100.0 
Cu (I) produced 
jiM* 
0 
1.10 
:2.12 
4.31 
'6.88 
9.47 
12.74 
13.89 
15.67 
18.64 
21.62 
26.21 
29.11 
32.26 
33.65 
36.76 
35.30 
35.32 
35.28 
35.13 
35.25 
35.30 
Concentration of Cu (I) were calculated by using the equation A=8cl in 
which molar absorptivity (e) of Cu (bathocuproine)2"^ complex = 13500 
and path length (1) = 1 cm, AA480 was obtained from A480 of the sample 
with and without Cu (II) addition. 
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Figure 29. Effect of MT on the survival of DNA repair proficient and 
defective mutant strains of E. coli K12. Each data point represents the 
mean ± SEM of three experiments. 
Figure 30. Concentration dependent effect of MT on lac z gene. Blue 
colonies representing lac" bacteria in presence of the chromogenic 
substrate, X-gal. Mutated colonies turned to white upon MT treatment. 
(A) Untreated control, (B-D) MT 250, 500 and 1000 ^iM. 
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Figure 31. Effect of MT on percent transformation efficiency of plasmid 
pUC19 in competent E. coli DH5a cells. Inset shows an increase in the 
number of mutant (white) colonies with increasing concentration of MT. The 
data points are the mean ± S.D of three independent experiments done in 
triplicate. Ct 1: untreated control, Ct 2: DMSO (1%) as solvent control. 
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3.8. MT-induced strand breaks in DNA 
Treatment of calf-thymus DNA with MT resulted in concentration dependent decrease 
in the fraction of duplex DNA with simultaneous increase in the degree of single 
strandedness in DNA (Figure 32). Based on the amount of duplex DNA remaining after 
alkali treatment for a specified time, the number of strand breaks formed per unit DNA 
were determined at corresponding MT concentrations. A parallel control does not show 
any reduction in the amount of duplex DNA. At the highest DNA nucleotide/MT molar 
ratio of 1:10 in absence and presence of Cu (II), approximately 4.4 and 8.9 strand breaks 
per unit of DNA were produced (Table 10). 
3.9. Alkaline hydrolysis ofMT- treated DNA 
Alkaline hydrolysis of MT-treated DNA exhibited progressive increase in the amount 
of acid-soluble nucleotides released both in the absence and presence of 100 i^M Cu (II) 
upon exposure to 0.1 and 0.5 M NaOH (Tables 11 and 12). At the highest DNA 
nucleotide/MT molar ratio of 1:10, the percent hydrolysis were estimated to be 45.6 % 
and 64 % with 0.1 and 0.5 M NaOH, respectively. The transition metal ion Cu (II) in 
presence of MT resulted in significantly higher DNA hydrolysis. The results showed 
around 75 % and 97 % DNA hydrolysis at DNA nucleotide/MT molar ratio of 1:10 with 
0.1 and 0.5 M NaOH, respectively. Under identical conditions, the untreated control 
native DNA and DMSO treated DNA at 1:10 molar ratio do not undergo any significant 
hydrolysis. 
3.10. Assessment of DNA damage in human lymphocytes by alkaline SCGE assay 
MT-induced single strand breaks in human lymphocytic DNA has been demonstrated 
using SCGE under alkaline conditions. Figure 33 (Panels D-G) shows dose-dependent 
increase in the size of comet tails with concomitant reduction in head size. The digitized 
images of representative comets clearly demonstrate the extent of broken DNA liberated 
from the heads of the comets during electrophoresis, with increasing MT dose. The 
quantitative data obtained from the comparative analysis of a set of 150 cells at each MT 
concentration with the untreated and DMSO treated control cells revealed 4.6-fold 
enhanced DNA migration at 1000 i^M MT. The MT-treated lymphocytes at 1000 |iM 
showed an OTM value of 40.28 (AU) as compared to 3.29 (AU) of untreated control. The 
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Figure 32. Alkaline unwinding of MT treated DNA. Fraction of 
duplex DNA recovered after treatment with increasing concentrations 
of MT, and plotted as a fianction of DNA nucleotide/MT molar ratio. 
The values plotted are mean ± SEM of two independent experiments 
done in duplicate. 
Table 10. Strand breaks in calf thymus DNA produced by MT and MT plus 100 i^ M Cu (II). 
DNA nucleotide/MT molar Number of breaks per unit DNA (n) 
ratio 
MT MT + Cu (II) 
Control untreated DNA N.D N.D 
Treated DNA (EMS, 1:10) 7.0 
1:2 1.09 2.96 
1:4 2.07 4.53 
1:6 3.13 6.68 
1:8 3.61 7.63 
1:10 4.38 8.82 
N.D: Not detectable. 
Table 11. Alkaline hydrolysis of MT treated calf thymus DNA. 
DNA nucleotide/ 
MT molar ratio 
Untreated native DNA 
DNA+ DMSO (1:10) 
DNA + EMS (1:10) 
1:1 
1:2 
1:4 
1:6 
1:8 
1:10 
O.lMNaOH 
Acid soluble 
nucleotides (|ig) 
N.D 
N.D 
198.06 
04.81 
14.65 
52.80 
126.30 
162.90 
228.20 
% hydrolysis 
N.D 
N.D 
39.60 
0.80 
02.90 
10.50 
25.20 
32.50 
45.60 
0.5MNaOH 
Acid soluble 
nucleotides (|ug) 
N.D 
N.D 
349.80 
09.480 
62.50 
127.80 
175.60 
261.80 
322.40 
% hydrolysis 
N.D 
N.D 
69.80 
01.80 
12.50 
25.00 
35.00 
52.30 
64.40 
N.D: Not detectable. 
Table 12. Alkaline hydrolysis of MT treated calf thymus DNA in presence of 100 }.iM Cu (II). 
DNA nucleotide/ 
MT molar ratio 
Untreated native DNA 
DNA+ DMSO (1:10) 
DNA + EMS (1:10) 
1:1 
1:2 
1:4 
1:6 
1:8 
1:10 
O.lMNaOH 
Acid soluble 
nucleotides (|.ig) 
N.D 
N.D 
202.84 
124.70 
198.07 
277.80 
314.50 
357.56 
375.10 
% hydrolysis 
N.D 
N.D 
40.50 
24.00 
39.60 
55.50 
62.80 
71.50 
75.06 
0.5MNaOH 
Acid soluble 
nucleotides (jj-g) 
N.D 
N.D 
440.28 
145.40 
274.60 
351.10 
379.80 
407.00 
485.00 
% hydrolysis 
N.D 
N.D 
88.00 
29.00 
54.00 
70.00 
75.90 
81.40 
97.00 
N.D: Not detectable. 
Figure 33. Epi-fluorescence comet images of MT-induced DNA damage in human 
lymphocytes. The representative photomicrographs have been acquired through 
Komet 3.0 software. (A), Untreated control: (B), DMSO (1%) as solvent control 
(C): EMS (2 mM) treated cells, as positive control: (D-G), cells treated with MT at 
250, 500, 750 and 1000 ^M, respectively. 
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MT-treated lymphocytes at the highest dose of 1000 \xM showed almost similar extent of 
DNA damage as observed with 2 mJVI EMS, as positive control. A significant increase in 
the values of OTM, % tail DNA and tail length (|^ m) at concentrations above 250 [xM 
was observed (Table 13). The advantage of comet assay is that it is capable of analyzing 
population of cells with various degrees of DNA damage. Thus, some differences exist in 
the distribution of damage in cell population. The heterogeneity in the distribution of 
DNA damage among cells is shown in Figure 34. The histogram shows that 100 % of 
EMS treated cells (positive control) have OTM> 20 as compared to 60 % cells of 
untreated controls with the OTM value of 4.0. At 250 |iM concentration, the OTM values 
of MT-treatment cells vary from 4.0 to 12.0. Around 40 % cells at this concentration 
were observed with OTM value of 8.0 and none were found to have the OTM of >20. 
The percentage of cells with OTM > 20.0 increased substantially from 10 % at 500 )aM to 
90 % andlOO % cells at 750 and 1000 |iM MT doses respectively. 
3.11. Micronucleus formation in MT exposed human lymphocytes 
Figure 35 shows a concentration dependent increase in the total number of BNMN 
human lymphocytes upon exposure to MT. The 24 treatment Avith MT resulted in a 
significant increase (p<0.05) in the mean BNMN/1000 cells as validated by one-way 
ANOVA. The mean BNMN with 50, 100 and 200 i^M of MT concentrations were 
determined to be 13.5, 21, and 45, respectively. The mean BNMN cells with the 
untreated, DMSO solvent and MMS as a positive controls were 7, 6 and 16, respectively 
(Table 14). In order to better characterize the effect of MT, NDI was also evaluated, 
which shows a decline in the BN cell formation. The MT treated groups showed the NDI 
of 1.87, 1.82 and 1.74 with 50, 100 and 200 \iM of MT vis-a-vis the untreated control 
showing an NDI of 1.9. Figure 36 (A-F) shows the binucleated cells in parallel sets of 
untreated, DMSO and MMS controls. The MT treated cells stained with Giemsa stain and 
propiodium iodide are shown in Figure 37 (A-D), clearly indicate the presence of 
micronucleus in MT treated human lymphocytes. 
3.12. Effect ofMT on mitochondrial membrane potential (A Wm) 
The flow cytometric data in Figure 38, representing counts on Y-axis vs. FLl-H on X 
axis provided the peak fluorescence intensities of the Rhl23 probe in MT-treated 
Table 13. MT-induced DNA damage in human lymphocytes analyzed using different 
parameters of SCGE assay. 
Groups 
Control 
DMSO 
(0.5%) 
EMS (2 mM) 
MT (fiM) 
250 
500 
750 
1000 
Olive tail moment 
(Arbitrary Unit) 
3.29 ±0.35 
3.34 ±0.09"' 
48.99 ± 5.29 '** 
6.96 ± 0.85"' 
15.05 ± 2 . 9 1 " 
30.09 ± 0.45 *" 
40.28 ± 2.64 *" 
Tail DNA (%) 
8.52 ±1.12 
8.52 ± 0.45"' 
*** 
51.55 ±3.62 
15.46 ± 0 . 7 2 ' 
25.19 ±3.17*" 
37.78 ± 0.40 *" 
44.39 ±2 ,03*" 
Tail length (fim) 
45.23 ±0.54 
43.78 ±0.71" ' 
204.41 ±1.09*" 
93.94 ± 0 . 8 4 " 
148.84 ± 1 . 0 6 " ' 
171.69 ±0.75"* 
201.22 ±1.09*" 
Data represent the mean ± SEM of three experiments, ns = non significant; * p<0.05; 
**p<O.Ol; ***/7<0.001; EMS: Ethyl methanesulfonate; DMSO: Dimethysulfoxide. 
EMS 2mM 
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Figure 34. Effect of MT concentrations on Olive tail moment of DNA comets. 
Percent distribution of control and MT-treated lymphocytes is shown based on 
varying OTM values obtained in MT concentration range of 250-1000 i^M. The 
untreated (Ct 1), DMSO (1.0%) (Ct 2) and EMS (2 mM) treated cells were 
taken as negative and positive controls. Each histogram represents the mean 
value of three independent experiments done in duplicate. 
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MT (jiM) 
Figure 35. Development of binucleated micronucleated cell (BNMN) in human 
lymphocytes exposed to MT for 24 h. Ctl: untreated control; Ct2: DMSO (1.2 %) solvent 
control; Ct3: methyl methane sulphonate (MMS) 100 |aM as positive control. Data are the 
mean ± S.D of three independent experiments, * = p<0.05, ns = non significant. 
Table 14. Effect of MT on micronuclei formation in human lymphocytes. 
Compound 
Control 
DMSO (%) 
MMS (|iM) 
MT ( i^M) 
Dose 
0 
1.2 
100 
50 
100 
200 
BNMN/1000 cells 
7.0 ±1.41 
6.0 ±1.38"' 
16.0 ±2.82* 
13.5 ±3.53"' 
21.0 ±3.48* 
45.0 ±5.65* 
NDI 
1.9 
1.9 
1.82 
1.87 
1.82 
1.74 
Data represent the mean ± S.D of three experiments done in duplicate. MMS: methyl 
methane sulphonate (as positive control); DMSO: solvent control; ns= non significant, *= 
p<0.05 analysed by Tukey test. 
Figure 36. Representative photomicrographs of the typical binucleated human 
lymphocytes appeared after 24 h of CBMN assay. Panels (A-C) represent 6 % Giemsa 
stained cells of (A) untreated, (B) DMSO (1%) as solvent and MMS (100 i^M) as 
positive controls. Panels (D-F) are the propiodium iodide (6 |ig/ml) stained cells of the 
similar set of controls. Arrow indicates the presence of micronucleus in MMS treated 
cells. 
Figure 37. Representative photomicrographs of the binucleated 
micronucleated cells appeared after 24 h of MT exposure. Panels (A 
and B) represent 6 % Giemsa stained cells treated with (A) MT 100 
and (B) MT 200 [iM. Panels (C-D) are the propiodium iodide (6 
|ag/ml) stained cells with similar treatment. Arrow indicates the 
presence of micronucleus in cells. 
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Figure 38. MT- induced reduction in mitochondrial membrane potential 
(A Wm). Change in the A Tm was measured by Rh 123, a fluorescent probe, 
with FACSCalibur at FLl channel with excitation wavelength of 488 nm. 
MFI: mean fluorescence intensity. 
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lymphocytes. The mean fluorescence intensity (MFI) values, as displayed for each plot 
has been computed by the software based on the peaks shown in Figure 38 have exhibited 
noticeable reduction, although an apparent change in the peak is not appreciable. The 
fluorescence probe Rhl23 selectively enters mitochondria with an intact membrane 
potential and is retained in the mitochondria. The mitochondrial fluorescence intensity 
decreases quantitatively in response to dissipation of the mitochondrial membrane 
potential (Lemasters et al., 1993). After 24 h treatment of lymphocytes with 50 and 100 
|iM MT, the /i Wm of human lymphocytes decreased significantly as compared to the 
untreated control. The extent of reduction in Rhl23 fluorescence was determined to be 
19.51% and 55% with 50 and 100 ^M MT, respectively (Figure 39). 
3.13. ROS generation in human lymphocytes upon MT exposure 
Intracellular ROS generation was detected in lymphocytes treated with MT in 
concentration range of 100-500 i^ M. Figure 40 shows enhancement of the fluorescence 
emission spectra of DCFH-DA stained MT treated human lymphocytes, after 24 h of 
treatment. The dye undergoes oxidation to yield substantial amount of fluorescent probe 
DFC, as compared to the untreated control. Considering the fluorescence intensity of 
untreated control cells as 100 %, the MT treated cells in concentration range of 100, 250 
and 500 ]xM exhibited 20.5 %, 25.24 % and 33.41 % higher fluorescence intensity of 
DCF. H2O2 (400 nM) and DMSO (1 %) taken as positive and solvent controls exhibited 
21 % and 0.61 % higher fluorescence intensity as compared to the untreated control cells 
(Figure 41). 
3.14. Assessment ofS-oxodG adducts in ^^Ppost-labeled calf thymus DNA (ct-DNA) 
The data in Figure 42 (A-F) and Table 15, show the qualitative and quantitative 
analysis of 8-oxodG adducts in untreated and MT treated ct-DNA. The autoradiographs 
of typical adduct spots exhibited a distinct difference in the intensity of the spots between 
untreated, MT treated ct-DNA and MB as positive controls, respectively. Quantitative 
measurement of adduct radioactivity revealed significantly higher adduct levels of 5.29 ± 
1.1 and 6.20 ± 0.01 8-oxodG adduct/10^ nucleotides (p<0.05) with MT (50 and 150 |aM). 
versus 3.67 ± 0.9 adducts/10^ nucleotides in untreated ct-DNA. The level of 8-oxodG was 
found to be comparable with the positive control MB, which on photoexciation induced 
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Figure 39. Histograms showing the Rhl23 fluorescence intensity of MT treated 
human lymphocytes. The results are expressed as the mean ± SD of data obtained 
in three independent experiments (*p <0.05 relative to control). Ct 1: untreated 
control. 
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Figure 40. Fluorescence emission spectra of MT treated cells showing the 
fluorescence enhancement of DCF with increasing concentrations of MT. From 
bottom to top, curves 1-6 are: untreated control, DMSO (1%) solvent control, H2O2 
(400 nM) positive control, MT 100, 250 and 500 |aM, respectively. 
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Figure 41. MT-induced ROS generation in human lymphocytes. Cells treated 
with varying concentrations of MT for 24 h showing significant enhancement in 
DCF fluorescence against controls. Ctl: untreated control; Ct2: DMSO (1%) 
solvent control; Ct3: H2O2 (400 |iM) positive control. The results are expressed 
as the mean ± SD of data obtained in three independent experiments (*p <0.05, 
ns= non significant). 
Figure 42. Autoradiogram of P post-labeled MT treated calf thymus DNA 
depicting 8-oxodG adducts. The spot in the images (Panels A-F) are 
represented as CI: untreated ct-DNA. MB land MB2: methylene blue (50 and 
100 |LiM) treated ct-DNA, taken as positive controls. MTl, MT-2 and MT-3: 
ct-DNA exposed to 25, 50 and 150 ^M MT. 
Table 15. Quantitative analysis of 8-oxodG formation in calf 
thymus DNA by •^^P-postlabeling. 
Treatment 8-oxodG /lO* N 
CI: Untreated ct-DNA 3.67 ±0.9 
MBl: ct-DNA+MB (50 ^M) 4.22 ± 0.5* 
MB2: ct-DNA+MB (100 ^M) - 6.38 ± 2.6* 
MTl: ct-DNA+MT (25 \iM) 1.57 ± 0.7"' 
MT2: ct-DNA+MT (50 )aM) 5.29 ± 1.1* 
MT3: ct-DNA+MT (150 ^M) 6.20 ±0.01* 
MB: methylene blue, as positive control; MT: methyl thiophanate. 
Data are the mean ± SE of two separate analysis. The level of 
significance was analyzed by performing Tukey test. 
*= significant at j!?<0.05, ns = non significant. 
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4.22 ± 0.5 and 6.38 ± 2.6 adducts/10^ nucleotides at a concentration of 50 and 150 i^M. 
At a lower concentration of 25 fxM, MT does not show any significant level of 8-oxodG. 
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4. Discussion 
In this study, interaction of MT with calf thymus DNA has been assessed by 
fluorescence spectroscopy, cyclic voltammetry and circular dichroism study. The mode 
and extent of interactions of MT with DNA have been confirmed by fluorescence 
measurements. The fluorescence data revealed quenching of intrinsic fluorescence of MT 
to a significant extent upon interaction with DNA. This may be due to masking or burial 
of MT chromophores either due to intercalation between the stacked bases within the 
helix and/or surface binding at the reactive nucleophilic sites on the heterocyclic 
nitrogenous bases of DNA molecule. The fluorescence data suggested weaker 
electrostatic interactions of MT with DNA. Such interactions resulted in the formation of 
MT-DNA binary complex. The Scatchard analysis revealed a significantly higher 
association constant (Ka = 0.5 x 10^ Imol" )^ between MT and DNA, which indicates the 
affinity of this fungicide towards DNA. 
Addition of Cu (II) results in formation of MT-Cu (II) DNA complex, which further 
augments the DNA damage mainly due to the formation of MT-Cu(II)-DNA ternary 
complexes, inducing the conformational changes by the local unwinding resulting the 
loss of the helical integrity of duplex DNA. It is surmised that irrespective of the nature 
of interaction, the binding of MT-Cu (II) cause perturbations in the secondary structure of 
DNA. The preferential binding of MT for the DNA minor groove has been explored by 
the fluorescence spectroscopy using the polypyrrole antibiotic Distamycin A (DistaA), 
which is characterized by repeating pyrrole units connected by amide bonds and ending 
with one or more positively charged nitrogen atoms. DistaA is capable of interacting with 
the minor groove of B-DNA based on its curved shape, which matches well with the 
topology of double-stranded DNA. Dista A and its derivative compounds have thus been 
referred to as "shape-selective" binders (Tse & Boger, 2004). In general, the deeper and 
narrower minor groove of AT-rich sequences, and the absence of the protruding 2-amino 
group of guanine (G), is optimal for accommodating the shape of the compound and for 
maximizing the stabilizing Van der Waal's contacts. Hydrogen bonding between the 
groove floor base pairs and the linking amides and electrostatic stabilizing interactions 
with the protonated amines are primary contributors to the overall ligand/DNA stability. 
A gradual decline in the fluorescence intensity of the DNA-DistaA complex with the 
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increasing molar ratios of MT suggested the possible displacement of DistaA and the 
formation of MT-DNA complex in the minor groove. MT is a benzimidazole class of 
compound and such interaction could be due to its structural similarity with other 
benzimidazoles which are the known binders of DNA minor groove (Nelson et al., 2007). 
Furthermore, the typical quasi-reversible redox peaks of cyclic voltammogram of the 
MT, as a small ligand, upon interaction with DNA and DNA-Cu (II) produced 
characteristic changes in the AEp and EO' values. The negative shift in formal potential 
{EO') indicated that MT binds favorably with DNA via electrostatic binding. This finding 
corroborates well with the observations of Carter & Bard (1989), who have reported 
electrostatic mode of interaction betweeri small molecules and DNA, if EO' shifts to a 
more negative value. However, if EO' shifts to more positive value, the interaction mode 
is intercalative (Zhang et al., 2005b). Nevertheless, the phenomena,of the shift of £0 ' and 
decrease of cathodic (ipc) and anodic (ipa) peak currents implied forming a new 
association complexes such as MT-DNA and MT-DNA-Cu (II). 
The CD data exhibiting substantial changes in the ellipticity values clearly suggested 
the structural alterations in fungicide and formation of MT-DNA-Cu (II) ternary 
complexes. These ternary complexes may indirectly enhance the surface binding of MT 
to DNA due to metal ion bridge formation. Furthermore, the stoichiometric data obtained 
from the Job plot with the Cu (I) specific chelating agent bathocuproine have revealed the 
possibility of binding of 7 equivalents of Cu (II) with MT, with subsequent reduction to 
Cu (I), as Cu (I) is required for damage to biomolecules (Burkitt, 2001; Jewett et al., 
1999). The overall interaction data reflecting spectral changes in the MT upon binding 
with DNA and Cu (II) ions, elucidate the significance of MT, DNA and Cu (II) 
interactions related to genotoxicity and cytotoxicity. Th e positive results of alkaline 
unwinding assay using hydroxyapatite, as a matrix for DNA binding, supported the 
hypothesis of MT-induced strand breakage. The data revealed approximately 4.4 and 9.0 
strand breaks per unit DNA molecule with MT alone and MT + Cu (II) , respectively. 
This suggests the role of Cu (II) in promoting the MT-induced DNA damage. It has also 
been reported that the DNA molecule when exposed to alkaline conditions beyond the 
helix-coil transition range (pH> 11.5) undergo strand separation, i.e. unwinding at each 
formal strand break under controlled experimental conditions (Daniel et al., 1985). The 
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amount of duplex DNA remaining after a given period of alkaline unwinding was 
determined to be inversely proportional to the number of strand breaks at the initiation of 
alkaline procedure. The direct effect of MT on DNA has also been assessed both in 
presence and absence of Cu (II) by alkaline hydrolysis with 0.1 and 0.5 M NaOH. 
Susceptibility of MT treated DNA to alkaline hydrolysis also suggests MT-Cu (II) 
induced DNA alkylation and creation of apurinic and/or apyrimidinic sites on the DNA 
molecule. The phosphodiester bond cleavage near each apurinic site produces acid-
soluble material upon alkaline hydrolysis (Tamm et ah, 1953). Thus, the release of acid 
soluble material from MT-treated DNA confirmed the formation of apurinic and/or 
apyrimidinic sites in the DNA molecule. It is reported that the purine residues methylated 
at N-3 and N-7 positions, are released at an accelerated rate (Lawley & Warren, 1976). 
The increased hydrolysis of alkylated DNA with 0.5 M NaOH suggests the formation of 
both the apurinic sites as well as phosphotriesters. These results are in agreement with the 
earlier studies demonstrating that the DNA hydrolysis with 0.1 M and 0.5 M NaOH 
possibly discerns the apurinic sites and phosphotriesters (Shooter & Merrifield, 1978). 
Induction of single strand breaks and alkali labile sites have also been reported in DNA 
treated with the alkylating agents N-nitrosourea (Su et al, 1983). 
A theoretical model for the mechanism of interaction between MT and DNA (G-C 
and A-T base pairs) has also been envisaged and presented as schemes-I and-II (Figures 
43 and 44). The proposed schemes explicitly suggested the possibility of methyl group 
(*'CH3) transfer to DNA nucleotides with the development of transient activated groups 
during the formation of stable MT-Cu (II) complex. In all likelihood, the basic chemistry 
involved in the interaction process is the transfer of free lone pair of electrons, at neutral 
pH, at the reactive C-2 and N-3 positions on the bilaterally symmetrical arms attached to 
the aromatic ring of MT, which facilitates the release of methyl cations. The methyl 
moieties could be preferentially trapped at the nucleophilic centers 0-6 and N-3 positions 
of guanine, N-6 and N-3 of adenine and 0-2 of thiamine. The addition of methyl group to 
the nitrogenous base perturbs their aromatic character, causing hydrogen bond breakage 
and consequent GC to AT mispairing. The possible alkylation at 0-6, N-3 positions of 
guanine and N-6 and N-3 of adenine and 0-2 of thiamine could be an additional factor 
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promoting MT genotoxicity. Several in vitro and in vivo studies have already reported the 
mutagenic and genotoxic properties of 0-6 alkyl guanine (Margison et al., 2002; 
Musarrate/'a/. 1995, 1996). 
The role of MT-DNA interaction in the genotoxicity and mutagenicity has been 
ascertained with sensitive test systems. The bacterial genotoxicity data revealed that MT 
grossly perturbs the structural integrity of cellular DNA. The survival pattern of DNA 
repair defective mutants of E. coli K-12 unequivocally suggested MT-induced 
genotoxicity, due to induction and persistence of cellular DNA damage. Significant 
reduction in the survival of the pol A" mutant indicates the formation of DNA strand 
breaks. Moreover, the substantial decrease in percent survival oi lex A~and rec A" 
mutants vis-a-vis wild-type counterpart implies the involvement of error-prone (SOS) 
repair pathway in repairing the MT-induced DNA lesions. The mutagenicity of MT has 
been further validated by the pUC19 DNA, which carries a short segment ofE. coli DNA 
that contains the regulatory sequences and coding information for the first 146 amino 
acids of the P-galactosidase gene (lacZ). Embedded in the coding region is a polycloning 
site that does not disrupt the reading frame but results in the harmless interpolation of a 
small number of amino acids into the amino terminal fragment of ;5-galactosidase. 
Vectors of this type are used in host cells (such as DH5a) that code for the carboxy 
terminal portion of the y5-galactosidase. Although neither the host-coded nor the plas'mid-
coded fragments are themselves active, they can associate to form an enzymatically 
active protein. This type of complementation, in which deletion mutants of the operator-
proximal segment of the lacZ gene are complemented by y5-galactosidase-negative 
mutants that have the operator proximal region intact, is called a-complementation 
(Short et al., 1988). The Lac"^  bacteria that result firom a -complementation are easily 
recognized because they form blue colonies in presence of a chromogenic substrate, X-
gal. However, mutation in the lacZ part of the plasmid almost invariably results in 
production of an amino terminal fragment that is not capable of a-complementation 
(Ahmad et al., 2005). The dose dependent increase in the mutant white colonies with 
simultaneous decrease in the blue colonies is a clear index of MT-induced mutagenesis in 
lacZ gene. The genotoxicity of MT on human systems has been further ascertained on 
lymphocytes, as these cells lymphocytes are highly exposed to compounds across the 
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blood stream. Therefore, human lymphocytes has been selected as model with the aim to 
provide better understanding of the MT genetic toxicity for industrial workers who might 
be exposed to this fungicide. The SCGE (comet) data revealed a significant increase in 
the OTM and comet tail length, as an index of MT concentration dependent DNA 
damage. The damage in treated lymphocytes might have occurred due to interaction of 
MT and/or its metabolites with cellular DNA, resulting in the formation of frank strand 
breaks and DNA adducts. This corroborates well with the earlier studies, which 
demonstrated the pesticide-induced chromosomal aberrations, sister chromatid exchanges 
and DNA adduct formation in human lymphocytes (King et al, 1993; Ribas et ah, 1996; 
Kevekordes et al, 1996). The intracellular MT-Cu (II) complex formation and the Cu 
(II)/Cu (I) redox cycling in vicinity of the DNA molecule may also result in the DNA 
damage owing to the formation of ROS. The intracellular measurement of ROS 
production as detected by the fluorescent probe DCFH-DA confirmed the MT-induced 
ROS formation. Also, the exposure of lymphocytes to MT significantly altered the 
mitochondrial membrane potential {A Wrri), as measured in terms of the reduction in the 
mitochondrial fluorescence intensity (FLl-H) peak by flow cytometry. A noticeable shift 
in the FLl-H peak upon MT treatment marked with lower fluorescence intensity, 
suggests the perturbation of the inner mitochondrial membrane, and consequent 
mitochondrial dysfunction as a result of ROS generation in cells. This corroborates well 
with earlier observation of Ling et al. (2003) and Derouet-Humbert et al. (2005). 
Treatment of lymphocytes with MT for 24 h with subsequent addition of Cyto B 
resuhed in formation of binucleate cells having variable number of micronuclei as 
function of MT concentration, which is suggestive of the clastogenicity of the fungicide. 
This is in agreement with the earlier report indicating the clastogenic potential of MT 
(Herila et al, 1996). The significant increase in the numbers of MN formation in 
binucleated cells at the MT doses of 100 and 200 \xM vis-a-vis untreated control, 
unequivocally demonstrated the DNA damaging potential of the test fungicide in human 
cells. The micronuclei formation, in response to any chemical/toxicant, has been regarded 
as a biomarker of genotoxicity (Colognato et al, 2007). MT treatment to cells also leads 
to oxidative stress as evident from the formation of 8-oxodG in treated DNA. The data on 
8-oxodG adducts formation, as a marker of oxidative DNA damage, by P^^  post-labelling, 
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clearly demonstrated significantly higher levels of 8-oxodG adducts in calf thymus DNA 
treated with MT under in vitro conditions. Earlier studies have also reported the 
formation of 8-oxodG DNA lesions with other pesticide treatments (Munnia et al., 1999; 
Le Goffer a/., 2005). 
In conclusion, MT has exhibited oxidation-reduction potential in aqueous 
environment, in addition to its tendency of releasing highly reactive oxygen species. Most 
likely, the MT in reduced form under goes oxidation with intracellular transfer of electron 
to either molecular oxygen to form superoxide (O2 ) anions or to transition metal ion Cu 
(II). Copper ions exhibit very high affinity for DNA, and the DNA-bound Cu (II) can 
undergo Cu (II)/Cu (I) redox cycling in a reducing environment, and also O2 reduced to 
O2 , which facilitates the generation of H2O2 (Murata et al., 1999). The H2O2 generated 
in turn reacts with Cu (I) to form a metal-oxygen complex, such as Cu (I)-OOH, and 
cause DNA damage (Murata et al., 1999). Also, the reaction of H2O2 with Cu (II) causes 
DNA damage with a site-specificity for thymine residues (Oikawa et al., 1995). Copper 
occurs in the mammalian cell nucleus, and contribute to high order chromatin structures 
(Burkitt, 1994). Thus, the MT induced DNA damage as demonstrated both in vitro and in 
vivo may pose serious health risks under higher intracellular Cu (II) conditions, 
particularly in MT exposed female agricultural workers, bearing a copper containing 
intrauterine pessar (lUP), which releases -50 [ig copper per day (Hagenfeldt, 1972). 
Also, the patients suffering fi-om Wilson's disease, a genetic disorder of copper 
metabolism, could be the vulnerable targets. Thus, the accumulation of MT-Cu (II) 
induced damage in DNA may triggers genotoxicity and mutagenesis, if the lesions are not 
accurately processed by the cellular DNA repair machinery. Thus, the direct interaction 
of MT with DNA, MT-Cu (II) complexation, ROS formation and/possible MT-induced 
DNA alkylation result in the induction of DNA strand breaks and promutagenic 8-oxodG 
lesions, which clearly demonstrate the potential for genotoxicity and oxidative stress of 
test fungicide in human lymphocytes. 
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1. Introduction 
Albumin represents 52-60 % of the total plasma protein content and plays an 
important role in transport of endogenous ligands and environmental chemicals and/or 
xenobiotics mostly through the formation of non-covalent complexes at specific binding 
sites (Bertucci & Domenici, 2002; Sugio et al., 1999). Covalent modification of proteins 
can have profound effects on their biological activities. Well-known physiological 
examples include phosphorylation (Krebs & Beabo, 1979), carboxylation (Vermeer, 
1990), methylation (Kim, 1996), glycosylation (Clarke, 1985) and fatty acylation (Towler 
et al., 1988). Most drugs bind reversibly to a number of binding sites on albumin (Peters, 
1996), and there is evidence of conformational changes in protein induced by its 
interaction with low molecular weight drugs. These changes appear to affect the 
secondary and tertiary structure of albumin. (Hushcha et al., 2000). The development of 
computational models for prediction of drug pharmacokinetics is an area of cur rent 
intense research in the pharmaceutical industry (Butina et al., 2002) and human serum 
albumin (HSA) has a central role in drug pharmacokinetics (Herve et al., 1994; Carter & 
Ho, 1994). 
Apart from the benefits driven from the albumin-drug binding, interactions of 
xenobiotics with 'critical' cellular macromolecules is thought to be an important step in 
the events that lead to cellular injury (Boelsterli, 1993). Toxicological processes can also 
lead to covalent changes affecting protein structure and biological activity. Among them 
there are modifications of protein amino acids by xenobiotic chemicals or their 
metabolites (Boelsterli, 1993). Modifications in the structural and functional integrity of 
proteins in plasma membranes and membranes of intracellular organelles may trigger 
alterations in energy metabolism, affecting biological cell activities such as synthesis of 
ATP, signaling, regulation of biosynthetic and catabolic reactions, transport of 
metabolites and ions (Palmeira, 1997). Competition between xenobiotic and endogenous 
substances for binding to plasma proteins can strongly affect the disposition of both 
substances, with possible serious physiological consequences (Bertucci & Domenici, 
2002). In some cases, binding of small molecules is responsible for the protective role of 
albumin, such as the binding of bilirubin from the spleen to the liver, or the binding of 
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exogenous toxins, reduc ing consequences from their toxicity (Bertucci & Domenici, 
2002). The molecular interactions between albumin (HSA) and many drugs have been 
investigated successfully (Tang et ah, 2006; Li et al., 2005). However, the binding of the 
pesticides to proteins has seldom been investigated. Owing to the wide application of 
herbicide, 2,4-D has been given special attention for its interaction with serum albumin 
(Purcell et al, 2001). However, it is rare to find any report on fimgicide-albumin 
interaction and fungicide-induced protein damage. 
This has prompted to investigate the MT-albumin interaction and MT-induced protein 
degradation, and to test the hypothesis that cellular protein degradation may be due to 
increased ROS generation during MT photoexcitation. No systematic study has been 
made till date to assess the quantitative binding of MT with serum albumin. In this study, 
human serum albumin (HSA) has been chosen as a model protein to investigate the (i) 
extent and nature of interactions of MT with HSA (ii) binding constant {Ka) and capacity 
(«) of HSA fo r MT, (iii) MT-induced conformational changes in protein, using the 
sensitive techniques such as fluorescence spectroscopy, circular dichroism and cyclic 
voltammetry. 
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2. Materials and Methods 
2.1. MT-HSA fluorescence measurements 
Fluorescence measurements were carried out on a Shimadzu 
spectrofluorophotometer, model RF5301PC equipped with RF 530XPC instrument 
control software, at 25 ± 0.1 °C, using a quartz cell of 1 cm path length. The fluorescence 
spectra were measured at a protein concentration of 3.0 fxM with a 1 cm path length cell. 
Excitation and emission slits were set at 3 imi each. The emission spectra were recorded 
in 290-380 nm range and the excitation wavelength was set at 280 nm, while MT was 
almost non-fluorescent in this range. All the stock solutions were filtered through 0.45 
f^ m Millipore filters prior to mixing, to minimize the inner filter effect (Chignell, 1972). 
2.2. Quantitative analysis of MT-HSA interactions 
Binding affinity of HSA with fungicide MT was determined according to the method 
of Levine (1977). In brief, to a fixed concentration (3.0 i^M) of protein solution, varying 
amount of MT was added to obtain the desired molar ratios. The final volume in each set 
of (MT/HSA) experiment was adjusted to 3 ml with Tris-HCl buffer, pH 7.4. The 
fluorescence intensity values at the emission maxima (340 imi) were used to determine 
the relative fluorescence, considering the fluorescence intensity of control untreated 
protein as 100. The least square analysis of the initial linear points of relative 
fluorescence vs. MT-HSA molar ratio was used to determine the maximal quench, (m) 
(slope of the plot) following the equation [F=Fo - mRJ; were F is the fluorescence 
intensity at MT to HSA molar ratio (R) and Fo is the fluorescence intensity of protein at 
zero concentration of pesticide. Selecting the data points deviating from straight-line 
behavior, the fractional quench ( 0 was determined, at each MT-HSA molar ratio (R). 
For an observed fluorescence intensity F, the fractional quench ( 0 was determined from 
the equation [Q =Fo - F/maximal quench (m)J. Fractional quenching (Q) was linearly 
related to MT.binding: [MT-HSA] / [HSA]T = Qm where the [HSA]T represents the total 
HSA concentration. Bindmg affinity (Ka) and binding capacity («) were determined from 
the slope and X- axis intercept of the straight line on the Scatchard plot Q vs. Q/(R-Q) 
[HSAJT (Levine, 1977). 
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2.3. Cyclic voltammetric analysis ofMT-HSA binding 
The redox potentials of the MT and MT-HSA were determined by cyclic voltammetry 
in aqueous medium containing 0.4 M KNO3, as a supporting electrolyte, at room 
temperature. Cyclic voltammetric experiments were performed using a CH Instruments 
Electrochemical Analyzer (Japan). A conventional three electrode system was employed 
with a platinum microcylinder as working electrode, platinum wire as an auxiliary 
electrode and Ag/AgCl as a reference electrode. The formal potentials (-E//2) was taken as 
the average of the anodic (Epd) and cathodic (jEpc) peak potentials. 
2.4. Site specific binding ofMT on HSA using marker ligands 
The site specific binding of MT on HSA molecule has been studied with the know 
marker ligands bilirubin and diazepam, which specifically binds to site I and site II on 
HSA molecule. In this study, HSA was used as fluorescence probe and the changes in 
fluorescence intensity of HSA bound MT were monitored at 340 nm after excitation at 
280 nm upon addition of varying amounts of marker ligands. The percent reduction in 
fluorescence intensity upon marker ligand binding was calculated considering the 
fluorescence intensity of MT-HSA complex as 100 percent and percent binding of MT at 
specific sites on protein. 
2.5. Synchronous fluorescence analysis ofMT treated HSA 
To explore the structural change of HSA by the addition of MT, synchronous 
fluorescence analysis has been performed. In brief, the fixed concentration of HSA (3 
|iM) were titrated with varying molar ratios (0-10) of MT. The wavelength ranges of 
synchronous scanning were from 310 to 370 nm {AX = 60 nm) and 280 to 330 nm {AX = 
15nm)at25±0.1°C. 
2.6. Circular dichroism (CD) measurements 
Effect of MT on the conformation of HSA were analysed by treating the fixed 
concentration of HSA (4.5 \M) with 0.1 and 0.2 \xM of MT to get the MT/HSA molar 
ratio of 1:0.02 and 1:0.04. The untreated and MT treated samples were incubated for 2 h 
in white light at 37 °C. CD measurements were carried out on a Jasco spectropolarimeter, 
model J-815, Italy. The instrument was calibrated with d-10-camphorsulphonic acid. All 
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the CD measurements were performed at 25 °C with a thermostatically controlled cell 
holder attached to a NESLAB RTE -110 water bath (NESLAB Instruments, Inc. USA) 
with an accuracy of ± 0.1 °C. Spectra were collected at a scan speed of 100 nm per min 
with a response time of 1 sec. Each spectrum was the average of four scans. Far-UV CD 
spectra (200-250 nm) of the untreated and treated HSA were at a 1mm path length cell. 
The protein samples for CD measurements were filtered through a Millipore filter 
(0.45^M) to remove any suspended material. The results were expressed as mean residue 
ellipticity (MRE) in deg.cm^.dmol'', which is defined as [MRE = 0 obs (mdeg)/10 x n x 1 
X Cp]. The 0 obs represents the ellipticity in millidegree, n is the number of amino acid 
residues (585), 1 is the path length of the cell in cm and Cp is the mole fraction. The a-
helical content of HSA was calculated from the MRE value at 222 nm using the equation 
% helix = [(MRE222 -2340)730300] x 100 as described by Chen et al. (1972). 
2.7. SDS-Polyacrylamide gel electrophoresis 
SDS-polyacrylamide electrophoresis of untreated and MT treated HSA was carried 
out on 10 % (w/v) gel, according to the method of Laemmli (1970). In brief, HSA (25 
|ig) treated with increasing concentrations (1 to 5 mM) of MT was photoexcited for 2 h at 
37 °C. The aliquots (6 \xg each) of untreated control and treated protein were loaded on 
the gel and run at 3 mA per well for 3 h. The gel was stained with coomassie brilliant 
blue R-250 (0.25 % w/v) and destained with 5 % methanol and 7.5 % glacial acetic acid 
at room temperature. 
2.8. MT-inducedfragmentation of serum albumin 
Fragmentation of HSA was assessed by measuring the TCA soluble amino groups 
according to the method of Moore and Stein (1954). A typical reaction mixture 
containing HSA (25 i^M) with varying concentrations (200-1000 \xM) of MT was 
exposed to white light for 2 h at 37 "C. The reaction was stopped with the addition of 100 
i^M EDTA followed by precipitation with 5 % (w/v) TCA. Supernatant was obtained 
after centrifligation at 2500 rpm for 30 minutes and the acid soluble amino group was 
quantitated using the calibration curve of glycine. Absorbance was read at 570 nm and 
plotted as a function of MT concentration. The carbonyl groups released from treated 
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serum albumin were also estimated using 2,4-dinitroplienylhydrazine reagent following 
the procedure of Lappin & Clark (1951). 
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3. Results 
3.1. Fluorescence quenching of HSA upon MT interaction 
The effect of MT on HSA was measured by monitoring the changes in the intrinsic 
fluorescence of serum albumin at different MT/HSA molar ratios. The fluorescence 
emission spectra of HSA alone and in presence of varying molar ratios (30:1) of 
MT/HSA was recorded in the in the range of 290-380 nm. The fluorescence intensities of 
protein decreased with increasing concentrations of MT. Figure 45 shows the 
fluorescence decay curves of the free HSA and HSA-MT complex. The titration curves 
exhibit a pronounced shift of about 30 nm in the emission maxima (>lem) for HSA have 
been recorded. The relative fluorescence intensities of HSA at varying MT/HSA molar 
ratios were determined from the spectra of MT and plotted as a function of [MT]/[HSA] 
molar ratio (Figure 46). The binding isotherms and the corresponding Scatchard plots of 
Q/[BJ X 10'^ vs Q for MT is shown in the inset of Figure 46. The binding isotherms 
exhibited a concentration dependent quenching of intrinsic fluorescence of protein. The 
total percent quench determined with different molar ratios of MT (2-30) were increased 
from 9.73 % to 64.42 % respectively. From the slope and intercept of the straight line 
obtained on the plot Q/[B] x 10'^ vs Q, the binding constant {Kd) and binding capacity («) 
of HSA towards MT were determined to be 4.5 x 10^ Imole'^ and 26, respectively. 
3.2. Cyclic voltammogram ofMT-HSA solution 
Figure 47 shows the cyclic voltammograms of MT in absence and presence of HSA. 
MT alone (Curve 1) exhibited a quasi reversible peak with an oxidation peak at -0.464 V 
and a reduction peak at -0.287 V. With the addition of equimolar concentration of HSA 
(1:1) the cathodic peak current {ipc) of MT decreased from 3.210 to 2.886. The formal 
potential, EO' (or voltammetric E1/2) taken as the average of Epc and Epa has been 
determined to be -0.376 with MT alone. Addition of HSA to MT solution slightly shifts 
the value ofEO' towards less negative potential. 
3.3. Site-specific binding ofMT on HSA molecule 
The competitive displacement of marker ligands specific for site-I (bilirubin) and site-
II (diazepam) with MT-HSA complex demonstrated the site specificity of MT binding on 
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Figure 45. Fluorescence decay in the emission spectra of HSA in absence (uppermost 
curve) and presence of increasing amounts of MT. The spectra were obtained in 10 mM 
Tris-HCl buffer, pH 7.4 at 28 V . The molar ratios of MT to HSA were: (top to bottom) 
0.0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28 and 30, respectively. Fluorescence 
decay and shift in the emission spectra are indicated by down and horizontal arrows. 
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Figure 46. MT-HSA binding isotherm showing relationship between relative 
fluorescence and molar ratio in the range of (2-30). Inset shows the Scatchard 
plot drawn by fitting the fluorescence quenching titration data for determining 
MT-HSA binding parameters. 
I 
4^ 
fi 
^ 
u 
4.0 
3.5 
3.0 
2.5 
2.0 
1.5 
1.0^ 
0.5 
0 
-0.5^ 
-1.0 
• • • ' ' J • • • • ' • • • • I i.-l I—I I i - L . , i I i • • ' • 
nn" 
-0.1 -0.2 -0.3 
• I • • • • I • • • • I • • • • I ' • • • I • 
-0.4 -0.5 -O.e -0.7 -0.8 
Potential / V 
' I • • • • I • • • 
-0.9 -1.0 -1.1 
Figure 47. Cyclic voltammograms showing typical Nemstian behavior at a scan 
rate of 0.3 Vs"'. Curve 1: MT (ImM); Curve 2: MT+HSA (ImM), respectively. 
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HSA molecule. The fluorescence emission spectra of MT-HSA compl ex at 340 n m 
reduced significantly with the addition of varying molar ratios of bilirubin, a shift of 
about 30 nm in the emission maxima has been observed with the addition of bilirubin 
(Figure 48). However, the addition of diazepam at the same molar ratios comparatively 
showed lesser reduction in the emission spectra of MT-HSA complex (Figure 49). 
Comparative data on the reduction in the initial fluorescence intensity of MT-HSA 
complex with the addition of bilirubin and diazepam are shown in Figure 50. The total % 
decline in the quenching effect of MT-HSA complex with the addition of bilirubin and 
diazepam in is presented Table 16. 
3.4. Conformational changes in HSA upon interaction with MT 
The synchronous fluorescence spectra present the information about the molecular 
microenvironment in the vicinity of the fluorophore functional groups. In the 
synchronous fluorescence of HSA, shift in position of maximum emission wavelength 
corresponds to the changes of polarity around the fluorophore of amino acid residues. 
The AX values, (scanning intervals, {AX = e^mission -Excitation) stabilized at 15 or 60 nm, 
synchronous fluorescence of HSA gives the characteristic information of tyrosine 
residues and tryptophan residues, respectively (Miller, 1979). The effect of MT on HSA 
synchronous fluorescence spectroscopy is shown in Figure 51. As can be seen from the 
Figure 51 (A), the fluorescence of tyrosine residues was weak and the position of 
maximum emission wavelength had no change when AX was 15 nm. However, the 
fluorescence of tryptophan residues was higher and the maximum emission wavelength 
show a moderate red shift when AX was 60 nm (Figure 51, B). 
3.5. Assessment of structural alterations in HSA upon MT treatment by CD analysis 
CD spectra were also used to monitor MT-albumin interaction. Titration of HSA with 
increasing concentrations of MT at the molar ratios between (1:0.02 and 1:0.04) has been 
recorded in the far-UV CD spectral range of 200-250 nm (Figure 52). CD spectra of HSA 
exhibit two negative bands in the ultraviolet region at 209 and 222 nm characteristic for 
a-helical structure of protein (He et al. 2005a). The reasonable explanation is that the 
negative peaks between 208,209 and 222-223 nm are contributed to n-^;r* transfer for 
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Figure 48. Fluorescence quenching of MT-HSA complex with the addition 
of increasing concentration of site I marker bilirubin. From top to bottom: 
HSA alone (3 ^M), MT-HSA complex (10:1), bilirubin-HSA molar ratio 
0.25, 0.5, 1.0, 1.5, 2.0, and 3.0, respectively. 
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Figure 49. Fluorescence quenching of MT-HSA complex with the addition 
of increasing concentration of site II marker diazepam. From top to bottom: 
HSA alone (3 |iM), MT-HSA complex (10:1), diazepam-HSA molar ratio 
0.25, 0.5, 1.0, 1.5, 2.0, and 3.0, respectively. 
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Figure 50. Decline in the initial fluorescence of HSA-MT (1:10) complex with the 
addition of increasing molar ratios of site 1 and site II markers (bilirubin and 
diazepam). 
Table 16. Effect of marker ligands on the binding of MT to HSA 
MT-HSA 
molar ratio 
HSA alone 
HSA-MT(1:10) 
HSA-MT(1:10) 
HSA-MT(1:10) 
HSA-MT(1:10) 
HSA-MT(1:10) 
HSA-MT(1:10) 
HSA-MT(1:10) 
Site I & II Marker 
molar ratio 
0 
0 
0.25 
0.50 
1.0 
1.5 
2.0 
3.0 
*Fluorescence quenchin 
Bilirubin (Site I) 
0 
0 
41.56 
54.18 
69.3 
77.54 
79.73 
83.09 
I with marker ligands 
Diazepam (Site II) 
0 
0 
8.28 
15.53 
21.46 
• 25.47 
28.63 
34.25 
* Calculated from the fluorescence intensity of HSA-MT complex in presence of marker 
ligands considering the fluorescence intensity of HSA-MT complex as 100. 
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Figure 51. Synchronous fluorescence spectrum of HSA in the absence and presence of 
MT. (A) dl = 15; (B) A>. = 60. (1^11) HSA (3.0 ^M), MT: 3,6,9,12,15,18,21,24, 27 
and 30 |aM, respectively. 
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Figure 52. CD spectra of HSA at different MT concentrations. (1) Free HSA, (2) MT 0.1 
^M, (3) MT 0.2 iiM. 
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the peptide bond of a-helix (Yang & Gao, 2002). A concentration dependent change in 
the elHpticity value has been recorded. The significant reductions in the MRE reflect the 
alterations in protein helicity. The percent changes in the a-helical content of the protein 
are shown in Table 17. At 0.2 \xM, the loss in protein helicity was determined to be 8 % 
vis-a-vis 54.81 % a-helical content in native untreated HSA. 
3.6. MT-induced fragmentation of HSA 
MT-induced degradation of HSA has been analyzed on SDS-polyacrylamide gel 
(Figure 53 A). With increasing concentration, MT forms complex with HSA and induces 
fragmentation of the protein. Compared to the untreated HSA band in lane 2, a 
discernible reduction in the intensity of MT treated HSA bands were noticed. The 
densitometric analysis revealed a prominent loss (78.03 %) in parent band at the highest 
concentration of 5 mM of MT (Figure 53 B). The quantitative spectrophotometric assays 
demonstrated significant release of carbonyl and acid soluble amino groups from the 
HSA. The 2 h MT treatment to HSA at the varying concentrations of 200, 400, 600, 800 
and 1000 |iM has resulted in 72.2,129.4, 222.4, 271.8 and 332.1 14M of carbonyl groups, 
respectively (Figure 54). An increase in the absorbance of blue color developed due to 
acid soluble amino groups was noticed upto 1000 |aM MT at 570 nm. The absolute 
amount of acid soluble amino groups released from the MT (200-1000 fiM) treated HSA 
i 
were 1.1, 3.0, 4.1, 5.9 and 7.1 i^M, respectively (Figure 55). 
Table 17. Change in relative a-helicity of HSA upon interaction with MT. 
MT-HSA 
molar ratio 
HSA (1:0) 
HSA-MT (1:0.02) 
HSA-MT (1:0.04) 
MRE222 
(deg.cm^.dmol'^) 
18950 
18142 
17670 
a-helix ; 
54.81 
52.15j 
50.59 
% 
perturbation 
-
5 
8 
66 kD 
36kD 
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Figure 53. (A) SDS-PAGE of HSA showing loss of parent band with 
increasing concentrations of MT. Lane 1: 5 |ig of standard protein marker; 
lane 2: untreated HSA 6 |xg; lane 3: MT (1 mM) + HSA (6 ^g); lane 4: MT 
(2 mM) + HSA (6 ^g); lane 5: MT (3 mM) + HSA (6 ^g); lane 6: MT 
(4mM) + HSA (6 ^g) ; lane 7: MT (5mM) + HSA (6 ng), respectively. (B) 
Densitometric analysis of above bands showing the loss of parent HSA band 
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Figure 54. Carbonyl group released from HSA treated with 
photosensitized MT for 2h. The data points represent the mean ± S.D. 
of three independent experiments done in duplicate. 
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Figure 55. Photosensitized MT induced protein fragmentation. 
HSA was treated with increasing concentration of MT for 2h and 
the amount of acid soluble amino group quantitated. The data 
represented are mean ± S.D. of three independent experiments 
done in duplicate. 
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4. Discussion 
Fluorescence of HSA originates from tryptophan (Trp), tyrosine (Tyr) and 
phenylalanine (Phe) residues. In fact, the intrinsic fluorescence of HSA is mainly 
contributed by the tryptophan residue alone located at position 214 of the chain, because 
the phenylalanine residue has a very low quantum yield and the fluorescence of tyrosine 
is almost totally quenched when it is ionized or nearby an amino group, a carboxyl group 
or a tryptophan (Sulkowska, 2002). HSA emits strong intrinsic fluorescence at the 
excitation wavelength of 280 nm. This intrinsic fluorescence is yery sensitive to its 
microenvironment, when local surroundings of HSA is altered even slightly, its intrinsic 
fluorescence would and factors such as protein conformational transition, biomolecule 
binding, and denaturation, etc. are in weakening the potential fluorescence (Yuan et al, 
2007). The change of intrinsic fluorescence intensity of HSA is mainly due to the 
interaction of tryptophan residue with small molecules with HSA (Li et al., 2007). Thus, 
the intrinsic fluorescence of proteins is considered as an indicator of their structural and 
functional dynamics and helps in understanding the protein folding and association 
reactions (Wang et al, 2006). 
In this study, the fluorescence intensity of HSA upon MT-HSA interaction 
undergoes proportionate reduction with the increasing concentrations of MT. Quenching 
of the HSA fluorescence could be due to change in microenvironment around the Trp 214 
residue as has been suggested by several earlier workers (Trynda-Lemiesz et al., 1999; 
Yuan et al., 2007). The quenching of the tryptophan 214 fluorescence, clearly indicate 
that the conformation of the hydrophobic binding pocket in subdomain IIA is affected 
(Trynda-Lemiesz, 2004). Also, Zhang et al. (2007) have recently reported similar 
changes in HSA intrinsic fluorescence treatment with paraquat. Decay in the fluorescence 
intensity of HSA with the addition of MT also implies that the HSA molecule was 
quenched in S1 state. According to empirical rules for fluorescent spectra of proteins 
(Freifelder, 1976) the tryptophan residue in MT-HSA system is considered to be brought 
to a more hydrophilic environment as a result of the MT binding near the tryptophan 
residue or its proximity. The possible factors of fluorescence quenching were the 
alteration of HSA conformation and/or the binding of MT to HSA to result in 
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fluorescence energy transferring from tyrosine and/or tryptophan of HSA to MT. A 
prominent shift of emission maxima to a shorter wavelength on addition of MT to HSA 
indicate clearly the MT binding with tryptophan residue of HSA and induced 
conformational change in the native structure of protein as also reported earlier (He et ah, 
2005; Zhou et al, 2007). This effect was further validated by the synchronous 
fluorescence spectroscopy. Moderate shift of emission wavelength toward longer 
wavelength at ?i,60 and simultaneous decline in fluorescence reflects the fact that the 
microenvironment of the tryptophan residue was significantly affected by MT binding. It 
is reported that the maximum emission wavelength (?imax) at 330-332 nm indicates that 
tryptophan resides are located in the nonpolar region, are buried in a hydrophobic cavity 
in HSA. Also, the Xmax at 350-352 nm shows that tryptophan residues are exposed to 
water, as the hydrophobic cavity in HSA is disagglomerated and the structure of HSA is 
compromised. Shift in the emission spectra in case of MT-HSA interaction suggests that 
MT bound to the hydrophobic cavity of HSA induce structural alterations in HSA as a 
consequence of increased polarity and reduced hydrophobicity (Wang et al., 2007a). 
MT-HSA binding was flarther confirmed by simple and convenient electrochemical 
technique widely used to study the sub-layer structure and physiological fiinctions of 
protein in the bioelectrochemistry (Hu et al., 2000). The results indicated that the addition 
of HSA to MT solution caused the decrease in the cathodic peak current (ipc). This could 
be explained in two possible ways, firstly the HSA interacts with MT to form a non-
electrochemical complex, which blocks the electron transfer between the quasi reversible 
peaks of MT and electrode, and secondly the competitive adsorption of HSA at the glassy 
electrode surface (Zhao et al., 2007). Nonetheless, the cathodic peak current is closely 
related to the conformation changes of serum albumin, i.e. the microenvironment of 
electron transfer of protein at electrode. The native form of the protein has a specific 
binding site consisting of a hydrophobic p atch close to a cationic group (Kelle y & 
McClements, 2003). To provide further information on the site-sjpecific binding of MT, 
bilirubin and diazepam as a site I and site II markers, respectively have allowed to 
competitively bind with HSA. The maximum decrease in the fluorescence intensity 
(about 83.09 %) of HSA-MT complex in presence of bilirubin suggests that MT most 
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likely binds to the hydrophobic pockets at or near the site I within sub domain IIA of 
albumin molecule. The reduction is due to replacement of MT from site I which exhibits 
more affinity for bilirubin (Trynda-Lemiesz, 2004). 
Conformational change in secondary structure of HSA has been ascertained using a 
sensitive circular dichroism upon interaction with MT lower molar ratios (1:0.02 and 
1:0.04). The data distinctly exhibited decrease in the band intensities at 209 and 222 nm 
in the far-UV region without any significant shift of the peaks. This suggests a 
considerable change in the protein secondary structure, primarily due to reduction in a-
helical content of treated protein. Furthermore, the results obtained from gel 
electrophoresis clearly show MT induced fragmentation of HSA. With the increasing 
concentration of MT, the parental band of HSA has disappeared, owing to hydrolysis 
producing a large number of indistinct random, fragments (Hawkins and Davies, 1999). 
The densitometric analysis of the band profile clearly shows the loss of the parent HSA 
band with increasing MT concentrations. Pesticides have also been reported for the 
interaction and complex formation with HSA (Purcell et al, 2001). The discemable 
protein fragmentation data of SDS PAGE has been fiirther strengthened by the 
quantitative spectrophotometric data which indicate that the protein degradation may be 
due to peptide bond hydrolysis and/or chain scission at a-carbon position. 
In conclusion, binding of MT with HSA and the consequent structural alterations in 
HSA were analyzed by fluorescence spectroscopy, cyclic vohammetry and CD 
spectroscopy. The fluorescence titration results showed that HSA possesses high binding 
affinity for MT with relatively higher binding number. MT selectively binds to the 
subdomain IIA on HSA, possibly by sharing the available lone pair of electrons between 
MT and HSA as substantiated by the CV data. The results of synchronous fluorescence 
and CD spectroscopy validated the MT-induced conformational change in HSA 
molecule. The conformational change leading to protein damage has been further 
confirmed by the spectrophotometer and gel electrophoresis data. Mechanism of MT 
induced HSA fragmentation is certainly due to chemical modification of critical amino 
acid residues. One possible modification could be the alkyl group transfer from MT to 
amino acid fiinctional groups. The plausible theoretical model (Figures 56 and 57) 
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Figure 56. Proposed mechanism of MT-induced modification of tryptophan. 
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proposed to explain the MT induced protein-alkylation mechanism suggest that the amino 
group of tryptophan and tyrosine residues possessing free lone pair of electrons may act 
as a nucleophile. It attacks the ethyl cation and facilitate the release of (^CHs) group from 
MT to side chain "^Ha group of tryptophan and tyrosine moieties on HS A. The protein 
containing dialkylated amino acids undergo fragmentation of the polypeptide chain. Thus 
the MT-HSA binding has demonstrated its toxicological implications. Till date no reports 
have been encountered on MT-HSA interaction. This study provides an important insight 
into the mechanism of interactions of a physiologically important protein HSA with 
pesticides and these measures are of particular interest in ecotoxicology and 
environmental risk assessment of MT. i 
Cfiapter-y 
Tftorate-VJ^JA Interaction 
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1. Introduction 
Organophosphorus (OP) insecticides have long been a serious environmental concern. 
Owing to the widespread use, OP's are reportedly present in the environment, food, and 
drinking water as residues (Kashanian et al, 2008). Alone, the OP accounts for 38 % of 
all pesticides used globally, and 26 % used in Europe (Debate Issue Briefs, 2005). These 
compounds are widely used in agriculture owing to their selective toxicity to insects 
(Matsumura, 1975). Nonetheless, some of them are regarded as potent genotoxicants for 
human health (Yasmashita et al., 1997). OP compounds mainly exert their toxicity by 
binding with acetylcholinesterase, an enzyme that breaks down the neurotransmitter 
acetylcholine, so that subsequent impulses can be transmitted across synapse. Inhibition 
of acetylcholinesterase activity results in repeated and uncontrolled furing of neurons 
leading to death usually by asphyxiation, due to loss of respiratory control (Forsyth & 
Chambers, 1989). Structurally, the OP pesticides are composed of a group of different 
chemicals, which have either the phosphoryl bond (P=0) or thiophosphoryl bond (P=S). 
There are reports indicating that the OP metabolites harboring (P=S) and (P=0) groups 
are potent genotoxicants (Garrett et ah, 1986; WilUams et al, 2006). 
Amongst of the OP pesticides, phorate is a class I, extremely toxic insecticide, known 
to inhibit the acetylcholinesterase (Hazardous Substances Data Base, 1988; O'Berin, 
1976). The inappropriate and wide scale application of phorate led its appearance in 
various food commodities above the permissible limits (Wauchope et al, 1992; 
Hazardous Substances Data Base, 1988; Zambonin et al, 2004; Pagliuca et al, 2006;). 
Phorate has also been reported to induce genotoxic effects, manifested in terms of 
chromosomal aberration (CA), sister chromatid exchange (SCE), DNA damage and 
inhibition of testosterone metabolism in phorate formulators (De Ferrari et al, 1991; 
Grover et al, 2003; Usmani et al, 2003). Similar effects have also been noticed in human 
lymphoid and Chinese hamster ovary cells with higher incidence of SCE, CA and 
micronucleus formation (MN) upon phorate treatment (Sobti et al, 1982; Lin et al, 
1987; Grover & Mahli, 1985; Mahli & Grover, 1987; Dhingra et al, 1990). In general, 
the toxicity assessment of phorate has been performed in vivo on the bone marrow cells 
employing conventional assays. Interestingly, most of the toxicity profile on phorate are 
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generated by chemical companies manufacturing or marketing the compound for the 
purpose of registration. Several of the unpublished reports available are based on the 
studies conducted in the 1960s and 1970s and do not meet current requirements. In the 
available literature, it is hard to find any report addressing the important issue of phorate-
DNA interaction and its mechanism, and the quantitative and qualitative analysis of DNA 
damage with especial consideration to human cells. This study has therefore been carried 
out to assess the (i) affinity and stoichiometry of DNA-phorate binding, (ii) effect of Cu 
(II) ions on DNA-phorate interaction and (iii) induced conformational changes in DNA 
upon phorate binding. Mechanism of phorate-DNA interaction and consequent estimation 
of DNA damage have been quantitatively assessed employing sensitive techniques. 
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2. Materials and Methods 
2.1. Phorate-DNA-binding analysis by fluorescence spectroscopy 
The assessment of phorate-DNA binding through fluorescence studies were made after 
incubating phorate-DNA solution in dark for 30 min. at 25 '^ C. The spectra were recorded 
under sub-dued light to prevent undesired photodegradation. The fluorescence quenching 
titration of phorate with increasing DNA/phorate molar ratios were performed in a 
continuous manner. To a fixed concentration of phorate (50 |iM), the increasing 
concentrations of DNA (2.5-50 \xM) were added to obtain the DNA/phorate molar ratios 
from 0.05 to 1. The final volume was adjusted to 3 ml with Tris-HCl buffer, pH 7.6. 
Fluorescence measurements were carried out on a Shimadzu spectrofluorophotometer. 
The excitation and emission slits were set at 3 nm and 10 nm, respectively. The excitation 
and emission wavelengths at which the phorate fluorescence recorded were 246 nm and 
272 rmi, respectively. The influence of divalent metal ion Cu (II) on the binding of 
phorate-DNA was also studied at a molar ratio of 1:0.2. Binding of phorate-DNA 
complex was determined following the method as described in section 2.1. of Chapter III. 
2.2. Assessment of phorate-DNA binding with cyclic voltammetry 
The electrochemical study of phorate and phorate-DNA complex in absence and 
presence of Cu (II) in a molar ratio of 1:1:1 were determined at room temperature by 
cyclic voltammetry in aqueous medium containing 0.4 M KNO3. Solutions of phorate, 
phorate-DNA and phorate-DNA-Cu (II) complex were separately analyzed for change in 
their formal potentials iEi/2) and peak current ratios taken as the average of the anodic 
(ipa) and cathodic {ip^ peak currents. The electrochemical analysis of phorate-DNA 
interaction has been done in the similar way as described in section 2.3. of Chapter III. 
2.3. Circular dichroism (CD) measurements 
CD analysis has been done to analyze change in the optical behavior of phorate in 
absence and presence of calf thymus DNA. CD measurements of phorate alone (20 \xM) 
and in presence of 50 and 100 jiM of calf thymus DNA to get a molar ratio of 1:2.5 and 
1:5 were obtained in 1 cm path length cell. The CD measurements were carried out in the 
similar way as described in section 2.4. of Chapter III. 
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2.4. Phorate-Cu (II) complexation analysis by stoichiometric titration 
Cu (I) specific chelater bathocuproine disulfonic acid (BCS) has been used to 
quantify the total amount of Cu (I) bound to phorate. Varying concentrations of Cu (II) 
(2.5-100 \iM) were added to the constant amount of phorate (10 |j,M) in the presence of 
fixed amount (0.3 mM) of bathocuproine. The extent of bathocuproine-Cu (I) complex 
formation at increasing Cu (Il)-phorate molar ratios was determined by reading the 
optical density at 480 rmi. 
2.5. Bacterial genotoxicity assay 
Phorate genotoxicity in bacterial test system were assessed in wild-rtype ABl 157 and 
DNA repair defective strains ofE. coli K-12, viz. AB 2463 {rec A"), AB 2494 {lex A"), 
AB 1886 {uvr A~) and JW 164 (pal AT). The untreated and phorate treated (0-400 i^M) 
bacterial cells were photoexposed to white light for 6 h at 30 °C. After washing the cells 
in Tris-Cl buffer, both the treated and untreated cells were serially diluted and plated on 
nutrient agar plates to assay the colony forming ability. After overnight incubation at 37 
"^ C, and the colonies were counted. Effect of phorate on the bacterial strains were 
determined by plotting the percent survival of wild type and mutants strains as a function 
of phorate concentration. 
2.6. Bacterial mutagenicity assay 
Phorate-induced mutagenesis has been assessed using plasmid pUC19 DNA (-25 ng) 
in Tris-HCl buffer (0.1 M, pH 7.5). Treatment with different concentrations of phorate 
(250-1000 |iM) in a final volume of 50 \A at 37 °C were done for 2 h following the 
method described in section 2.7 of chapter III. The number of mutants (white colonies) 
versus the number of normal (blue colonies) were scored. 
2.7. Alkaline unwinding assay 
Quantitative estimation of phorate-induced strand breaks in the DNA were assessed by 
alkaline unwinding assay using hydroxyapatite batch procedure of Kanter & Schwartz 
(1979). Single stranded DNA was selectively eluted from the hydroxyapatite matrix with 
0.125 M potassium phosphate buffer, pH 7.0 containing 20 % formamide. However, 
duplex DNA was removed with 0.5 M potassium phosphate buffer, pH 7.0 containing 20 
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% formamide. Strand breaks were calculated following the equation described in section 
2.8. of Chapter III. 
2.8. Alkaline hydrolysis of phorate-treated DNA 
The release of acid-soluble nucleotides as an effect of phorate-induced DNA 
degradation was estimated following the method of Schneider (1957). Fixed amount of 
DNA (500 Jig) were treated with varying concentrations of phorate in the DNA 
nucleotide/phorate molar ratio of 1:1-1:10 in presence of white light for 2 h at 37 °C. in 
the presence and absence of 0.1 mM Cu (II), respectively. Estimation of acid soluble 
nucleotides were done as described in section 2.9. of chapter III. 
2.9. Alkaline single cell gel electrophoresis (comet assay) 
For comet assay, the human lymphocytes were isolated by diluting blood in 1:1 with 
RPMI 1640 and layered over 2 ml of cold Histopaquel077. The freshly isolated 
lymphocytes were incubated at 37 "C in RPMI medium for 3 h in the presence or absence 
of different concentrations (0, 10,100, 250, 500, 750, 1000 |aM) of phorate. Comet assay 
was performed following the methods of Singh et al. (1988) as modified by Bajpayee et 
al. (2002), as described in section 2.10. of Chapter III. 
2.10. Cytokinesis blocked micronucleus (CBMN) assay 
Phorate induced micronucleus formation were morutored using the CBMN assay with 
human whole blood following the method of Kalantzi et al. (2004). Cells were treated 
with varying concentrations of phorate (50-200 |iM) and incubated at 37 °C in presence 
of 5 % CO2. The cells were pelleted by at 1000 rpm after 24 h resuspended in complete 
medium without phorate after washing twice with RPMI 1640. Cytokinesis was blocked 
by adding Cyto B (6 i^g/ml) after 44 h of incubation. The binucleated lymphocytes were 
harvested after 72 h of culture condition at 1000 rpm for 10 min. Cells were then treated 
with hypotonic solution (0.56% KCl), fixed and processed for slide preparation as 
described in section 2.11. of Chapter III. 
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2.11. Measurement of mitochondrial membrane potential and intracellular reactive 
oxygen species 
Phorate induced change in the mitochondrial membrane potential {AWm) was 
measured using fluorescence dye Rhl23 according to the method of Wang et al. (2007a). 
Phorate in the concentration of 50, 100 and 200 |iM were added to the human 
lymphocytes and cultured for 24 h at 37 °C in presence of 5 % CO2.' After 24 h cells 
were pelleted, washed and processed for flow cytometric analysis as described in section 
2.12 of chapter III. Intracellular ROS production was assessed quantitatively with the 
varying concentration of phorate (50-500 nM) using a fluorescent probe DCFH-DA 
following the method of Huang et al. (2008) as described in section 2.13. of chapter III. 
2.12. ELISA based quantitation ofS-oxodG 
Varying concentrations of 500,1000,1500 and 2000 ng untreated, phorate (1000 ^M) 
treated and methylene blue (1000 \iM) treated calf thymus DNA samples were 
immobilized by a simple dry absorption procedure with incubation for overnight at 40 °C. 
The blocking of the non-specific sites was performed using 300 |il of solution containing 
3 % BSA in PBS (Ca^ & Mg^ free). The plates were fiirther incubated at 37 °C for 3 h. 
Polyclonal antibody (Goat Anti 8-Hydroxyguanosine) against 8-oxodG were diluted to 
(1:1,00,000) in blocking solution and added as 100 |.il/well and incubated at ambient 
temperature for 2 h. The plates were washed twice with PBS containing Tween 20 (0.05 
I 
%). Secondary antibody (Donkey Anti Sheep/Goat IgGiHRP) diluted 1:25,000 in 
blocking solution was then added to each well (100 |il/well) and incubated for 2 h at 37 
°C. The plates were again washed three times with PBS and the substrate of (IX) TMB 
(3,3',5,5'-Tetramethylbenzidine) 50 |j.l/well was added. Reaction was stopped by addition 
of 2M H2SO4 (50 |il/well). The optical density of the blue color developed was measured 
at 450 nm using ELISA reader (Labsystems, USA). The 8-oxodG quantitation was done 
using the calibration curve of 8-oxodG using the commercially available 8-oxodG as 
standard. 
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3. Results 
3.1. Fluorescence quenching ofphorate upon binding with DNA 
Phorate interaction with calf thymus DNA was studied by observing changes in the 
intrinsic fluorescence of phorate at varying molar ratio of phorate-DNA. The 
fluorescence emission spectra of phorate and phorate-DNA complex at the excitation 
wavelength 246 nm is shovm in Figure 58. A gradual decline in the intrinsic fluorescence 
of fixed amount of phorate has been noticed as a consequence of increasing 
concentrations DNA. The relative fluorescence intensities at varying DNA-phorate molar 
ratios of (0.05-1.0) were determined (Figure 59). The binding isotherm and 
corresponding Scatchard plot of Q/[B]x ICf^ vs. Q is shown in the inset of Figure 59. At 
the highest DNA/phorate molar ratio, the percent quench of phorate fluorescence was 
determined to be 65 %. The slope and intercept of the straight line obtained on the plot 
Q/[B]x 10'^ vs. Q provided the binding constant and binding capacity of DNA for 
phorate. The data revealed the binding affinity {Ka) and the binding capacity (n) values 
of DNA for phorate to be as 0.48 x 10^ Imole"' and 0.9, respectively. 
The representative fluorescence emission spectra of phorate both in absence and 
presence of 10 |iM Cu (II) is shown in Figure 60. The extent of quenching at a phorate-
Cu (II) molar ratio of 1:0.2 was determined to be 13.4 %. However, the intrinsic 
fluorescence of phorate in combination with DNA alone and phorate-DNA-Cu (II) 
decreased to the extent of 53.48 % and 57.52 %, respectively (Figure 60). The results 
clearly exhibit significant DNA-Cu (II) mediated phorate fluorescence quenching as 
compared to DNA or Cu (II) alone. The percent quenching were determined considering 
the fluorescence intensity value ofphorate alone as 100 %. 
3.2. Voltammetric analysis of phorate-DNA binding 
The voltammetric behavior of phorate, phorate-DNA and phorate-DNA-Cu (II) 
complex is shown in Figure 61. Interaction ofphorate with DNA and Cu (II) at room 
temperature has been studied within the sweep range from + 0.2 V to -1.2 V. The cyclic 
voltammogram of phorate, as a ligand, exhibits a quasi-reversible redox peak with AEp 
value of 319 mV. The equimolar addition of DNA to phorate changes the AEp values to 
327 mV. However, no change in the AEp was observed with the addition of Cu (II). The 
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Figure 58. Fluorescence emission spectra of phorate in 
absence (uppermost curve) and presence of increasing 
amounts of DNA upon excitation of phorate at 246 nm. 
The molar ratios of DNA to phorate ranges from 0.05-1.0 
(top to bottom). 
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Figure 59. Binding isotherm indicating DNA-induced quenching of phorate 
fluorescence at increasing molar ratios. Inset shows the Scatchard plot 
drawn by fitting the fluorescence quenching titration data for determining 
phorate-DNA binding parameters. 
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Figure 60. Effect of Cu (II) on phorate fluorescence. Phorate 
fluorescence was measured in absence and presence of 50 ^M DNA 
and 10 nM Cu (II). (Curve 1) Phorate alone (50 ^M), (Curve 2) 
Phorate+Cu (II), (Curve 3) Phorate+DNA and (Curve 4) 
Phorate+DNA+Cu (II). 
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Figure 61. Cyclic voltammograms showing typical Nemstian behavior of phorate 
at a scan rate of 0.3 Vs"'. The peaks 1 to 3 represent: Curve 1: Phorate (ImM); 
Curve 2: phorate (ImM) + DNA (ImM); Curve 3: Phorate+DNA+Cu (II) (ImM 
each). The curves 1 to 3 £ind 1' to 3' represent the oxidation and reduction peaks, 
respectively. 
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cathodic (ipc) and anodic (ipa) peak currents as well as their ratio (ipa/ipc) were 
decreased. The addition of Cu (II) to phorate-DNA complex exhibited an enhancement of 
one fold higher cathodic (ipc) peak current. The cathodic peak potential (Epc) shifts 
towards more negative value. However, the anodic peak potential (Epa) shifts towards a 
less negative value under identical conditions at a scan rate of 0.3 Vs' . The formal E1/2 
was determined to be -0.271 and -0.275 for phorate and phorate plus DNA. Addition of 
DNA to phorate solution at 1:1 molar ratio shifts the value of E]/2 towards more negative 
potential. 
3.3. Circular dichroism of Phorate-DNA-Cu (II) complexes 
CD analysis of phorate interaction with DNA in the molar ratios (1:2.5 and 1:5) is 
shown in Figure 62. The CD spectrum of phorate exhibited positive bands at 201, 207, 
210, 213 and 215 nm, respectively. DNA at the molar ratio of 1:5 induces disappearance 
of the phorate parental peaks at 201,210 and 213 nm. At the same molar ratio the peak of 
phorate at 215 imi has blue shifted by 7 nm with the appearance of a peak at 214 rmi 
exhibiting prominent reduction in the phorate ellipticity. 
3.4. Stoichiometry of phorate-Cu(II) interactions and quantitation ofCu (I) production 
The quantitative binding of transition metal ion Cu (II) to phorate was determined by 
the Job plot (Figure 63). A linear increase in the absorbance was observed up to 10:1 
molar ratio of eq Cu (II)/phorate and reaches to a plateau at higher Cu (n)-phorate molar 
ratios. At the highest Cu (II)/phorate molar ratio of (10:1) 14.37 i^ M Cu (I) were 
produced from 100 |^ M of Cu (II). The amounts of Cu (I) produced are shown in Table 
18. 
3.5. Genotoxicity assessment of phorate using E. coli K-12 strains 
Phorate treatment to E coli K-12 cells in increasing concentration range of 0-400 |iM 
resulted in a concentration dependent reduction in the colony forming ability of bacteria. 
The viability count was much higher in the wild type AB 1157 as compared to the mutant 
strains (Figure 64). The sensitivity of mutants towards phorate exposure was found to be 
in the order of polA~ > lexA~ > recPC > uvrA~. At the highest dose of 400 |iM the 
polymerase I defective strain j!7o/ A" exhibited maximum sensitivity and had shown 88 % 
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Figure 62. CD spectra of phorate (20 nM) in 10 mM in Tris-HCl buffer, pH 7.4 in the 
absence and presence of 50 and 100 jiM DNA. The characteristic positive bands of 
phorate are marked by arrows. 
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Figure 63. Stoichiometry of Cu (Il)-phorate binding at a fixed concentration 
of phorate (10 |iM). The difference in absorbance at 480 nm of the samples 
with and without added Cu (II) is plotted versus equivalents of Cu (II) per 
molar equivalent phorate. The value of the independent variable at the 
intersection of the two lines is a measure of the ratio of Cu (II) to phorate. 
The plotted curve show more than 5.0 equivalents Cu (II) to 1 equivalent of 
phorate. 
Table 18. Production of Cu (I) upon phorate-Cu (II) interaction. 
Cu(II)/Phorate Cu (II) added Cu (I) produced 
molar ratio }iM. ^M* 
Phorate alone (10 fxM) 
0.25 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10 
0 
2.5 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
35.0 
40.0 
45.0 
50.0 
55.0 
60.0 
65.0 
70.0 
75.0 
80.0 
85.0 
90.0 
95.0 
100.0 
0 
0.37 
1.33 
2.29 
3.92 
5.03 
6.44 
8.07 
9.48 
10.66 
12.81 
13.40 
14.29 
14.37 
14.22 
14.29 
14.37 
14.22 
14.14 
14.29 
14.22 
14.37 
Concentration of Cu(I) were calculated by using the equation A=scl in 
which molar absorptivity (e) of Cu (bathocuproine)2'^ complex = 13500 
and path length (1) = 1 cm, AA480 was obtained from A480 of the sample 
with and without Cu (II) addition. 
200 300 
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Figure 64. Effect of phorate on the survival of DNA repair proficient 
and defective mutant strains ofE. coliKll. Each data point represents 
the mean ± SEM of three experiments. 
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reduction in survival followed by 66 %, 54 % and 36 % survival of lex A ,rec A and uvr 
A~ strains, respectively. 
3.6. Phorate-induced mutations in lacZ gene 
Phorate induces a dose-dependent increase in white colonies (mutants) of E. coli 
DH5a with simultaneous decrease in the blue colonies (Figure 65). Exposure of pUC19 
DNA with phorate (250, 500 and 1000 ]xM) has resulted in the loss of percent 
transformation efficiency of the plasmid in E. coli DH5a cells. Consequently, an increase 
in number of mutant colonies lacking a-complementation has been observed. Loss of 
percent transformation efficiency and fold increase in the mutants colonies are shovra in 
Figure 66. 
5.7. Phorate-induced strand breaks in DNA 
Alkaline unwinding assay of phorate and phorate-Cu (II) treated DNA demonstrated 
the selective elution of treated DNA on hydroxyapatite matrix with a dose dependent 
reduction in the fraction of double stranded DNA (Figure 67). At the highest DNA 
nucleotide/phorate molar ratio (1:10) in presence of 100 \\M Cu (II) the total number of 
strand breaks were almost similar as obtained with EMS treatment. The total number of 
strand breaks (n) determined for phorate and phorate-Cu (II) treated DNA were; 1.0, 1.5, 
2.2, 2.8, 4.0 and 1.6, 2.8, 3.7, 4.6, 6.5 at DNA nucleotide/phorate molar ratio of 1:2, 1:4, 
1:6, 1:8 and 1:10, respectively. The untreated calf thymus DNA taken as negative control 
does not show any reduction in the amoimt of duplex DNA. Treatment with EMS (2 mM) 
taken as positive control has induced 7.0 breaks/unit of DNA (Table 19). 
3.8. Alkaline hydrolysis of phorate- treated DNA 
Progressive increase in the amount of acid-soluble nucleotides from phorate and 
phorate-Cu (II) treated DNA has been released upon exposure to 0.1 and 0.5 M NaOH 
(Tables 20 and 21). The percent hydrolysis at the highest DNA nucleotide/phorate molar 
ratio of 1:10 with phorate alone was 38 % and 47.80 %, with 0.1 and 0.5 M NaOH, 
respectively. Cu (II) in presence of phorate resulted in higher DNA hydrolysis. Around 
75 % and 78 % DNA hydrolysis has been observed in presence of Cu (II) at DNA 
nucleotide/phorate molar ratio of 1:10 with 0.1 and 0.5 M NaOH, respectively. Under 
Figure 65. Concentration dependent effect of phorate on lac z 
gene. Blue colonies representing lac^ bacteria in presence of the 
chromogenic substrate, X-gal. Mutated colonies turned to white 
upon phorate. (A) Untreated control, (B-D) phorate 250, 500 and 
1000 laM. 
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Figure 66. Effect of phorate on percent transformation efficiency of plasmid 
pUC19 in competent E. coli DH5a cells. Inset shows an increase in the 
number of mutant (white) colonies with increasing concentration of phorate. 
The data points are the mean ± S.D of three independent experiments done in 
triplicate. Ct 1: untreated control, Ct 2: DMSO (1%) as solvent control. 
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Figure 67. Alkaline unwinding of phorate treated DNA. Fraction of 
duplex DNA recovered after treatment with increasing concentrations 
of phorate, and plotted as a function of DNA nucleotide/phorate molar 
ratio. The values plotted are mean ± SEM of two independent 
experiments done in duplicate. 
Table 19. Strand breaks in calf-thymus DNA by Phorate-Cu (II) complex. 
DNA nucleotide/Phorate 
molar ratio 
Control untreated DNA 
EMS treated DNA (1:10) 
1:2 
1:4 
1:6 
1:8 
1:10 
Number of breaks 
Phorate 
N.D 
7.0 
1.0 
1.5 
2.2 
2.8 
4.0 
per unit DNA (n) 
Phorate+ Cu (II) 
0.0 
N.D 
1.6 
2.8 
3.7 
4.6 
6.5 
N.D: not done. 
Table 20. Alkaline hydrolysis of phorate treated calf thymus DNA. 
DNA nucleotide/ 
Phorate molar ratio 
Untreated native DNA 
DNA+ DMSO (1:10) 
DNA + EMS (1:10) 
1:2 
O.lMNaOH 
Acid soluble 
nucleotides (|ig) 
N.D 
N.D 
173.14 
5.06 
% hydrolysis 
N.D 
N.D 
34.61 
1.02 
0.5MNaOH 
Acid soluble 
nucleotides (|ig) 
N.D 
N.D 
321.61 
15.00 
% hydrolysis 
N.D 
N.D 
61.36 
3.00 
1:4 12.58 2.50 32.00 6.40 
1:6 20.60 4.00 49.24 9.80 
1:8 73.18 14.00 120.80 24.00 
1:10 192.45 38.00 239.38 47.80 
Phorate treatment was performed in white light (20 J/m ) for 2 h. N.D: Not detectable. 
Table 21. Alkaline hydrolysis of phorate treated calf thymus DNA in presence of 100 ^M Cu (II). 
DNA nucleotide/ 
Phorate molar ratio 
Untreated native DNA 
DNA+ DMSO (1:10) 
DNA + EMS (1:10) 
1:2 
1:4 
O.lMNaOH 
Acid soluble 
nucleotides (jig) 
N.D 
N.D 
194.17 
139.90 
165.40 
% hydrolysis 
N.D 
N.D 
36.50 
27 
33 
0.5MNaOH 
Acid soluble 
nucleotides (|ig) 
N.D 
N.D 
340.28 
141.00 
216:30 
% hydrolysis 
N.D 
N.D 
68 
28 
43 
1:6 232.22 46 290.00 58 
1:8 273.58 54 318.00 63 
1:10 377.01 75 391.20 78 
Phorate treatment was performed in white light (20 J/m^) for 2 h. N.D: Not detectable. 
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identical conditions, the untreated control native DNA and DMSO treated DNA in the 
ratio of 1:10 have not shown any hydrolysis. 
3.9. Assessment of DNA damage in human lymphocytes by alkaline SCGE assay 
Exposure of human lymphocytes with increasing concentrations of phorate (10-1000 
^M) for 3 h at 37 °C has resulted in a dose-dependent increase in the comet Olive tail 
moment. Figure 68 (Panels A-I) shows a dose-dependent increase in the size of comet 
tails with concomitant reduction in head size, which clearly demonstrate the extent of 
broken DNA liberated from the heads of the comets during electrophoresis, as a function 
of phorate treatment in the range of 250-1000 fj,M. However, no comet formation has 
been observed at the 10 and 100 \iM. phorate treatments (Figure 68, Panels D and E). 
The quantitative analysis of Olive tail moment (OTM), % tail DNA and tail length 
(|im) of phorate treated cells showed significant increase at concentrations above 100 i^M 
(Table 22). The comparative analysis of the comet data obtained at phorate concentration 
of 1000 |iM vis-a-vis untreated and DMSO treated controls revealed 4.5 and 4.2-fold 
enhanced DNA migration in phorate treated cells. At 1000 |J.M concentration phorate 
showed DNA migration with an OTM value of 26.12 ± 1.97 as compared to the OTM of 
3.25 ± 0.08 and 3.72 ± 0.09 with untreated and DMSO controls, respectively. The extent 
of DNA damage noticed at 1000 jiM was found to be almost similar to the damage 
caused by EMS (2 mM) used as a positive control. The heterogeneity in the distribution 
of DNA damage among cells is shown in Figure 69. The histogram shows that 100 % of 
EMS treated cells (positive control) have OTM> 20 as compared to 91 % cells of 
untreated controls with the OTM value of 4.0. At 250 |iM concentration, the OTM values 
of phorate-treatment cells vary from 4.0 to 16.0. Around 25 % cells at this concentration 
were observed with OTM value of 10.0 and none were found to have the OTM of >20. 
The percentage of cells with OTM > 20.0 increased substantially from 7 % at 500 \iM to 
37 % and76 % cells at 750 and 1000 [iM, phorate treatments respectively. 
3.10. Micronucleus formation in phorate exposed human lymphocytes 
Phorate-induced chromosomal brealcs in human lymphocytes have been examined by 
CBMN assay. Figure 70 shows the concentration dependent increase in the number of 
^k^^ j^^^^^^^^^H 
Figure 68. Epi-fluorescence comet images of phorate induced DNA damage in human 
lymphocytes. The representative photomicrographs have been acquired through Komet 3.0 
software. (A), Untreated control: (B), DMSO (1%) as solvent control: (C), EMS (2 mM) as 
positive control: (D-I), cells treated with phorate at 10, 100, 250, 500, 750 and 1000 |jM, 
respectively. 
Table 22. Phorate- induced DNA damage in human lymphocytes analyzed using different 
parameters of comet assay. 
Groups 
Control 
DMSO (0.5%) 
EMS (2: 
Phorate 
10 
100 
250 
500 
750 
1000 
mM) 
(MM) 
Olive tail moment 
(Arbitrary Unit) 
3.25 ±0.08 
3.72 ±0.09"' 
30.52 ±3.48*" 
4.07 ±0.16"' 
5.89 ±0.44"' 
9.21 ±1.43* 
12.58 ±2 .23" 
18.30 ±1.99"* 
26.12 ±1.97*** 
Tail DNA (%) 
7.08 ±0.17 
9.27 ±0.30"' 
38.63 ±1.95 
10.03 ±0.54"' 
12.58 ±0.55** 
16.46 ±1.00*** 
19.73 ±2.08*** 
23.03 ±1.05*** 
28.13 ±0.76*** 
Tail length (|u,m) 
57.61 ±3.85 
63.03 ±5.19"' 
187.57 ±12.70*** 
74.72 ±9.95"' 
123.19 ±16.16** 
163.36 ±29.93*** 
191.86± 11.71*** 
238.08 ±19.66*** 
261.84 ±17.98*** 
Data represent the mean ± SEM of three experiments, ns = non significant; * ;7<0.05; ** 
p<0.0\; ***i7<0.001; EMS: Ethyl methanesulfonate; DMSO: dimethysulfoxide. 
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Figure 69. Effect of phorate concentrations on Olive tail moment of DNA comets. 
Percent distribution of control and phorate-treated lymphocytes is shown based on 
varying OTM values obtained in phorate concentration range of 10-1000 |iM. The 
untreated (Ct 1), DMSO (1.0%) (Ct 2) and EMS (2 mM) treated cells were taken as 
negative and positive controls. Each histogram represents the mean value of three 
independent experiments done in duplicate. 
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Figure 70. Development of binucleated micronucleated cell (BNMN) in human 
lymphocytes exposed to phorate for 24 h. Ctl: untreated control; Ct2: DMSO (1.2%) 
solvent control; Ct3: methyl methane sulphonate (MMS) 100 ^M as positive control. 
Data are the mean ± S.D of three independent experiments, * = p<0.05, ns = non 
significant. 
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BNMN cells appeared upon phorate treatment for 24 h. The mean BNMN at 50, 100 and 
200 \xM. of phorate concentrations were determined to be 11, 16.5 and 26.5, respectively. 
The mean BNMN cells with the untreated, DMSO solvent and MMS as a positive 
controls were 4.1, 5.0 and 15.3, respectively (Table 23). The level of statistical 
significance of phorate concentration performed with Tukey test started from 100 to 200 
^M (p<0.05). The NDI value determined for the phorate treated groups were 1.92, 1.89 
and 1.80 with 50, 100 and 200 |iM of phorate vis-a-vis the untreated control showed a 
NDI of 1.94. Figure 71 (A-F) shows the binucleated cells in parallel set of untreated, 
DMSO and MMS controls. The phorate treated cells stained with Giemsa stain and 
propiodium iodide are shown in Figure 72 (A-F), clearly indicate the presence of 
micronucleus in phorate treated human lymphocytes. 
3.11. Effect of phorate on mitochondrial membrane potential (A Wm) 
Change in the peak fluorescence intensities of Rhl23 of untreated and phorate 
treated human lymphocytes analyzed by flow cytometry is shown in Figure 73. A 
significant change in the A Wm of phorate treated human lymphocytes have been recorded. 
Compared to the untreated control, 24 h treatment of lymphocytes with 50, 100 and 200 
\iM of phorate reduced the Rhl23 fluorescence upto 71.18, 75.65 and 81.77 %, 
respectively (Figure 74). 
3.12. ROS generation in human lymphocytes upon phorate exposure 
Phorate induced generation of ROS in human lymphocytes have been analyzed in the 
concentration range of 50-500 |j,M. Lymphocytes cultured with phorate for 24 h have 
resulted in the enhancement of fluorescence emission spectra of DCFH-DA stained cells 
(Figure 75). The dye undergoes oxidation to yield substantial amount of fluorescent 
probe DFC, as compared to the untreated control. Considering the fluorescence intensity 
of control cells as 100 %, the phorate treated cells in concentration range of 50-500 |xM 
exhibited 17 % to 60.43 % higher fluorescence intensity of DCF, respectively. H2O2 (400 
|iM) and DMSO (1 %) taken as positive and solvent controls exhibited 19 % and 3.11 % 
higher fluorescence intensity as compared to the untreated control cells (Figure 76). 
Table 23. Effect of phorate on micronucleus formation in human lymphocytes. 
Compound 
Control 
DMSO Control 
MMS (laM) 
Phorate ( i^M) 
Dose 
0 
1.2% 
100 
50 
100 
200 
BNMN/1000 cells 
4.1 ±1.71 
5.0 ±1.58"' 
15.3 ±2.97* 
11.0±1.4r ' 
16.5 ±3.53* 
26.50 ±2.12* 
NDI 
1.94 
1.95 
1.82 
192 
1.89 
1.80 
MMS: methyl methane sulphonate (as positive control), DMSO: solvent control. ns= 
non significant, *= p<0.05, analysed by Tukey test. 
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Figure 71. Representative photomicrographs of the typical binucleated human lymphocytes 
appeared after 24 h of CBMN assay. Panels (A-C) represents 6 % Giemsa stained cells of (A) 
untreated, (B) DMSO (1%) as solvent and MMS (100 |iM) as positive controls. Panels (D-F) 
are the propiodium iodide (6 |ig/ml) stained cells of the same set of controls. Arrow indicates 
the presence of micronucleus in MMS treated cells. 
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Figure 72. Representative photomicrographs of the 
micronucleated binucleated cells appeared after 24 h of 
phorate exposure. Panels (A and B) represent 6 % Giemsa 
stained cells treated with (A) phorate 100 and (B) phorate 200 
\iM. Panels (C-D) are the propiodium iodide (6 ^g/ml) stained 
cells with similar treatment. Arrow indicates the presence of 
micronucleus in cells. 
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Figure 73. Phorate induced reduction in mitochondrial membrane potential 
{AWm). Change in the zl!Pm was measured by Rhl23, with FACSCalibur at FLl 
channel with excitation wavelength of 488 nm. MFI: mean fluorescence 
intensity. 
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Figure 74. Histograms showing Rhl23 fluorescence intensity of phorate 
treated human lymphocytes. The results are expressed as the mean ± SD of 
data obtained in three independent experiments (*p <0.05 relative to control). 
Ct 1: untreated control. 
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Figure 75. Fluorescence emission spectra of phorate treated cells showing the 
fluorescence enhancement of DCF with increasing concentrations of phorate. From 
bottom to top, curves 1-7 are: 1: control, 2: DMSO (1%) solvent control, 3: phorate 
50 ^M, 4: H2O2 (400 ^M) as positive control, 5-7: phorate 100, 250 and 500 nM, 
respectively. 
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Figure 76. Phorate-induced intracellular ROS generation in human lymphocytes 
treated with indicated concentrations of phorate for 24 h showing significant 
enhancement in DCF fluorescence against controls. Ctl: untreated control; Ct2: 
DMSO (1%) solvent control; Ct3: H2O2 (400 [iM) positive control. The results are 
expressed as the mean ± SD of data obtained in three independent experiments (*p 
<0.05, ns= non significant). 
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3.13. ELISA based quantitation of 8-oxodG formation inphorate treated ct-DNA 
Phorate-induced 8-oxodG DNA-adduct formation in ct-DNA is shown in Figure 77. 
The amount of 8-oxodG in phorate treated DNA increased with increasing amount of 
DNA analyzed by ELISA. Compared to the untreated control, a 2.3 fold higher level 8-
oxodG DNA adduct were detected in phorate treated ct-DNA. 
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Figure 77. ELISA based quantitative analysis of 8-Hydroxy-2'-deoxyguanosine (8-
oxodG) DNA adduct formation in phorate (ImM) treated calf thymus DNA for Ih 
in white light. Methylene blue (MB) ImM treated ct-DNA were run as positive 
control. 
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4. Discussion 
Phorate has been investigated for its genotoxic implications on humans as well as 
animals, however, none have attempted to quantify the extent of DNA damage and 
studied the mechanism of phorate-DNA interaction. In this study, the interaction of calf 
thymus DNA with phorate insecticide has been demonstrated by fluorescence 
spectroscopy, cyclic voltammetry and circular dichroism techniques. The fluorescence 
data revealed quenching of intrinsic fluorescence of phorate to a significant extent upon 
interaction with DNA. The results revealed the binding affinity (Ka) and the binding 
capacity (n) of DNA for phorate as 0.5 x 10^  Imole"^ and 0.9, respectively. However, 
phorate does not induce any change in the fluorescence intensities of EtBr-DNA and 
DistaA-DNA complexes (data not shown), which are known to specifically bind with 
DNA by intercalation and to the minor groove. This suggests that the quenching in 
intrinsic fluorescence of phorate upon interaction with DNA may be due to the masking 
of phorate chromophores due to surface binding, electrostatic and other weak 
interactions. Electrostatic binding is the interaction between cationic species and the 
negatively charged DNA phosphate backbone that occurs along the external DNA double 
helix and does not possess selectivity (Erkkila et al., 1999). Addition of Cu (II) to phorate 
and DNA results in formation of phorate-Cu (II)-DNA complex, which further augments 
the DNA damage mainly due to the formation of ternary complex, inducing the 
conformational changes by the local unwinding causing the loss of the helical integrity of 
duplex DNA. It is surmised that irrespective of the nature of interaction, the binding of 
phorate-Cu (II) cause perturbations in the secondary structure of DNA. 
The phorate-DNA interaction has been further validated using the low cost, easy to 
use, high sensitivity, electrochemical technique (Revenga-Parra et al, 2007). The 
electrochemical techniques have been used as a rapid and inexpensive method for the 
study of DNA interactions with different compounds including pesticides (Zhao et al., 
1999a; Kashanian et al., 2008). The data revealed that the typical quasi-reversible redox 
peaks of cyclic voltammogram of the phorate, as a small ligand, upon interaction with 
DNA and DNA-Cu (II) produced changes in the AEp and EO' values. The negative shift 
in formal potential {EO') indicated that phorate binds favorably with DNA via 
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electrostatic binding (Carter and Bard, 1989). Nonetheless, decrease of cathodic (ipc) and 
anodic (ipa) peak currents and shift of EO' suggesting the formation of a new association 
complexes such as phorate-DNA and phorate-DNA-Cu (II). Decline in the peak currents 
may be due to the imbalance in the equilibrium concentration of free phorate in solution 
owing to the presence of DNA, which induces the diffusion of phorate-DNA complex, 
and not due to blockage of the electrode surface by an adsorbed layer of DNA that could 
possibly form at the electrode surface (Zhao et al., 1999a; Kashanian et al., 2008). 
Binding of phorate with DNA have been further supported by the CD analysis. 
Phorate is optically active and thus exhibits CD spectra. Addition of ct DNA to phorate in 
the molar ratios of (1:2.5 and 1:5) exhibited substantial changes in the ellipticity values, 
which clearly suggested the structural alterations in phorate and formation of phorate-
DNA complex. Furthermore, the stoichiometric data obtained from the Job plot with the 
Cu (I) specific chelating agent bathocuproine have revealed the possibility of binding of 5 
equivalents of Cu (II) to 1 equivalent of phorate, with subsequent reduction to Cu (I), as 
Cu (I) is required for damage to biomolecules (Burkitt, 2001; Jewett et al, 1999). The 
overall interaction data reflecting spectral changes in the phorate upon binding with DNA 
and Cu (II) ions, elucidate the significance of phorate, DNA and Cu (II) interactions 
related to genotoxicity and cytotoxicity. 
The dose-dependent reduction in the survival of £. coli K-12 unequivocally suggested 
phorate-induced genotoxicity, due to cellular DNA damage as a manifestation of grossly 
perturbed structural integrity of cellular DNA. Moreover, the substantial decrease in 
percent survival of ;7o/ A", lex A" , rec A"and uvr A" mutants vis-a-vis wild-type 
counterpart implies the involvement of error-prone (SOS) repair pathway in repairing the 
phorate-induced DNA lesions. Also, the dose-dependent increase in the mutant white 
colonies with simultaneous decrease in the blue colonies served as a clear index of 
phorate-induced mutagenicity in lacZ gene. Furthermore, the brief exposure of human 
lymphocytes to varying concentration of phorate resulted in the enhancement of comet 
tail, appeared as a consequence of DNA single or double strand breaks. The reported 
studies on phorate genotoxicity in humans have many short comings and weaknesses, 
including the low number of subjects and selection bias Bull et al. (2006). It is difficult to 
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assess the association of individual pesticide exposure, as most occupations involve a 
large number of different pesticides, together with other chemicals such as co-formulants, 
which may vary greatly in their toxicity and potency. In contrast, the comet data has 
demonstrated genotoxic potential of phorate. The CBMN assay revealed significant 
increase in mean BNMN/1000 human lymphocytes upon phorate treatment, which 
corroborates well with the MN formation in phorate treated mice (Sobti et ah, 1982; 
Dhingra et ah, 1990). Since, the human lymphocytes are able to repair the DNA damage 
(Gonz'alez et al., 2003), an increase in the MN formation strongly suggests phorate 
induced DNA damage to extent beyond the error-jfree repairing capacity cellular 
machinery in Go phase of cell cycle. Several in vitro studies have also demonstrated the 
pesticides potential to induce chromosomal aberrations (Saram et ah, 1998; Ribas et al., 
1996), MN in peripheral blood lymphocytes (Saram et al, 1998; Gebel et al, 1997) and 
sister chromatid exchanges (Ribas et ah, 1996; Kevekordes et al., 1996). 
The number of strand breaks in treated lymphocytic DNA, as determined by alkaline 
unwinding assay were found to be 4.0 and 6.5 strand breaks per unit of DNA molecule 
with phorate and phorate+Cu (II), respectively. The role of Cu (II) ions in intracellular 
redox reactions and its affinity for DNA have been extensively studied (Burkitt, 1994; 
Murata et al., 1999). The intracellular phorate-Cu (II) complex formation and the Cu 
(II)/Cu (I) redox cycling in vicinity of the DNA molecule may triggers the ROS 
formation ultimately resulting in DNA damage. The intracellular ROS production as 
detected by the fluorescent probe DCFH-DA validated the phorate-induced ROS 
formation, which may be responsible for promoting oxidative stress in human subjects as 
has been reported for other organophosphorus insecticides (Ranjbar et al. 2005). 
Exposure of human lymphocytes to phorate also resulted in altering the mitochondrial 
membrane potential {A Wm), as monitored in terms of reduction in the mitochondrial 
fluorescence intensity (FLl-H) peak by flow cytometry. A noticeable shift in the FLl-H 
peaks with phorate treatment at increasing doses and the significant reduction in mean 
fluorescence intensity (MFI) suggests the perturbation of the irmer mitochondrial 
membrane, and consequent mitochondrial dysfiinction, as a result of ROS generation in 
cells (Ling et ah, 2003; Tay, 2005). Changes in the mitochondrial inner membrane 
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function are accompanied by an increase in outer membrane permeability, leading to the 
release of apoptogenic factors from mitochondria into cytosol (Kim et al., 2002). Also, 
the disruption mA¥m of cells often precedes nuclear DNA degradation (Marchetti et al., 
1996). The production of ROS upon phorate may unequivocally induce the oxidative 
stress in treated cells. Under the oxidative stress more than 20 different types of DNA 
modifications are -formed (Halliwell and Aruoma, 1991), including strand breaks and 
oxidation of sugars and bases (Fridovich, 1983; Breimer, 1990). Among major products 
oxidative damage, 8-oxodG has received considerable attention due to its demonstrated 
mutagenic potential (Ames and Gold, 1991; Moriya and Grollman, 1993; Musarrat and 
Wani, 1994). The structure of 8-oxodG, as the 6,8-diketo tautomer in the syn 
conformation, provides a basis for mispairing and DNA templates are misread both at the 
base and at adjacent positions (Kuchino et al. 1987). This has been shown to cause G to T 
and G:C-^'C:G base substitution (Cheng et al. 1992; Lin et al., 2001). The promutagenic 
8-oxodG modification is considered to be an excellent marker of oxidative DNA damage 
(Musarrat and Wani, 1994). Therefore, the level of 8-oxodG as a marker of oxidative 
damage in DNA upon phorate treatment has been measured using an in vitro 
immunoassay. The data on phorate induced 8-oxodG adducts formation clearly 
demonstrated significantly higher levels of 8-oxodG adducts in treated ct DNA. The 
mode and mechanism of interaction between phorate and the nitrogenous bases GC and 
AT of DNA has also been envisaged and proposed as schemes-I and-II (Figure 78 and 
79). 
The proposed schemes explicitly suggested the possibility of ethyl group (^ CH2CH3) 
transfer to DNA nucleotides with the development of transient activated groups during 
the formation of stable phorate-Cu (II) complex. Most likely, at neutral pH, the ethyl 
cations as (electrophiles) attack on the most preferred nucleophiles N-3 and N-1 of 
guanine, N-4 and 0-2 of cytosine, N-3 and N-6 of adenine and 0-2 of thiamine, 
respectively. The ethyl group transfer fi:om phorate may perturb the aromatic character of 
GC resulting in loss of interaction and consequent GC^AT, such lesions results in 
depurination (Drablos et al, 2004; Lin et al, 2001). The suggested alkylation could be an 
additional factor promoting phorate genotoxicity. 
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In conclusion, the data clearly demonstrates that phorate is a genotoxic insecticide 
with potential to induce damage in the hereditary material. In addition to DNA adduct 
formation, oxidative DNA damage may play an important role in phorate-induced ROS 
generation and mutagenesis. 
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1. Introduction 
The present study is focused on biophysical interaction of an organophosphorus 
insecticide phorate with human serum albumin (HSA), which plays an important role in 
drug transport and storage in vertebrates. The most important property of albumin is its 
binding ability to variety of endogenous and exogenous ligands (Carter & Ho, 1994). 
Exogenous ligands varying in structure and chemical properties bind to albumin in a 
reversible manner with low to high values of association constants (Peters, 1992; Carter 
& Ho, 1994). Binding of pesticides to plasma protein have toxicological importance, 
because plasma protein control free and active concentrations of pesticides in serum. 
Also, the binding process reduces the degree, duration and the action time of pesticides in 
body (Kragh-Hansen, 1981). Competition between xenobiotic and endogenous 
substances for binding to plasma proteins strongly affects the disposition of both 
substances with serious physiological consequences (Bertucci & Domenici, 2002). 
Phorate has been mostly studied for its toxicity in in vitro test systems, animals, as 
well as in occupationally and non-occupationally exposed humans (Sobti et al., 1982; 
Mahli & Grover, 1987; Morowati, 2001; Henderson et al., 2004; Vandana & Zzaman, 
1997; De Ferrari et al., 1991). It is regarded that phorate also induces biochemical 
changes in serum of animals (Morowati, 2001) and fishes (Jyothi & Narayan, 1999). 
However, the phorate-HSA interaction and the mechanism of phorate induced 
conformational changes in HSA have not been actively and systematically pursued. 
Unlike the drugs-HSA interaction, the reports on pesticide-albumin interaction are scanty 
(Zhang et al., 2007; Jaiswal et al., 2002; Rosso et al., 1998; Sulayos et al., 1984; Haque 
et al., 1975). Few studies have been encountered on the binding of organophosphorus 
pesticides viz. methyl parathion, paraoxon and clorpyrifos with HSA and BSA (Silva et 
al., 2004; Mourik & Jong, 1978; Sultatos et al., 1984). In this country phorate is widely 
used and farm worker apply the pesticides without any protective measures and therefore 
remained exposed to variety of pesticides which is imbibed by various routes. Most 
likely, the workers are subjected to phorate exposure, by inhalation, dermal contact and 
oral intake which may accumulate and metabolized in the body leading to interactions 
with biological macromolecules. In this stand point the interaction of phorate with HSA 
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has been investigated with the aim to understand the (i) extent and nature of interactions 
of phorate with HSA (ii) binding constant (Ka) and capacity (n) of HSA for phorate, (iii) 
phorate-induced conformational changes in serum albumin. 
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2. Materials and Methods 
2.1. Phorate-HSA fluorescence measurements 
Interaction of phorate with HSA was studied using spectrofluorophotometer. To the 
fixed amount of HSA (3 |iM) varying concentrations of phorate (51 |^ M) have been 
added to get phorate/HSA molar ration in the range of 1:17. The fluorescence 
measurements were carried out in similar way as described in section 2.1. of chapter IV. 
The excitation and emission slits were set at 3 nm each. The spectra were recorded in 
290-380 nutn range and the excitation wavelength was set at 280 nm, while phorate was 
almost non-fluorescent in this range. 
2.2. Quantitative analysis of phorate-HSA interactions 
The quantitative estimation of HSA binding affinity for phorate has been determined 
following the method of Levine (1977). The fluorescence intensity of HSA at the 
emission maxima of 340 nm in absence and presence of varying molar ratios of phorate 
(1-17) were used to determine the relative fluorescence. Considering the fluorescence 
intensity of control untreated protein as 100. The association constant {Ka) and number of 
binding sites {n) were determined by Scatchard analysis as described previously in 
section 2.2. of chapter IV. 
2.3. Site specific binding of phorate on HSA using marker ligands 
The marker ligands bilirubin and diazepam know to bind specifically at site I and site 
II on HSA molecule were used to identify the site specific binding of phorate. Reduction 
in the fluorescence intensity of HS A+phorate complex with the addition of bilirubin and 
diazepam was monitored at 340 nm. Considering the phorate-HSA complex fluorescence 
intensity as 100 %, reduction in the fluorescence intensity was calculated reflecting the 
competitive displacement of phorate by the marker ligands. 
2.4. Synchronous fluorescence analysis of phorate treated HSA 
The structural change of HSA upon addition of phorate were measured by 
synchronous fluorescence. In brief, a fixed concentration of HSA (3 |iM) was titrated 
with varying molar ratios (0-10) of phorate. The synchronous scanning was performed in 
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the wavelength range of 310 to 370 nm (J/l = 60 nm) and 280 to 330 nm (J>1 = 15 nm) at 
25±0.1°C. 
2.5. Circular dichroism (CD) measurements 
CD measurements of phorate-HSA complex formed with 0.1 and 0.2 |iM phorate 
were performed at 25 °C in a thermostatically controlled cell holder attached to a water 
bath with an accuracy of ± 0.1 °C. Spectra were collected at a scan speed of 100 nm per 
min with a response time of 1 sec. Each spectrum was the average of 4 scans. Far-UV CD 
spectra (200-250 nm) were taken at a protein concentration of 4.5 |iM with a 1mm path 
length cell. The results were expressed as mean residue ellipticity (MRE) in 
deg.cm^.dmol"^ as described previously in section 2.6. of chapter IV. 
2.6. SDS-Polyacrylamide gel electrophoresis 
Phorate induced HSA fragmentation were studied on SDS-polyacrylamide 
electrophoresis. The untreated and phorate (1 to 5 mM) treated HSA were photoexposed 
to white light for 2h and loaded on 10 % (w/v) gel according to the method of Laemmli 
(1970). The gel was run at 3 mA per well for 3 h. Staining and destaining of of gel was 
performed in the similar way as described in section 2.7. of chapter IV. 
2.7. Phorate-inducedfragmentation of serum albumin 
The colorimetric assessment of phorate treated HSA were done in the same way as 
described previously in section 2.8. of chapter IV. In brief, acid soluble amino group 
were estimated in the typical reaction mixture containing HSA (25 iJ,M) with varying 
concentrations (200-1000 \xM) of phorate photoexposed to white Ught for 2 h at 37 "C. 
The reaction was stopped with the addition of 100 ^M EDTA followed by precipitation 
with 5% (w/v) TCA. Absolute amount of acid soluble amino group was quantitated using 
the calibration curve of glycine. Absorbance was read at 570 nm and plotted as a function 
of phorate concentration. Carbonyl group estimation were done using 2,4-
dinitrophenylhydrazine reagent following the procedure of Lappin & Clark (1951). 
237 
3. Results 
3.1. Fluorescence quenching ofHSA upon phorate interaction 
Decline in the fluorescence emission spectra of HSA alone and in presence of varying 
molar ratios (1: 17) of HSA/phorate was recorded in the in the range of 290-380 nm. A 
gradual decline in the intrinsic fluorescence of HSA has been observed with the addition 
of increasing molar ratios of phorate (1-17) (Figure 80). At the highest molar ratio of a 
pronounced blue shift of about 29 nm in the emission maxima (Aem) for HSA have been 
noticed. The relative fluorescence intensities, binding isotherms and the corresponding 
Scatchard plots of Q/[B] x 10'^ vs Q for phorate is shown in the inset of Figure 81. The 
binding isotherms exhibited a concentration dependent quenching of intrinsic 
fluorescence of protein. The total percent quench at different molar ratios of phorate (1-
17) were determined to be 6.82%, 12.0%, 15.01%, 20.53%, 25.0%, 28.37%, 32.70%, 
36.97%, 39.51%, 42.07%, 44.71%, 45.53%, 47.05% and 47.34%, respectively. The 
binding constant (Ka) and binding capacity («) of HSA towards phorate were determined 
to be 0.10 X 10 Imole" and 10, respectively. 
3.2. Site-specific binding of phorate on HSA molecule 
A gradual decline in the fluorescence intensity of phorate-HSA complex was 
observed with the addition of marker ligands bilirubin and diazepam. Addition of varying 
molar ratios of bilirubin (0.25-3) has shifted the phorate-HSA complex spectra to 27 nm 
(Figure 82). However, addition of diazepam at the same molar ratios showed less 
reduction in the emission spectra of phorate-HSA complex (Figure 83). The comparative 
reduction in the initial fluorescence intensity of phorate-HSA complex with the addition 
of bilirubin and diazepam is shown in Figure 84. The % decline in the fluorescence 
intensity of phorate-HSA complex with the addition of marker ligands is presented in 
Table 24. 
3.3. Conformational analysis of HSA upon interaction with phorate 
The results of the effect of phorate on HSA as obtained by synchronous fluorescence 
spectroscopy is shovra in Figure 85. Figure 85 (A) represents the fluorescence of 
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Figure 80. Fluorescence decay in the emission spectra of HSA in absence (uppermost 
curve) and presence of increasing amounts of phorate. The spectra were obtained in 10 
mM Tris-HCl buffer, pH 7.4 at 28 °C. The molar ratios of phorate to HSA were: (top to 
bottom) 0.0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 15 and 17, respectively. Fluorescence 
decay and shift in the emission spectra is indicated by down and horizontal arrows. 
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Figure 81. Phorate-HSA binding isotherm showing relationship between 
relative fluorescence and molar ratio in the range of (1-17). Inset shows the 
Scatchard plot drawn by fitting the fluorescence quenching titration data for 
determining phorate-HSA binding parameters. 
.t 
a 
9j 
63 
O 
S 
290 380 
Wavelength (nm) 
Figure 82. Fluorescence quenching of phorate-HSA complex with the 
addition of increasing concentration of site I marker bilirubin. From top to 
bottom: HSA alone (3 nM), Phorate-HSA complex (10:1), bilirubin-HSA 
molar ratio 0.25, 0.5, 1.0, 1.5, 2.0, and 3.0, respectively. 
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Figure 83. Fluorescence quenching of phorate-HSA complex with the 
addition of increasing concentration of site II marker diazepam. From top to 
bottom: HSA alone (3 jaM), Phorate-HSA complex (10:1), diazepam-HSA 
molar ratio 0.25,0.5,1.0,1.5,2.0, and 3.0, respectively. 
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Figure 84. Decline in the initial fluorescence of HSA-phorate (1:10) 
complex with the addition of increasing molar ratios of site I and site II 
markers (bilirubin and diazepam). 
Table 24. Effect of marker ligands on the binding of phorate to HSA 
Phorate-HSA 
molar ratio 
HSA alone 
HSA-Phorate(l:10) 
HSA-Phorate (1:10) 
HSA-Phorate (1:10) 
HSA-Phorate (1:10) 
HSA-Phorate (1:10) 
HSA-Phorate (1:10) 
HSA-Phorate (1:10) 
Site 18c II Marker 
molar ratio 
0 
0 
0.25 
0.50 
1.0 
1.5 
2.0 
3.0 
*Fluorescence quenching with marker ligands 
Bilirubin (Site I) Diazepam (Site II) 
0 
0 
44.00 
48.33 
56.92 
63.54 
68.25 
76.84 
0 
0 
35.53 
37.75 
41.04 
41.83 
42.46 
44.90 
* Calculated from the fluorescence intensity of HSA-phorate complex in presence of marker ligands 
considering the fluorescence intensity of HSA-phorate complex as 100. 
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Figure 85. Synchronous fluorescence spectrum of HSA in the absence and presence 
of phorate. (A) Al = 15; (B) M = 60. (1^11) HSA (3.0 |aM), phorate: 
3,6,9,12,15,18,21,24, 27 and 30 iiM, respectively. 
245 
tyrosine residues. The response is weak as evident from the spectra with no significant 
change in the intensity as well as in the position of maximum emission wavelength at AX 
was 15 nm. However, the fluorescence of tryptophan residues AX 60 was comparatively 
higher and exhibiting a moderate shift in maximum emission wavelength (Figure 85 B). 
3.4. Structural properties of the HSA-phorate 
CD spectra of HSA with increasing concentrations (0.1-0.2 \xM) of phorate obtaining 
the molar ratios in the range of 1:0.02 and 1:0.04 have been recorded in the far-UV CD 
spectral range of 200-250 nm (Figure ^6). A concentration dependent change in the 
ellipticity value has been noticed. Significant reduction in the • MRE reflects the 
alterations in protein helicity. The percent changes in the a-helical content of the protein, 
estimated at the test concentrations are shown in Table 25. At 0.2 \xM the loss in protein 
helicity was determined to be 6.5 % with 51.2 % a helicity vis-a-vis 54.81% a-helical 
content in native untreated HSA. 
3.5. Phorate-inducedfragmentation of HSA 
Phorate-induced degradation pattern of HSA from 1-5 mM on SDS-polyacrylamide 
gel is shown in Figure 87 (A). Treatment of HSA with high concentrations of phorate in 
presence of white light triggered fragmentation as evident from the electrophorogram. 
No degradation has been noticed at concentration lower than 1 mM. Compared to the 
untreated HSA, a discernible reduction in the intensity of bands in lanes 5 to 7 were seen. 
The densitometric analysis revealed a significant loss in protein to the extent of 84.5 % at 
the highest concentration of 5 mM phorate (Figure 87 B). However, the quantitative 
spectrophotomefric assays demonstrated significant release of carbonyl and acid soluble 
amino groups from the phorate treated protein at low concentrations. The extent of HSA 
fragmentation in the concentration range of 0-1 mM phorate is shown in Figures 88 and 
89. An increase in the absorbance of red wine color developed due to carbonyl groups 
was noticed upto ImM phorate at 480 nm (Figure 88). The amount of carbonyl groups 
released was higher than the acid soluble amino groups from the phorate-treated protein 
(Figure 89). The Figure 93 also shows a concentration dependent increase in the intensity 
of purple color at 570 nm developed due to reaction of ninhydrin reagent with free amino 
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Figure 86. CD spectra of HSA at different phorate concentrations. (Curve 1) Free HSA, 
(Curve 2) phorate 0.1 |iM, (Curve 3) phorate 0.2 |iM. 
Table 25. Change in relative a-helicity of HSA upon interaction with phorate. 
Phorate-HSA 
molar ratio 
HSA (1:0) 
HSA-Phorate (1:0.02) 
HSA-Phorate (1:0.04) 
(dc 
MRE222 
ig.cm .^dmor^) 
18950 
18324 
17861 
a-helix 
54.81 
52.75 
51.22 
% 
perturbation 
-
3.75 
6.54 
66 kD 
B 
1 2 3 4 
Phorate Concentration (mM) 
Figure 87. (A) SDS PAGE of HSA showing loss of parent band with varying concentrations 
of phorate. Lane 1: 6 |ig of standard protein marker; lane 2: untreated HSA 6 |ag; lane 3: 
Phorate (1 mM) + HSA (6 ^g); lane 4: Phorate (2 mM) + HSA (6 ^g); lane 5: Phorate (3 
mM) + HSA (6 ^g); lane 6: Phorate (4mM) + HSA (6 l^g) ; lane 7: Phorate (5mM) + HSA 
(6 fig), respectively. (B) densitometric analysis of showing the loss in parent HSA band with 
increasing concentration of phorate. 
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Figure 88. Carbonyl group released from HSA treated with 
photosensitized phorate for 2 h. The data points represent the mean ± 
S.D. of three independent experiments done in duplicate. 
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Figure 89. Photosensitized phorate induced protein fragmentation. 
HSA was treated with increasing concentration of phorate for 2 h and 
the amount of acid soluble amino group quantitated. The data 
represented are mean ± S.D. of three independent experiments done 
in duplicate. 
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groups of the amino acid released from phorate treated protein. The absolute amount of 
acid soluble amino group released as a function of phorate concentration is shown in the 
inset of Figure 89. 
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4. Discussion 
The 66 kDa monomeric polypeptide of HSA is stabilized by 17 disulphide bridges 
with three homologous a-helices domains (I-III). Each domain contains 10 helices and is 
divided into antiparallel six-helix and four sub domains (A and B) (Silva et al. 2004). A 
valuable feature of intrinsic fluorescence of proteins is the high sensitivity of tryptophan 
to its local environment (Sharma and Schulman, 1999). Changes in emission spectra of 
tryptophan are common in response to protein conformational transitions, subunit 
association, substrate binding, or denaturation. Therefore, the intrinsic fluorescence of 
HSA thus provides considerable information about its structure and dynamics, and is 
often considered for the study of protein folding and association reactions (Sulkowska, 
2002). With this view point the present study has been carried out to reveal the 
conformational changes in HSA as a consequence of phorate exposure. 
The spectrofluorescence data exhibiting concentration dependent decay in the intrinsic 
fluorescence of native HSA upon interaction with insecticide clearly suggest the binding 
of phorate v^th HSA. The significant quenching of the HSA fluorescence reflects that 
the microenvironment around the tryptophan residue has changed (He et al, 2005a; Li et 
al., 2007). Addition of phorate to HSA induced a blue shift in the emission maxima 
suggestive of strong phorate binding to tryptophan residue of HSA and induced 
conformational ch ange in its native structure (He et al, 2005 a; Zhou et al, IQQl). 
Another contributing factor could be the reduction in polarity around tyrosine residue as 
reported earlier by Lehrer & Fasman, (1967) and Jin et al (2007). Phorate-induced 
conformational alterations in the native structure of HSA have also been substantiated by 
the synchronous fluorescence spectroscopy. Moderate shift of emission wavelength 
toward longer wavelength at AX, 60 along with decline in fluorescence reflects the fact 
that the microenvironment of the tryptophan residue was significantly affected by phorate 
binding. The moderate red shift suggests that phorate binds in the hydrophobic cavity, 
which perturbs the structure of HSA. This could be due to increase in the polarity around 
tryptophan residue, with the reduction in hydrophobicity (Wan g et al, 2007b). The 
quenching of the tryptophan fluorescence, clearly indicate that the conformation of the 
hydrophobic binding pocket in subdomain IIA is affected (Trynda-Lemiesz, 2004). 
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Lately, the organophosphorus insecticides methyl parathion has been reported to dechne 
the intrinsic fluorescence of HSA with the binding constant of 1.8 x 10'* M'' (Silva et al. 
2004). Competitive binding of phorate with site I markers (bilirubin) confirms the 
specific binding site for phorate at the hydrophobic pockets or near the site I within sub 
domain IIA of albumin molecule (Trynda-Lemiesz, 2004). 
In order to gain better understanding of the effect of phorate on the conformation of 
HSA, circular dichroism analysis has been performed. The CD spectra of free HSA have 
exhibited characteristic negative bands at 208 and 209 and 222-223. However, it is 
noticed from the CD spectra that the addition of increasing concentration of phorate 
distinctly decreases the band intensity at 209 and 222 nm in the far-UV region without 
any significant shift of the peaks. This clearly indicates changes in the protein secondary 
structure, in particular decrease the a-helical content of HSA. The calculated results 
exhibited a reduction of a-helix structures from 54.81 to 51.22 % at the highest molar 
ratio phorate/HSA 1:0.04. Similar changes in the native conformation of HSA have been 
reported for the binding of drug to HSA (Trynda-Lemiesz, 2004; He et al, 2005a). As 
can be seen from the electrophorogram phorate induces fragmentation of the treated HSA 
at the high concentrations of 3-5 mM. The possible.explanation for the fragmentation 
phorate treated HSA is the hydrolysis of protein, thus producing indistinct random, 
fragments (Hawkins and Davies, 1999). Nonetheless, effect of low concentrations of 
phorate on HSA fragmentation has been fiirther validated by the spectrophotometric 
analysis of carbonyl and acid soluble amino groups. At the highest concentration of 
phorate (1 mM) the absolute amount of carbonyl and acid soluble amino groups released 
from the HSA were determined to be 215 and 3.6 |j,M, respectively. The 
spectrophotometric data fiirther confirms phorate induced HSA fragmentation at even at 
low concentration. Fragmentation of HSA may have occurred due to the availability of 
free lone pair of electrons on the tryptophan and tyrosine residues. This may act as a 
nucleophile to attack phorate, thus releasing the methyl cation (^CH2CH3). The "''CH2CH3 
thus alkylate the aromatic residues and facilitates the release of amino acids from the 
HSA (Figures 90 and 91). 
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